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This work focussed on synthesis of polyamine ligands by functionalisation of a linear hexamine 
starting material with 1,8-naphthalic anhydride to create two naphthalimide groups. This ligand 
was designed to be incorporated into a heterodinuclear redox-activated prodrug complex of 
cisplatin and cobalt. The naphthalimide groups were intended to block associative ligand 
exchange on the platinum centre that would otherwise result in premature release or 
inactivation of the prodrug. 
Reaction of the impure 3,6,9,12-tetraazatetradecane-1,14-diamine starting material with 1,8-
naphthalic anhydride gave a complex mixture of products, including branched and piperazine 
compounds and trinaphthalimides. Efforts were made to separate the desired linear 
dinaphthalimide product from the side products using a process of purification by complexation. 
This purification strategy relied on the desired compound and its complex having different 
properties to any side products that might lead to their separation. The copper can then be 
removed from the separated complex using EDTA to recover the desired dinaphthalimide ligand. 
Throughout this process, the copper complex of the dinaphthalimide ligand was successfully 
synthesised and followed by copper removal. This process led to enrichment of the desired 
ligand material in the reaction fractions following removal of copper with EDTA. 
Attempts were made to synthesise cobalt complexes from the dinaphthalimide ligand containing 
mixtures. ESI-MS evidence was obtained for both the [Co(C34H36N6O4)CO3]+ and 
[Co(C34H36N6O4)(NO2)2]+ complexes. Additionally, a deprotonated ligand cobalt complex was 
observed by ESI-MS. 
Structural elucidation of a copper complex of a trinaphthalimide ligand was also performed 
based on crystallographic data. The trinaphthalimide ligand was synthesised from a branched 
isomeric impurity in a new hexamine starting material, 3,7,10,14-tetraazahexadecane-1,16-
diamine. The crystal structure showed the copper centre was also coordinated to a sulfate anion 
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Fas/FAS receptor: Death receptor on the cell surface that is implicated in the apoptosis process  
 
G0, G1, S, G2: Terms for the phases of the cell cycle. G0 is the ‘resting’ phase adjacent to the 
cycle where the cell spends the majority of its life and performs its usual functions. G1 is where 
the cell begins to ready for DNA replication by increasing in size and number of proteins. S phase 
is where the cell replicates DNA. G2 is the phase where the cell will begin to produce proteins to 
allow the cell to divide, ready to progress into the following mitosis phase. 
HMG Proteins: High Mobility Group Proteins. These proteins are regulators of transcription. 
PAH: Polyaromatic hydrocarbons. 
VEGFR Kinase: Vascular Endothelial Growth Factor (VEGF) Receptor (VEGFR). Kinases related 
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It is reported that the global cancer burden amounts to 9.6 million deaths annually, making it the 
second largest cause of death worldwide, with 18.1 million new diagnoses in 2018.1 Despite 
being an illness that can affect any person, socioeconomic status and cancer are closely linked.2 
It is estimated that 70% of cancer deaths are among those in lower socioeconomic groups, 
implying that treatment success relies not only on the efficacy of the regime but also upon the 
cost.3 Unfortunately, the global cost of cancer is rising every year along with the growing number 
of diagnoses.1 This is attributed to both the growing population as well as the development of 
many nations – many of the risk factors for cancer development are associated with 
modernisation and industrialisation, both of which are largely shouldered by less privileged 
socioeconomic groups in richer nations.2  
Cancer is a disease characterised by the uncontrolled proliferation of cells. This proliferation 
results in increased density of cells, termed a tumour.3 These cells do not function in the way of 
a healthy cell and this, combined with the growing tumour, causes detrimental impacts to the 
tissue or organ in which they reside. Over time, the cancer impairs the function of the organ 
resulting in failure. Cancers can also metastasise, spreading from the affected organs to others 
through release of cancerous cells from the tumour into the bloodstream. The deadliness of 
cancer is due to this impact on the organs and the spread to other organs through metastasis.3  
Cell division is essential for life and is usually a tightly controlled process involving various 
enzymatic pathways.4-6 Cell division is regulated by the cell cycle which determines progression 
through the life cycle of a cell.4 Most of the life of a cell is spent in a resting phase, noted as the 
G0 phase (Figure 1.1).4 During this phase, the cell is technically adjacent to the cell cycle, in a 
state that allows it to perform its usual activities. The cell re-enters the cell cycle by entering 
interphase once it begins to ready for replication.4 Interphase consists of three stages, G1, S and 
G2.6 The G1 phase prepares the cell by ensuring all required resources are present and is 
distinguished by an increase in cell volume.6 The S phase follows, representing the point during 
which DNA is replicated, creating a second complete set of DNA.5 The cell then proceeds into the 
G2 phase, where the DNA and the cell are both prepared for division before the cell enters 
mitosis.6 During this short phase, the two copies of the DNA are separated and the cell begins to 






Figure 1.1: The cell cycle, showing relative durations and the important changes associated 
with each phase.4-6 
Before proceeding to each phase of the cycle, the cell must pass through checkpoints to ensure 
that the current phase is complete.4-7 These checkpoints consists of cell signalling pathways, 
involving cyclins, cyclin dependant kinases and other more specialised checkpoint proteins.7-8 
These proteins are initiated by key biomolecules used as indicators of the cells readiness to 
progress to the next phase – presence of these molecules indicates the cell has been fully 
prepared by the current phase.7 These checkpoint proteins then begin a cascade that progresses 
the cell into the next phase.7 
This process attempts to limit the opportunity for something to go wrong. The more checkpoints 
there are along the way, the more likely it is that a potential problem with the cell will be 
identified leading to controlled apoptosis.7 However, despite this, the complexity of the system 
also creates more points at which something could go wrong. Issues with replication that are not 





healthy to cancerous.7-12 Damage to any of the biomolecules involved in replication can cause a 
cell to become cancerous, begin to proliferate in an uncontrolled manner, and form a tumour. 
The tightly controlled cell cycle process has evolved as it minimises the opportunity for DNA 
damage. In fact, it is commonly agreed that the incidence of cancer due to carcinogens is 
dependent on two factors – the presence of the carcinogen, and the opportunity for this to 
affect the cell.13-14 Most cells that become cancerous are believed to do so through damage to 
DNA above all other biomolecules, which is reinforced by the fact that the vast majority of 
identified carcinogens act on DNA.3, 11, 15-16 DNA is at its most vulnerable during replication or 
during transcription of proteins, as in both cases DNA goes from double stranded, with bases 
protected by backbones, to single stranded.4 During the G0 phase, DNA is in a state termed 
chromatin.4 This chromatin is wrapped around histone proteins, which act to protect the DNA 
both by tightly bundling the DNA around themselves and also through the association of other 
protection proteins to the complex.4, 6 When undergoing transcription, a section of the DNA is 
unzipped and the gene copied. Damage done to the DNA during this state may be able to be 
rectified prior to the next use of the DNA and biomolecules – many enzymes are designed to 
identify the resulting lesions of DNA and associated cell machinery caused by xenobiotics.4-6 In 
the case of replication, the DNA is unwound and replicated from multiple sites simultaneously 
and over a longer duration, and the opportunity for damage is much greater.4, 17 It also holds 
true that damage sustained during this time may not have time to be repaired before the cell is 
preparing to divide. The presence of the second strand can mean that damage such as 
mismatches can be identified and replaced with the correct base through pairing to the existing 
correct one in the second strand. This mismatch repair mechanism may allow for damaged bases 
through carcinogens to be found and replaced in the process.6 Cells that are not prepared to 
divide due to unrepaired DNA damage are sent down the controlled apoptosis pathway, a 
response that has no doubt evolved due to the need to prevent cancer. Unfortunately, this 
process does not always work as intended so when a carcinogen is present and there is an 
opportunity for it to affect DNA, rather than the cell repairing this damage or entering apoptosis, 
it may instead become cancerous or reproduce to form a cancerous daughter cell.  
There are many physiological differences between healthy cells and cancerous cells aside from 
the distinctly different rates of proliferation. Often the cancerous cells have different levels of 
various proteins to their healthy cell counterparts, either as a direct result of the initial cause of 
the cancer or through indirect mechanisms due to the resulting dysfunction of the cell.9, 18-21 A 
further difference relates to the cell oxygenation state. This is normally a closely monitored 





modifications of the proximal oxidation environment in order to function.4 Cancer cells, 
however, are often hypoxic due to their rapid proliferation.9, 22 Under standard conditions, 
development of more tissue also requires formation or extension of blood vessels to provide 
nutrients and oxygen to the cell and to remove waste products. Cancer cells often replicate too 
quickly to allow full formation of this vasculature, instead forming a dense tumour. Some cells in 
the centre of this tumour are far from the blood oxygen supply and therefore have much less 
oxygen than is typically allowed for a cell, leading to changes in the cells redox state.9, 22 
A further issue with cancer involves metastasis or the development of secondary cancers, which 
can occur through a few primary routes. Firstly, tumour cells are often loosely held together due 
to the rapidity of their proliferation rendering them unable to properly bind together.6 These 
cells can easily become detached from the tumour and travel to other areas of the body through 
the bloodstream.4 The detached cell can then implant elsewhere and begin to proliferate again, 
causing the development of a new tumour. Another method for secondary cancer development 
is through chemotherapy itself. Anticancer drugs are often carcinogenic through their 
mechanism of action, so while taking these medications may treat a patient’s cancer, they may 
also result in further cancer development in future. These secondary cancers occur on average 
fifteen years after the initial treatment.23 
Anticancer agents come in many forms which are often targeted to the specific form of cancer 
they treat. Their effects are wide ranging but primarily impact on biomolecules that are critical 
for cancer cell physiology, but less critical to healthy cells, or biomolecules that are more likely to 
be affected in cancer cells than healthy cells.13, 24 This makes DNA a primary target for anticancer 
agents.13-14 Binding to DNA and preventing replication is likely to impact cancer cells far more 
than healthy cells due to the proportion of time each spends in replication. Similarly, critical 
proteins such as topoisomerase25 or permeability glycoprotein26 (which is involved in efflux of 
drugs in multidrug resistance27) can be the targets, either because they are not present in most 
healthy cells or because they are present in much greater quantities in cancer cells. These can 
even be targeted to the specific cancer, such as vascular epidermal growth factor receptor 
(VEGFR) kinase inhibitors which are used for renal cancers15. Chemotherapy usually involves a 
combination treatment regime including both medications and methods such as surgery to 
remove large tumours.13 
Unfortunately, anticancer agents have drawbacks. The fact that they target biomolecules makes 
them largely carcinogenic, which means they have ability to cause secondary cancers.9, 11 Many 





required to get anticancer properties, however, even those that pass clinical trials have toxic 
impacts on the body.11, 28 Nephrotoxicity is of particular concern as kidneys are affected during 
the excretion of medications and therefore can be exposed to high concentrations.9, 29 
Neurotoxicity is also of concern, as degradation of brain and nerve cells by these medications is 
irreversible due to the lack of regeneration of these cells.9-10, 30 
Despite decades of ongoing research, the elusive ‘cure’ for cancer has not been discovered. 
Many have hypothesised8, 10, 15, 31 that the nature of mitotic replication inherently links humanity 
to cancer; without completely changing the basis by which cells propagate we can never 
completely eliminate cancer development. Instead, the focus has shifted towards improving our 
therapeutics to allow for more effective and efficient treatment regimens resulting in fewer 
detrimental side effects. Many advances have been made in this direction9-10, 15, 30, 32-35, and the 
focus of my research is to make further developments through the improvement of an existing 
anticancer drug by increasing its selectivity. 
1.2. Intercalating Agents  
DNA intercalators are compounds with the ability to associate with the DNA by inserting 
between two pairs of bases in the DNA ladder, deforming the DNA and occasionally resulting in 
modification to the bases, including frameshift mutageneses.5, 36 They can also inhibit many 
central dogma enzymes by competing for interaction with the DNA. This results in many 
biological impacts, including mutation, inhibition of cell growth and cell death, making 
intercalators a major class of carcinogen.36 
Intercalation is usually achievable due to the presence of extended aromatic systems that allow 
for π stacking with the bases.37 π stacking involves stabilisation from the interaction of 
temporary and induced dipoles, also described as dispersion forces.38 This interaction is 
important biochemically to stabilise both folding of proteins between aromatic amino acids and 
to stabilise nucleic acid strands through stacking between pairs.39 π stacking between two 
benzene molecules amounts to 10 kJ mol-1, which is easily overcome and therefore only imparts 
a small amount of stability.38 However, heteroatoms increase the stability and in the case of DNA 
the interaction can amount to 40-70 kJ mol-1 depending on the order of the bases, the strongest 
interaction being between guanine-cytosine stacks.40  
Intercalating agents are able to form relatively stable reversible interactions with DNA by 
inserting between bases and stacking with the aromatic bases.37 Many therapeutics already 





are designed to function by stabilising the DNA-intercalator-topoisomerase II ternary complex 
that forms when the DNA replication process is hindered by intercalation.8  
The degree of intercalation of these agents can be determined using viscosimetry 
measurements, wherein the viscosity of DNA can be measured before and after the addition of 
intercalating agents.34, 36 This is because the intercalation disrupts the stacking and the result is a 
drop in the degree of rotation the DNA would normally undergo for that step of the DNA, 
essentially unwinding the DNA at each intercalated step. This results in a change of viscosity, and 
this combined with the concentrations of both DNA and intercalator can determine the 
intercalative ability, and therefore efficacy, of an intercalating drug candidate.36 
1.3.  Cisplatin 
Cisplatin (Figure 1.2), or cis-diamminedichloridoplatinum(II), was discovered to be an anticancer 
agent thanks to electrochemical research performed on microorganisms.48 Microorganisms 
elongated throughout the experiment due to their inability to replicate, and a platinum 
compound was found to be the cause.49 Platinum electrodes were chosen due to their near-inert 
nature, however, trace amounts of platinum compounds including one with two ammonia and 
two chloride ligands. could be identified in the solution. The presence of the cisplatin complex 
was discovered to integral to causing the disrupted replication.50 Interestingly, the cis isomer of 
diamminedichloridoplatinum(II) is active against cancer while the trans isomer is not. This is due 
to the mechanism by which cisplatin results in the induction of cell death. 
  
Figure 1.2: Cis- and trans- platin (diamminedichloridoplatinum(II)). 
Cisplatin is sparingly soluble in aqueous environments due to the overall neutral charge, and it 
must be administered intravenously as the low solubility precludes absorption into the blood if 
taken orally.9-10 The active forms of cisplatin are the aquation products that form upon entry to 
the cell – chloride ligands are displaced by ligand exchange for water, coordinating through the 
oxygen atom (Figure 1.3). The blood concentration of chloride ions is around 100 mM whereas 
the cellular concentration ranges from 3 to 20 mM, and the substantial drop in concentration 
makes the aquation of platinum more thermodynamically favourable.30 This process is 
considered essential for the subsequent efficacy of cisplatin, as the aquation products 





negatively charged DNA backbone. These complexes are then able to react with the nitrogenous 
guanine and adenine bases of the DNA ladder.30 The positive charge on the complex also makes 
it more soluble in the aqueous cell environment, increasing the bioavailability.9 
 
Cisplatin is the active geometry of the complex due to its ability to form multiple kinds of 
intrastrand adducts to DNA, while trans can only make interstrand crosslinks. The adducts 
between adjacent guanine and/or adenine residues are the most efficient form of causing 
 
Figure 1.3: An example of cisplatin aquation to the diaqua product, and subsequent 





cytotoxic DNA lesions, meaning the trans form is inactive as the geometry renders it incapable of 
forming such intrastrand crosslinks.9, 51 Formation of the intrastrand crosslink results in 
cytotoxicity due to the formation of even larger DNA lesions, which consist of the DNA strand, 
the cisplatin adduct and various replicative machineries.9 Enzymes such as helicase and 
topoisomerase that are involved in DNA replication or repair are inhibited by the lesion of the 
cisplatin DNA adduct, either through the direct action of cisplatin on the enzyme or due to the 
kinked nature of the DNA around the adduct, or a combination of the two.9 Topoisomerase II is 
the enzyme responsible for relieving supercoiling in the DNA due to the process of unwinding by 
DNA helicase during replication. In order to perform their role, both enzymes move along the 
DNA double helix, helicase unwinding as it goes and topoisomerase II occasionally nicking the 
strand to allow the supercoiling to release before reforming the bond.6 When encountering the 
cisplatin adduct, these enzymes are unable to move further along the strand, causing a DNA 
lesion to develop.10 It has recently been deduced that topoisomerase II is also directly inhibited 
by cisplatin. Cisplatin in the adduct can bind to sulfur atoms in key residues of many proteins 
including topoisomerase, resulting in inhibition as it is no longer able to perform its catalytic 
activity.  
Cisplatin within the adduct also interacts with other biomolecular targets in addition to DNA, 
including cell signalling caspases and High Mobility Group (HMG) proteins.10, 51 HMG proteins 
compete with histones (the proteins that bind DNA to protect it while inactive after replication), 
preferentially binding single stranded DNA to prime and protect it in an optimised state for 
transcription. It has been found that HMG is able to bind to cisplatin adducts due to sulfur atoms 
of cysteine residues (Figure 1.4).10 This allows the HMG protein to contribute to the formation of 
DNA lesions through direct interaction with cisplatin adducts. Interestingly, the HMG proteins 
have low binding affinity for transplatin.9 It is also reasonable to propose that the HMG protein 
may be involved in delivering the cisplatin moiety to the DNA, by binding to cisplatin, associating 
with DNA, then allowing cisplatin to bind to the DNA. The reason why the HMG protein is able to 
associate with cisplatin even once cisplatin is already bound through two bonds to DNA is due to 
the ‘softness’ of the sulfur donor atom.9 Platinum and sulfur are both soft atoms, whereas 
oxygen, nitrogen and even chloride are hard donor atoms. Despite the strong interaction of 
platinum with its nitrogen donor atoms from the DNA and ammonia ligands, sulfur atoms of the 
HMG cysteine residues are still able to displace a nitrogen to bind to the adduct, adding to the 
formation of the cytotoxic lesion. It has been shown that this interaction prevents the cell from 
being able to repair the adduct by removing cisplatin and is therefore important for the efficacy 






Figure 1.4: Crystal structure showing the DNA kink by movement of guanine residues out of 
alignment by cisplatin adduct formation. Note: platinum is shown silver, not burgundy, to 






Figure 1.4 (continued): the same crystal structure showing the association of an HMG 
protein to the DNA adduct.51 
Cisplatin has also been implicated in cell death processes through interactions with other 
biomolecules. Cisplatin is known to interact with caspases and cyclins directly and indirectly 
through a complicated network of other proteins, resulting in the initiation of controlled cell 
death pathways.9-10 Caspases are proteases generally responsible for regulating the induction 
and execution of apoptosis and have roles in the transduction of some phases in the cell cycle, 
whereas cyclins are primarily responsible for modulation of the cell cycle and signalling the 
transition between phases.6 It has been shown that inhibition of caspase proteins prevents 





involved in the activation of various initiator and executioner caspases52. Initiator caspases are 
involved in induction of apoptosis by activation of downstream caspases through the cascade of 
tumour necrosis factor through the FAS receptor, then procaspase-8 to cleave and therefore 
activate the downstream caspases.7 These include the executioner caspases that are responsible 
for cleavage of various biomolecules, notably some DNA repair enzymes, an inhibitor that 
prevents DNA digesting caspases from acting, other nuclear proteins, and cytoskeletal proteins. 
Studies on various cell lines have shown that cisplatin treatment results in an increased presence 
of these caspases. The exact mechanism for this is not understood and is believed to be through 
direct binding to the caspases as addition of peptide caspase inhibitors precluded cisplatin 
induced activation, however, caspases have somewhat ambiguous binding sites making this 
difficult to confirm.52 The combination of cisplatin activation of executioner caspases, reducing 
cellular levels of DNA repair machinery and initiator caspases to initiate apoptosis, contribute to 
the way cisplatin causes cell death. 
These cisplatin mechanisms of apoptotic induction along with DNA binding are inherently 
selective for cancer cells, as cell death is primarily reliant on the cell entering the replicative 
phase of its cell cycle.7 Cancer cells are known to replicate at a much greater rate on average 
than healthy cells, which spend as little as ten percent of their lifespan replicating.5 In addition, 
cells have repair mechanisms to remove molecules bound to DNA to prevent cytotoxic effects.5 
As healthy cells replicate much less frequently than cancer cells, there is more opportunity for 
adducts to be found and removed before the cell begins replicating. Cancer cells are therefore 
more likely to be affected than healthy cells. 
Unfortunately, despite this level of selectivity, healthy cells are still able to be affected by 
cisplatin treatment.9, 11 Any cells that replicate quickly, including those involved in the 
production of stomach mucus and follicular cells, will be heavily impacted by treatment.9, 11 This 
is responsible for the characteristic chemotherapy side effects from cisplatin; hair loss and 
digestive disorders including nausea.53 Other detrimental effects have also been reported as a 
result of cisplatin therapies, including organ toxicity, resistance and secondary cancers.9  
Cisplatin has been associated with specific organ toxicities that result in a lower applicable dose. 
Arguably, the most severe is the impact on kidneys – cisplatin accumulates in the kidneys due to 
excretory processes. Cisplatin is also associated with ototoxicity through apoptosis of auditory 
sensory cells, neuropathy and gastrointestinal toxicity.9 The continued accumulation results in 
the death of cells in these systems, and the cisplatin induced apoptosis that is essential for 





the dose at which toxicity is observed, but at a high enough dose to result in anticancer 
efficacy.11 This impact is not unique to cisplatin - it affects all anticancer agents and poses a 
challenge that all new chemotherapeutics must overcome to enter clinical use. 
Resistance to frontline drugs is also a major and developing issue in cancer treatment and has 
been observed in the cisplatin family of therapeutics.9 Some forms of resistance are inherent 
due to an inability of the cancer cell to interact with cisplatin as expected, reducing its efficacy. 
An example of this is through slight mutation of caspases, which does not affect their standard 
activity but does prevent them from recognising cisplatin adducts and therefore prevents the 
cisplatin adduct from inducing apoptosis as expected.9  
Other forms of resistance occur in an example of natural selection – cells that happen to 
produce a protein that reduces their susceptibility to cisplatin have a higher rate of survival than 
other cancer cells. These cells then reproduce, forming a tumour of resistant cells. An example 
of this can be seen through glutathione induced resistance.9, 18-19, 21 Glutathione is a tripeptide 
(Glu-Cys-Gly) involved with maintenance of cell oxidation state through the equilibrium of 
glutathione with its dimerised form. The monomeric form of glutathione can act as an 
antioxidant and heavy metal binding agent, preventing damage from these species.19 Thiol 
groups, such as the cysteine side chain, can act as reducing agents and react with oxidants in the 
cell. Two molecules of glutathione can be oxidised to form a dimer, donating an electron in the 
process to reverse oxidation processes in the cell.18-19 This dimer can also be reduced back down 
to the monomeric form.6 Glutathione is integral for maintaining cellular redox state through the 
ratio of free versus dimeric glutathione.5 Cancer cells that are already higher in glutathione are 
able to develop resistance to cisplatin as the increased glutathione has been shown to reduce 
cytotoxicity of cisplatin.18  
One of the proposed mechanisms involves increased efflux of cisplatin through xenobiotic 
transporters, many of which use glutathione as a substrate.19 Glutathione-cisplatin conjugates 
have been observed in leukaemia cells – the thiol group of cysteine serves as an excellent ligand 
donor atom for soft metals, which is why glutathione is effective in removal of heavy metals.19 A 
second route is through cytoprotection, as increased presence of mRNA associated with 
enzymes responsible for glutathione synthesis was found in cells exposed to cisplatin, however, 
a direct mechanism has not been elucidated to date.19 
One way in which many of these detrimental and dose-limiting side effects can be overcome is 
through increased selectivity, whereby cisplatin can differentiate between healthy and 





treatment times and thus reducing cost, both economic and emotional, of treatment. This could 
be achieved through coupling of cisplatin to a compound that has the ability to detect whether it 
is in a healthy or cancerous cell through exploitation of an innate physiological difference 
between the two. This project focusses on the use of cobalt to achieve this goal. 
1.4.  Cobalt 
Cobalt is a transition metal of the first series with the electronic configuration [Ar]4s23d7. Cobalt 
exists predominantly in sulphide ores, and when mined from these ores it is often produced 
alongside nickel. As a transition metal, it has the ability to exist in multiple oxidation states 
based on the loss or gain of these 4s and 3d electrons.54 The most common oxidation states are 
the 2+ state and the 3+ state, however, cobalt can exist in the 3-, 1-, 1+, 4+ and 5+ states in 
some rare compounds. The 2+ state occurs when the two 4s electrons are lost, and the 3+ state 
once a 3d electron is then also lost.54  
An interesting feature of the 2+ and 3+ oxidation states is their vastly different labilities. Lability 
is defined as the speed at which the replacement of a ligand for another occurs.54 Co2+ is labile, 
rapidly exchanging its ligands on the order of milliseconds whereas Co3+ is defined as inert, 
replacing its ligands very slowly on the timescale of minutes to hours.54 In fact, many syntheses 
of Co3+ complexes take advantage of the higher lability of Co2+ by first synthesising the analogous 
Co2+ complex before oxidising it to Co3+.55 The difference in lability is related to the electronic 
structure of the ions in complex. As cobalt is an octahedral metal centre, ligand field theory 
suggests that lability is related to the occupation of the eg orbitals - metal centres with occupied 
or partially occupied eg orbitals are labile, whereas those with unoccupied eg orbitals but full or 
near full t2g orbitals are inert. This holds true for cobalt; Co2+ has seven 3d electrons, six in the t2g 
orbitals and one in the eg orbitals while Co3+ has six 3d electrons, all of which are in the t2g 
orbitals.54 
The ability to exist in these two oxidation states gives cobalt the ability to act as an agent to add 
selectivity to cisplatin. Co2+ complexes are labile and therefore easily exchange their ligands, 
whereas Co3+ complexes retain their ligands. The reduction from Co3+ to Co2+ could act as a 
targeted delivery system, utilizing this lability difference to allow for selective release of a 
cisplatin moiety in cancerous cells and not in healthy cells.56 This could be done through 
exploitation of the inherent physiological difference in oxidation state between the two cells. A 
Co3+ complex of the cisplatin moiety would remain mostly intact in the homeostatic oxygenation 
state of a healthy cell, either remaining oxidised or experiencing rapid re-oxidation upon 





centre would be reduced to Co2+ and is not likely to be re-oxidised before it releases the active 
cisplatin agent. 
1.5. Dinuclear Complexes 
In order to use cobalt as a redox sensor for selective cisplatin release, the platinum and cobalt 
centres must be linked. These complexes are termed heterodinuclear as there are two centres 
that differ from each other linked through bridging ligands.57-63 Dinuclear complexes in general 
were first extensively proposed by Werner and were based around the action of a metal centre 
in a coordination complex as a Lewis base and interacting with another metal as a Lewis acid.63 
This can occur due to coordinative unsaturation in the case of the coordinating metal, which iis 
observed in many examples of platinum dinuclear complexes.63 Dinuclear complex formation 
can be encouraged using polydentate linear ligands. Indeed, many examples can be seen where 
a soft metal binds through the soft sulfur donor of ambidentate thiocyanate while a hard metal 
centre coordinates to the hard nitrogen donor atom.63 Many of the first synthesised 
heterodinuclear complexes exploited this motif.63 Complexation is also possible through direct 
metal-metal bonds, which is beyond the scope of this project.63 
In many cases, it is favourable to form the dinuclear complex using complexes of each centre 
with the ligands intended to be used as bridging ligands. Stable dinuclear complexes of cobalt 
and platinum are already known, and hydroxide bridging ligands appear to favour formation.62 
Synthesis of the intended dinuclear complex should be attempted through synthesis of both the 
platinum and cobalt(III) complex with diaqua or aqua/hydroxide ligands before attempting to 
synthesise the dinuclear complex. This should also reduce the number of products formed as 
there are fewer combinations possible; whether a ligand leaves the cobalt or platinum 
coordination sphere to allow for complexation the result should be the same.  
Aqua or hydroxide cobalt amine complexes are not usually synthesised directly, rather 
synthesised from a cobalt amine starting material that allows for replacement of ancillary ligands 
for the aqua or hydroxide ligands. There is a range of ancillary ligands that can be used to 
perform this function. 
One of the ligands that can be displaced for aqua is nitrite, NO2-.64 This ligand exchange reaction 
proceeds through protonation to the nitrite by acidification, resulting in NO+ and OH-.65 The 
reaction produces the OH- side product, and additional acid will be required to perform the 
ligand exchange as some will react with the nitrite ligand and some with the hydroxide 





mixture may change colours as the coordination sphere goes from having nitrogen to oxygen 
donor atoms. If the nitrite ligand is bound using the oxygen donor atom, the reaction 
progression may be difficult to track through colour alone. The solubility of the complex may 
also change as each nitrite ligand replaced with an aqua ligand will increase the charge on the 
complex by one. 
Carbonate ligands are also able to be displaced through the reaction with acid.64, 66 In this case, 
the carbonate is decomposed by the acid to form CO2 and water. Again, two equivalents of acid 
will be required per carbonate, however, as the carbonate is bidentate this will likely require less 
acid for the overall process to occur than for the nitrite ligand. The carbonate binds through 
oxygen donor atom, as does the aqua ligand, therefore the colour change of the reaction is not 
likely to be useful in tracking reaction progression. The reaction produces gaseous CO2, which is 
a useful indicator of the reaction progression as effervescence will be observed while the 
degradation of carbonate is still occurring. The charge will again change during the exchange, 
increasing by two for every carbonate displaced which may have an impact on the solubility of 
the complex. Carbonate has an additional benefit when used in this way in that it is a bidentate 
ligand. This means that when it is decomposed, two cis donor sites will be replaced with aqua 
ligands to produce the aqua complex.67 This makes it more likely that the product formed will be 
the cis product, unless the other ligands allow for isomerisation. By contrast, the trans isomer 
would be possible for the nitrite complex. Carbonate complexes are often used in this manner to 
encourage cis aqua ligands as well as to reduce the number of isomers produced by the initial 
ligand exchange.64 
In order to displace the intermediate ligand in favour of an aqua ligand, which is a poor ligand 
that is easily displaced, an acid with a sufficiently non-coordinating conjugate base must be used 
to prevent complexation of the conjugate base instead of the aqua ligand. Triflic acid can be also 
be used – the triflate anion may coordinate to the vacant donor sites yet is sufficiently labile that 
is can be replaced with an aqua ligand either following isolation of the triflate species or by 
performing the reaction under aqueous conditions.64, 68 
Halide ligands can also be displaced in favour of aqua ligands in transition metal complexes.62 As 
opposed to treatment with acid, this ligand exchange is usually performed using silver. The silver 
addition results in precipitation of the insoluble silver halide salt, and the halide ligand is 
replaced by an aqua ligand. This process is also dependent on the use of silver salts with non-





ligand. Silver nitrate can be used for this purpose, due to the potential for perchlorates to form 
explosive compounds, but the nitrate anion is a ligand, albeit a poor one. 
1.6. Rationale behind Ligand Design 
The dinuclear motif has been synthesised by a previous student working in the Hartshorn group 
(Figure 1.5).62 This was achieved using polydentate amine or polycarboxylate ligands, with a 
hydroxide ligand and an aqua ligand to create the cobalt(III) and platinum centres. These centres 
could then be reacted to synthesise the dinuclear complex.62 Unfortunately, the resulting 
complexes were either unable to be isolated due to high solubility (Compounds 1.5.1, 1.5.2, 
1.5.3, 1.5.4 below), or unable to be fully characterised due to their very low solubility 
(Compounds 1.5.5, 1.5.6, 1.5.7 below) (Figure 1.5). The latter compounds were insoluble in all 
solvents attempted barring dimethyl sulfoxide (DMSO), which resulted in reaction. The sulfur 
atom of DMSO provides a soft donor atom that can interact with the soft platinum centre.62 As 
the platinum centre is square planar, it can undergo associative ligand substitution.54 Associative 
substitution occurs through the new ligand binding to the metal centre before the outgoing 
ligand leaves. As this mechanism occurs through a higher coordinative intermediate, it is 
favoured by geometries with lower coordination numbers, including square planar.54 In this 
manner DMSO can interact with the platinum centre through an associative mechanism and 
result in decomposition of the dinuclear complex.  
These unintended interactions are predominantly possible due to the square planar geometry of 
platinum centre encouraging associative ligand exchange and the subsequent degradation of the 
dinuclear complex. To overcome this issue, this research focusses on surrounding the platinum 
centre with pendant groups to physically hinder this process. These groups should be attached 
to the cobalt centre to prevent loss of cisplatin functionality (so this functionality can be 
restored once released from the cobalt centre) and should be sufficiently large to prevent 
interaction of the platinum centre with the surroundings. Ideally, the pendant should contain 
only functional groups with poor coordinative ability to prevent them coordinating the platinum 
centre. 
The proposed motif (Figure 1.6) involves using naphthalimide groups to perform this role, 
attached to a polyamine ligand coordinated to the cobalt centre. The naphthalimide candidate 
fulfils the requirements of the pendant group and may also have the additional benefit of their 
own potential anticancer efficacy as an intercalator, making this a potentially double pronged 






















Figure 1.5: 3+ Charged (1.5.1, 1.5.2, 1.5.3, 1.5.4) and neutral (1.5.5, 1.5.6, 1.5.7) complexes 
synthesised by a previous student working in the Hartshorn group62. 1.5.1, 1.5.2, 1.5.3 and 
1.5.4 were too soluble for complete isolation and characterisation, whereas 1.5.5, 1.5.6 and 










Dinuclear compound of cobalt (III) and platinum (II) – proposal 
 
Proposed simplified synthetic pathway to the dinuclear complex 
Figure 1.6: Proposed dinuclear motif coordinating cobalt(III) to platinum(II) through hydroxido 






Figure 1.7: Rendered proposal of the cobalt centre intercalation. An existing crystal structure 
of a bisnaphthalimide intercalating DNA has here been modified to show the potential for 
the cobalt complex to coordinate. 
 
In order to synthesise this ligand motif, primary amines and naphthalic anhydride are reacted 
together to form an imide between the terminal amine and the anhydride functionality.8, 34, 43-44 
The primary amine of the starting material acts as a nucleophile on the slightly electrophilic 
carbon of the anhydride. This process results in the loss of water. The resulting secondary amide 






1.7. Naphthalimide Antitumoural Agents 
The first naphthalimide therapeutic to enter clinical trials was mitonafide, a 3-nitro substituted 
naphthalimide synthesised by Braña et al (Figure 1.8).34, 42, 69-70 The design was chosen to 
implement the features observed in many intercalating agents, including the naphthalene 
moiety and the alkyl chain.42 It was found that the efficacy of the mitonafide motif was indeed 
based on its ability to act as a DNA intercalating agent through the naphthalene, which made it 
potent against many strains of cancer cells tested, and that the basic headgroup was essential 
for cytotoxicity despite lack of clear mechanism42. Unfortunately, the central nervous system 
toxicity of mitonafide in stage I precluded its use as the dose required for efficacy was too close 







UNBS516271 Azonafide8 Elinafide34, 71 Bisnafide72 Rong et al73 
Figure 1.8: The structures of various naphthalimide based drug candidates. 
Amonafide quickly followed in an array of mitonafide derivatives synthesised by the Braña 
group, designed to reduce the toxicity.43 The nitro group was identified as a key for DNA binding 





for exploration. Amonafide differs from mitonafide by reduction of the 3-nitro group to an 
amine.43 Clinical trials performed on this derivative were advanced to phase II, however, the 
neurotoxicity and haematoxicity precluded it from proceeding further.73  
Following these mononapthalimides, the Braña group synthesised elinafide, a 
bisnaphthalimide.44 This motif was chosen to increase the efficacy of the therapeutics thus 
decreasing the required dose. This can be seen in other bisintercalative molecules including 
ruthenium complexes with the ability to introduce strand breaks and similar aromatic 
anthracene derivatives.74 The elinafide compound synthesised was discovered to intercalate 
along the major groove in a sequence specific manner, induce DNA strand breaks and inhibit 
topoisomerase.8 Bisintercalation was confirmed through viscosity studies, showing the extent of 
DNA unwinding corresponded to bisintercalation rather than monointercalation.33 Interestingly, 
the lack of substitution on the naphthalene moiety did not inhibit the cytotoxicity of the 
compound as it was the most cytotoxic of the compounds tested.8 Elinafide has subsequently 
passed phase I clinical trials and entered phase II.43 
Following the success of the naphthalimide motif, many other experimental candidates including 
azonafide, UNBS5162 and bisnafide have been developed as potential chemotherapeutics.8, 72-73 
In this way, the use of the dinaphthalimide ligand proposed in this study to act as a blocking 
group on the platinum centre may also provide a second therapeutic approach for the prodrug. 
Steric hindrance would likely prevent intercalation of the naphthalimide groups prior to 
platinum dissociation, making the dinaphthalimide group a secondary benefit of the redox 
sensitive prodrug candidate. 
Another possible area of investigation that is relevant to explore is the solubility of the target. 
Previous work around the heterodinuclear system exposed issues in the purification of the 
compound due to solubility.62 One way to overcome this issue would be to add substituent 
groups, for example nitrite or sulfite, to the aromatic moiety. Adding a polar or charged group 
may preclude the intercalative ability of the aromatic group, however, other charged and polar 
intercalators are known including ethidium bromide and berberine, as well as mitonafide 
above.75 
  




 Crude Ligand Synthesis and Attempted Purification 
by Complexation to Copper 
 
2.1. Introduction 
As described in Chapter One, the tetradentate naphthalimide ligand 2.1 (Figure 2.1) was 
designed combining two rationale – the ability to hinder associative exchange on platinum 
centre of the heterodinuclear motif, and the similarity to existing anticancer agents. The 
pendant motif was chosen to physically block associative ligand exchange and redox chemistry 
on the platinum centre while still leaving the cobalt centre available to interact with the 
surroundings. This is important as the redox sensitive release of the cisplatin moiety relies on 
reduction of the cobalt centre, and synthesis of the heterodinuclear complex also relies on 
interaction of the platinum with the cobalt coordination sphere.  
 
2.1 
Figure 2.1: Compound 2.1 The desired compound, a dinaphthalimide based on the linear 
hexamine 
It is important to its fitness for purpose that the ligand contain these blocking pendant groups, 
with the pendants extending past the cobalt centre to block the platinum centre. The rest of the 
ligand should wrap around the cobalt and leave the cobalt as unhindered as possible. In order to 
coordinate to the cobalt centre, amines were chosen due to their well-known ability to form 
cobalt complexes. 
The pendants themselves would potentially reduce the probability of ligand coordination due to 
their low solubility in polar solvents and the potential steric interactions of these large groups 
while the ligand is wrapping around the metal centre. To compensate for this the ligand was 
designed to contain multiple donor atoms to allow the chelate effect to encourage the 
coordination. To further enhance complex stability, the nitrogen donor atoms would be 
separated by two or three atoms to form five or six membered chelate rings once coordinated. 
The orientation of the ligand pendants with respect to the metal centres is itself critical to the 
function of the heterodinuclear compound. In order to encourage the pendants to be oriented 




around the platinum centre, the ligand is designed to leave two ‘vacant’ coordination sites on 
the cobalt for later complexation to the platinum centre between the pendants. Additionally, 
the ligand should be able to be synthesised from common reagents in as few steps as possible. 
To fulfil all these requirements, the ligand design used in this project was chosen, as shown in 
compound 2.1. To give a tetradentate ligand with five membered chelate rings, 3,6,9,12-
tetraazatetradecane-1,14-diamine (pentaethylenehexamine) was chosen. This amine is used 
industrially as well as in coordination chemistry as a hexadentate ligand directly. To form the 
pendants 1,8-naphthalic anhydride was chosen due to the accessibility of the material and the 
ease of which it can be reacted with amines to form imides. The resulting imide motif resembles 
existing therapeutics, opening up the prospect of a secondary therapeutic affect as described 
previously in Section 1.6.  
This chapter describes the attempted to synthesise a tetradentate, dinaphthalimide ligand based 
on 3,6,9,12-tetraazatetradecane-1,14-diamine, and the subsequent attempts to enrich the 
samples of the target compound, 2.1, through complexation and separation of the complex. 
2.2. Experimental 
2.2.1. General Procedures 
All reagents were used as received, unless otherwise stated. 3,6,9,12-Tetraazatetradecane-1,14-
diamine was purchased technical grade, with a specified purity of 31-32.5%. Solvents were 
evaporated under reduced pressure at 40-60 °C using a rotary evaporator. Silica column 
chromatography was performed under gravity using silica gel (Fluorochem Silica LC 60 Å) as the 
stationary phase and HPLC grade solvents as eluent. Reactions were monitored by thin layer 
chromatography where possible. TLC was performed on plastic sheets pre-coated with silica gel. 
The plates were visualised by the quenching of UV fluorescence and/or by staining with a ceric 
ammonium nitrate solution dip followed by heating with a heat gun. Melting points were 
obtained using samples isolated after purification without further recrystallisation. 
2.2.2. Ion Exchange Chromatography 
To separate crude metal complexes based on charge, ion exchange chromatography was 
performed under gravity using DOWEX® and Sephadex® ion exchange resins. The resins were 
prepared following the manufacturer’s instructions and packed into glass columns. More details 
can be found under the relevant sections (Section 2.2.6.5, Appendix B.5). 




2.2.3. Nuclear Magnetic Resonance Studies 
Proton magnetic resonance spectra (1H NMR) and carbon magnetic resonance spectra (13C NMR) 
were recorded at 400 MHz or 600 MHz and 101 MHz or 151 MHz respectively and were 
recorded on a JEOL JNM-ECZ400S 400 MHz spectrometer with ASC64 autosampler, Agilent 
400MR with Varian 7600-AS auto-sampler or JEOL JNM-ECZ600R 600 MHz spectrometer NMR 
equipped with an ASC30 auto-sampler. NMR samples were run primarily using 5 mm NMR tubes 
due to the low solubility of the compounds. D6-DMSO, CDCl3, CD3OD, 1:1 CDCl3:CD3OD and 1:1 
D2O:CD3CN solvent systems were used, as described in the relevant experimental sections. 1H 
and 13C spectra were collected under standard conditions. Chemical shifts (δ) were reported in 
parts per million (ppm) and referenced to the residual solvent peak. NMR signals are described 
by multiplicity as singlet (s), doublet (d), triplet (t) or multiplet (m). Coupling constants (J) are 
quoted in Hertz to the nearest 0.1 Hz where feasible. 
2.2.4. Mass Spectrometry Studies 
Mass spectrometry was performed generally using a mixture of acetonitrile and water 1:1, made 
up into a bottle and regularly ‘blank’ tested for residual signals. To prepare the samples, a small 
amount of solid or a drop of the reaction mixture was taken into a vial and diluted through 
addition of 1-1.5 mL of the acetonitrile and water mixture. For dilute samples (which was 
defined here as samples taken directly from a reaction liquor or following elution from a 
column), one drop of this was used directly and added in to 1-1.5 mL of the acetonitrile and 
water mixture in a septum capped vial. For solids and concentrated solutions (such as those 
formed during in vacuo concentration), the diluted sample was diluted further by taking one 
drop and adding 1 mL of the acetonitrile water mixture. One drop of the resulting solution was 
added to a septum vial containing 1-1.5 mL of the acetonitrile and water solvent mixture.  
Mass spectra were recorded by Dr. Marie Squire or Dr. Amanda Inglis on a BrukerMaXis4G 
spectrometer. The instrument was operated in a high-resolution positive ion electron spray 
mode, except for selected samples that were run in negative ion mode if an anionic product was 
probable. 
2.2.5. Infrared Spectroscopy Studies 
Infrared spectroscopy was performed using a Bruker FTIR spectrometer equipped with Alpha’s 
Platinum ATR single reflection diamond and analysed using the OPUS software. Only significant 
absorptions outside of the fingerprint region are reported in wavenumbers with the following 
terms to describe intensity: w (weak), m (medium), s (strong), br (broad) or a combination of 
these terms. 




2.2.6. Ligand Synthesis and purification by complexation 
The following flowchart (Figure 2.2) is a pictorial representation of the procedure followed 


























Figure 2.2: Flowchart depicting the purification by complexation followed, with each box 
representing a fraction or phase of a reaction. The methods section outlines the procedures 
followed to transition between the different fractions, which are labelled by the section 
number of the method to produce them. The colours used indicate the approximate colour of 
that reaction fraction. 
Generation of crude ligand material 
through mechanochemical procedure 
Section 2.2.6.1 
Dissolved in methanol and refluxed. 





Refluxed in water with 
solid EDTA (1:1 with 
copper) added at reflux 
Returned to reflux with 
solid EDTA (1:1 with 
copper) added at reflux 
Complex Solid 
post EDTA Solid  
Section 2.2.6.3 





post EDTA Solid 
Section 2.2.6.4 
Complex Liquor 
post EDTA Solution 
Section 2.2.6.4 





















2.2.6.1. Ligand Synthesis 
 
1,8-naphthalic anhydride (C12H6O3 30 g, 151 mmol) was placed in a 15 cm mortar and ground 
with a pestle until a fine powder was achieved. Chloroform (CHCl3, 50 mL) was then added to the 
mortar and mixed with the anhydride to give a paste. To this, 3,6,9,12-tetraazatetradecane-1,14-
diamine (C10H28N6, 12 mL, 49 mmol) was added in a single addition and the mixture was ground 
for ten minutes. During this time, the mixture went from a pale beige paste to a very sticky 
brown then to a crumbly pale brown solid as grinding continued. Grinding ceased once the 
mixture became a fine pale brown powder (59.1 g).  
1H NMR (CDCl3, 400 MHz) δ: 8.45 ppm (4H, dd, ArCH), 8.15 (4H, dd, ArCH), 7.70 (4H, ddd, ArCH), 
4.25 (4H, t, CH2 proximal to imide), 2.95 (4H, t, CH2), 2.80 (4H, t, CH2), 2.70 (8H, m, CH2).  
13C NMR (CDCl3, 151 MHz) δ: 164 ppm, 134, 131, 125, 122, 54, 51, 50, 48, 40. 
Mass: 297.1478 2+ (Predicted 297.1477 for C34H38N6O4), 593.2884 1+ (predicted 593.2876 1+ for 
C34H37N6O4). 297.1478 2+ was one of the major peaks. 
IR: 3381 cm-1 (m, br), 3230 (m, br), 1694 (m), 1650 (s), 1621 (m), 1587 (s), 1513 (w), 1439 (m), 
1375 (m), 1346 (s, br), 1237 (s), 1202 (m), 1173 (w), 1074 (m, br). 
2.2.6.2. Complexation to Copper 
 
Crude ligand material (59.1 g) was placed in a 1 L round bottom flask. Methanol (500 mL) was 
then added with stirring. The flask was fitted with a condenser and heated at reflux on a hot 
plate stirrer with constant stirring. Once the reaction mixture was at reflux, copper sulfate 




(CuSO4∙5H2O, 9.95 g, 40 mmol) dissolved in warm methanol (200 mL) was added dropwise down 
the condenser. The reaction mixture gradually became blue with formation of a blue solid. The 
reaction mixture was heated at reflux with stirring for 3 hours. After cooling, the clear blue 
solution was decanted and the oily blue solid produced was washed twice with minimal 
methanol (less than 10 mL each) and the washings combined with the decanted solution. The 
methanolic liquor was refrigerated overnight and the liquid decanted off the blue oil that 
formed. The blue oil was combined with the solid remaining in the reaction vessel from the 
previous step. The solids and the reaction liquor were then characterised by ESI-MS (Table 2.3, 
Table 2.5, Table 2.15) and treated separately for the following steps. 
2.2.6.3. Treatment of the solid material from the reaction of copper with 
crude ligand material 
 
Water (700 mL) was added to the oily blue solid in the reaction vessel and this solution was 
brought to reflux. Disodium EDTA (Na2C10H14N2O8∙2H2O, 14.87 g 44 mmol) was added as a solid 
through the neck over the course of two minutes in five roughly equal portions, with the solid 
residue on the neck of the flask from the addition washed into the solution using five mL of 
water. This mixture was heated at reflux for a further three hours. The cool reaction mixture was 
filtered to separate the brown oil produced from the turquoise solution. The oil and the reaction 
solution were then characterised by ESI-MS (See Table 2.15). 
2.2.6.4. Treatment of the reaction liquor from the reaction of copper 
with crude ligand material 
 
The liquor was treated with EDTA by returning the methanolic solution (~700 mL) to reflux 
followed by gradual addition of the solid disodium EDTA (Na2C10H14N2O8∙2H2O, 14.87 g, 44 
mmol). EDTA was added over the course of two minutes in five roughly equal portions, with the 
solid residue on the neck of the flask from the addition washed into the solution using five mL of 
+ 
+ 




methanol. This reaction was heated at reflux overnight before the reaction material was filtered 
to separate the resulting white powder and brownish oil from the green solution. The solids and 
the reaction liquor were then characterised by ESI-MS (See Table 2.15). 
2.2.6.5. Treatment of the Turquoise Solution Post EDTA 
The solution from the solid EDTA treatment step (Section 2.2.6.3) was taken and extracted six 
times with 100-150 mL of chloroform. Approximately half of the aqueous phase (~350 mL) was 
then run through DOWEX 1X8 resin in the chloride form to separate neutral and charged species 
by cation exchange. The sample was brought to pH 7-8 and loaded onto a 10 cm long 5 cm 
diameter column directly. The first fraction was eluted using 2 L of distilled water, giving a pale 
turquoise solution. The bright blue band that remained on the column was then eluted using 
0.25 M NaCl solution followed by 1 M NaCl solution to ensure complete elution. 
Following this, the second half of the aqueous phase was reduced to half the total volume, 
removing any residual chloroform, and then diluted back to twice the reaction volume in order 
to load it onto the column. During this process, a very pale blue precipitate formed and was 
collected by filtration. This precipitate was then dried under vacuum and used for subsequent 
reactions (0.50 g, used in Sections 3.2.2 and 3.2.5). The column fractions and the precipitate 
were then analysed by ESI-MS (See Table 2.15). 
  





2.3.1. Crude Material 
 
The crude material produced in each reaction showed a similar overall composition which is 
shown in Table 2.1 as ESI-MS results, with relative intensities determined by comparison of the 
peak intensity to the largest peak in any given spectrum. The percentage values are given by the 
percentage 2.1 out of the total for 2.1, 2.3, 2.4 and 2.5. These compounds were selected as they 
are the most prevalent and possess the highest relative intensities of the side products. The 
compound numbers are in reference to the structures in Figure 2.3. These compounds are likely 
products of the reaction between the starting material amine mixture and 1,8-napthalic 
anhydride. These compounds will be listed by compound number in the results and further 
emphasised in the discussion. Each compound is represented by a single isomer, but in most 
cases many isomers are possible. 
Table 2.1: Crude Ligand Material ESI-MS results. Desired compound is listed first. 
Identity m/z Predicted m/z 










[2.1+2H+] 2+ 297.1472 2+ 297.1477 2+ for C34H38N6O4 1.0 0.89 1.0 0.20 1.0 
[2.1+1H+] 1+ 593.2865 1+ 593.2876 1+ for C34H37N6O4 
[2.4+2H+] 2+ 310.1549 2+ 310.1556 2+ for C36H40N6O4 0.68 1.0 0.93 0.19 0.90 
[2.4+1H+] 1+ 619.3045 619.3033 2+ for C36H39N6O4 
[2.3+2H+] 2+ 387.1572 2+ 387.1583 2+ for C46H42N6O6 0.49 0.47 0.71 0.41 0.46 
[2.3+1H+] 1+ 773.3104 1+ 773.3088 1+ for C46H41N6O6 
[2.5+2H+] 2+ 396.1623 2+ 396.1636 2+ for C46H44N6O7 0.26 0.92 0.77 0.26 0.29 
[2.20+2H+] 2+ 408.6780 2+ 408.6794 2+ for C48H47N7O6 0.23  0.37 0.13 0.17 
[2.19+2H+] 2+ 318.6673 2+ 318.6688 2+ for C36H43N7O4 0.15   0.28 0.20 
[2.13+2H+] 2+ 275.6260 2+ 275.6266 2+ for C32H33N5O4 0.12 0.11 0.10 0.05 0.09 
[2.22+2H+] 2+ 331.6754 2+ 331.6767 2+ for C38H45N7O4 0.11  0.23  0.11 
[2.2+2H+] 2+ 207.1362 2+ 207.1372 2+ for C22H40N6O2 0.09  0.15  0.13 
[2.7+2H+] 2+ 306.1526 2+ 306.1558 2+ for C34H40N6O4 0.05 0.94 0.59  0.25 
[2.21+2H+] 2+ 417.6829 2+ 417.6847 2+ for C48H49N7O7  0.26 0.28  0.10 
[2.12+1H+] 1+ 370.2235 1+ 370.2243 1+ for C20H28N5O2 0.06 0.06 0.07  0.08 
Unknown 239.0319 Unidentified 0.02  0.03   
[2.25+2H+] 2+ 254.1047 2+ 254.1055 2+ for C30H28N4O4 0.02 0.02  0.09 0.01 
[2.18+2H+] 2+ 288.6333 2+ 288.6345 2+ for C34H35N5O4 0.05 0.10 0.08  0.05 
2.26 or 2.29 
353.1961 353.1978 1+ for C20H25N4O2 
or 2+ for C40H50N8O4 
    0.02 
[2.30+1H+] 1+ 199.0393 1+ 199.0395 1+ for C12H7O3 0.06 0.49 0.31 0.37 0.21 
Percentage of desired (2.1 as a proportion of2.1, 2.3, 2.4 and 2.5) 
Mean: 31% 
41% 27% 29% 19% 38% 







2.2: The linear hexamine substituted with a single naphthalimide group 
 
2.3: The branched hexamine substituted with three naphthalimide groups 
 
2.4: The piperazine derivative of the hexamine substituted with two naphthalimide groups 
 
2.5: Hexamine substituted with two naphthalimide groups and a naphthalamide group 
Figure 2.3: List of the compounds identified by ESI-MS during this work. These are identified by 
compound number and referred to throughout the results and discussion. 





2.6: The piperazine derivative of the hexamine substituted with two naphthalimide groups and 
a naphthalamide group 
 
2.7: Hexamine substituted with a naphthalimide group and a naphthalamide group 
 
2.8: Dibranched hexamine substituted with four naphthalimide groups 
 
2.9: Branched hexamine substituted with three napthalimide groups and one naphthalamide 
group 
Figure 2.3 (continued) 





2.10: Piperazine derivative of the branched hexamine substituted with three naphthalimide 
groups 
 
2.11: Piperazine derivative of the hexamine substituted with a naphthalimide group 
 
2.12: Pentamine substituted with one naphthalimide group 
 
2.13: Pentamine substituted with two naphthalimide groups 
 
2.14: Pentamine substituted with one naphthalimide group and one naphthalamide group 
Figure 2.3 (continued) 
 





2.15: Branched pentamine substituted with three naphthalimide groups 
 
2.16: Pentamine substituted with two naphthalimide groups and one naphthalamide group 
 
2.17: Piperazine derivative of the pentamine substituted with one naphthalimide group 
 
2.18: Piperazine derivative of the pentamine substituted with two naphthalimides 
 
2.19: Heptamine substituted with two naphthalimide groups 
Figure 2.3 (continued) 
 





2.20: Branched heptamine substituted with three naphthalimide groups 
 
2.21: Heptamine substituted with two naphthalimide groups and a naphthalamide group 
 
2.22: Piperazine derivative of the heptamine substituted with two naphthalimide groups 
 
2.23: Piperazine derivative of the branched heptamine substituted with three naphthalimide 
groups 
Figure 2.3 (continued) 
 





2.24: Piperazine derivative of the heptamine substituted with two naphthalimide groups and a 
naphthalamide group 
 
2.25: Tetramine substituted with two naphthalimide groups 
 
2.26: Piperazine derivative of the tetramine substituted with one naphthalimide group 
 
2.27: Branched octamine substituted with three naphthalimide groups 
 
2.28: Piperazine derivative of the octamine substituted with two naphthalimide groups 
Figure 2.3 (continued) 
 





2.29: Piperazine derivative of the branched octamine substituted with three naphthalimide 
groups 
 
2.30: 1,8-Naphthalic anhydride 
Figure 2.3 (continued) 
  




2.3.2. Purification by complexation 
This flowchart is based upon the one shown in the experimental, and shows which species were 



























Figure 2.4: This flowchart shares the layout of the one in Figure 2.2, this time identifying the 
major peaks in the ESI-MS spectra for each of the different fractions to show the tracking of 
the desired compounds (2.1 and Cu(2.1)) through each step. 
Generation of crude ligand material 
through mechanochemical procedure 
2.1 2.4 
2.3 2.5 
Dissolved in methanol and refluxed. 






2.3  2.4 Cu(2.1) 
2.1 2.6 Cu(2.19) 
Refluxed in water with 
solid EDTA (1:1 with 
copper) added at reflux 
Returned to reflux with 
solid EDTA (1:1 with 
copper) added at reflux 
Complex Solid 
post EDTA Solid  
2.1 
2.3  2.4 
Complex Solid post 
EDTA Solution 




post EDTA Solid 
2.3 
2.6  2.4 
Complex Liquor 
post EDTA Solution 
2.3  2.4 
2.6 2.1 







2.5 2.18 2.1 2.6 
















The following tables (Table 2.3 to Table 2.14) summarise the relative intensities of major and 
assignable peaks in the ESI-MS spectra for each of the fractions from this reaction. Each table 
shows the compound assignment, the modification of the species by the ESI process, the mass 
to charge ratio of the found peak (and the prediction for the mass that species), and the relative 
intensity. For species where both the 1+ and 2+ peaks could be assigned, the species was given 
one relative intensity to cover both peaks. The relative intensities were found by measuring the 
height of each peak and dividing this by the height of the largest peak in that particular ESI-MS 
spectrum. This gives an indication of how much of each peak there was compared to the major 
peak, allowing for tracking of changes in the relative compositions of the species.  
While ESI-MS is not a quantitative technique, as different species will ionise to differing extents, 
comparing the relative intensities of a pair of compounds between two spectra will show you 
whether the relative amounts of these species had changed with respect to each other. The 
ionisation ability of an individual species may differ from the others within the reaction mixture 
but should remain roughly consistent across a range of reaction compositions. This allows the 
species to be tracked. For example, if compound two had a relative intensity of 0.5 compared to 
compound one, which then drops to 0.25 in the next step of the reaction, it was clear that the 
amount of compound 2 had decreased, or compound one had increased. These tables were then 
compiled further to give Table 2.15 (see Table 2.15 for further explanation). 
Table 2.2: ESI-MS results for the crude ligand material synthesised in Section 2.2.6.1. The desired 
ligand compound is highlighted in green. 
Species Identity m/z Predicted m/z Relative Intensity 
2.1 [M +2H+] 2+ 297.1471 2+ 297.1477 2+ for C34H38N6O4 1.0 
2.4 [M +2H+] 2+ 310.1550 2+ 310.1556 2+ for C36H40N6O4 0.90 
2.3 [M +2H+] 2+ 387.1577 2+ 387.1583 2+ for C46H42N6O6 0.46 
2.5 [M +2H+] 2+ 396.1628 2+ 396.1636 2+ for C46H44N6O7 0.29 
2.7 [M +2H+] 2+ 306 306.1558 2+ for C34H40N6O4 0.25 
2.30 [M +1H+] 1+ 199.0391 1+ 199.0395 1+ for C12H7O3 0.21 
2.19 [M +2H+] 2+ 318.6673 2+ 318.6688 2+ for C36H43N7O4 0.20 
2.20 [M +2H+] 2+ 408.6782 2+ 408.6794 2+ for C48H47N7O6 0.17 
2.2 [M +2H+] 2+ 207.1362 2+ 207.1372 2+ for C22H40N6O2 0.13 
2.22 [M +2H+] 2+ 331.6754 2+ 331.6767 2+ for C38H45N7O4 0.11 
2.21 [M +2H+] 2+ 417.6834 417.6847 2+ for C48H49N7O7 0.10 
2.13 [M +2H+] 2+ 275.6256 275.6266 2+ for C32H33N5O4 0.09 
2.12 [M +H+] 1+ 370.2239 370.2243 1+ for C20H28N5O2 0.08 
2.18 [M +2H+] 2+ 288.6333 288.6345 2+ for C34H35N5O4 0.05 
2.26 [M +1H+] 1+ 353.1961 353.1978 1+ for C20H26N4O2 0.02 
 




Complexation reaction of copper with crude ligand material 
Table 2.3: ESI-MS results for the solid produced by the complexation process described in Section 
2.2.6.2. The desired complex is highlighted in blue. 
Species Identity m/z Predicted m/z Relative Intensity 
2.3 
[M +2H+] 2+ 387.1563 2+ 387.1583 2+ for C46H42N6O6 
1.0 
[M +H+] 1+ 773.3074 1+ 773.3088 1+ for C46H41N6O6 
Cu(2.1) [M]2+ 327.6031 
327.6047 2+ for 
[Cu(C34H36N6O4)]2+ 
0.43 
2.4 [M +2H+] 2+ 310 310.1556 2+ for C36H40N6O4 0.41 
2.6 [M +2H+] 2+ 409.1719 2+ 409.1714 2+ for C48H46N6O7 0.13 
2.13 [M +2H+] 2+ 275.6256 2+ 275.6266 2+ for C32H33N5O4 0.13 
2.20 [M +2H+] 2+ 408 408.6794 2+ for C48H47N7O6 0.10 
Cu(2.19) [M]2+ 349.1235 349.1257 2+ for [Cu(C36H41N7O4)]2+ 0.10 
2.1 [M +2H+] 2+ 297.1461 297.1477 2+ for C34H38N6O4 0.09 
Cu(2.20) [M]2+ 439.1335 439.1363 2+ for [Cu(C48H47N7O6)]2+ 0.08 
2.30 [M +H+] 1+ 199.0395 199.0395 1+ for C12H7O3 0.08 
2.5 [M +2H+] 2+ 396 396.1636 2+ for C46H44N6O7 0.07 
2.18 [M +2H+] 2+ 288 288.6345 2+ for C34H35N5O4 0.07 
2.23 [M +2H+] 2+ 421 421.6872 2+ for C50H49N7O6 0.06 
2.9 [M +2H+] 2+ 486.1712 486.1741 2+ for C58H48N6O9 0.04 
 
Table 2.4: ESI-MS results for the solid produced following cooling of the complexation liquor 
described in Section 2.2.6.2. The desired complex is highlighted in blue. 
Species Identity m/z Predicted m/z Relative Intensity 
Cu(2.1) [M]2+ 327.6026 2+ 
327.6047 2+ for 
[Cu(C34H36N6O4)]2+ 
1.0 
2.3 [M +2H+] 2+ 387.1553 2+ 387.1583 2+ for C46H42N6O6 0.23 
2.4 [M +2H+] 2+ 310.1536 2+ 310.1556 2+ for C36H40N6O4 0.14 
2.20 [M +2H+] 2+ 408.6757 2+ 408.6794 2+ for C48H47N7O6 0.14 
2.1 [M +2H+] 2+ 297.1457 2+ 297.1477 2+ for C34H38N6O4 0.12 
Cu(2.20) [M]2+ 439.1320 2+ 439.1363 2+ for [Cu(C48H47N7O6)]2+ 0.05 
Cu(2.19) [M]2+ 349.1226 349.1257 2+ for [Cu(C36H41N7O4)]2+ 0.04 
2.30 [M +1H+] 1+ 199.0393 1+ 199.0395 1+ for C12H7O3 0.02 
2.13 [M +2H+] 2+ 275.6249 2+ 275.6266 2+ for C32H33N5O4 0.02 
 
  




Table 2.5: ESI-MS results for the liquor produced by the complexation process described in 
Section 2.2.6.2. The desired complex is highlighted in blue. 
Species Identity m/z Predicted m/z Relative Intensity 
2.4 
[M +2H+] 2+ 310.1544 2+ 310.1556 2+ for C36H40N6O4 
1.0 
[M +H+] 1+ 619.3017 1+ 619.3033 1+ for C36H39N6O4 
2.3 
[M +2H+] 2+ 387.1562 2+ 387.1583 2+ for C46H42N6O6 
0.95 
[M +H+] 1+ 773.3075 1+ 773.3088 1+ for C46H41N6O6 
Cu(2.1) [M]2+ 327.6034 
327.6047 2+ for 
[Cu(C34H36N6O4)]2+ 
0.87 
2.30 [M +H+] 1+ 199.0399 1+ 199.0395 1+ for C12H7O3 0.47 
2.6 [M +2H+] 2+ 409.1706 2+ 409.1714 2+ for C48H46N6O7 0.35 
Cu(2.19) [M]2+ 349.1240 2+ 
349.1257 2+ for 
[Cu(C36H41N7O4)]2+ 
0.29 
2.1 [M +2H+] 2+ 297.1466 2+ 297.1477 2+ for C34H38N6O4 0.28 
2.13 [M +2H+] 2+ 275.6258 2+ 275.6266 2+ for C32H33N5O4 0.20 
2.22 [M +2H+] 2+ 331 331.6767 2+ for C38H45N7O4 0.16 
2.18 [M +2H+] 2+ 288 288.6345 2+ for C34H35N5O4 0.13 
2.5 [M +2H+] 2+ 396 396.1636 2+ for C46H44N6O7 0.09 
2.23 [M +2H+] 2+ 421 421.6872 2+ for C50H49N7O6 0.08 
2.24 [M +2H+] 2+ 430 430.6925 2+ for C50H51N7O7 0.04 
Cu(2.20) [M]2+ 439 
439.1363 2+ for 
[Cu(C48H47N7O6)]2+ 
0.04 
2.9 [M +2H+] 2+ 486.1711 2+ 486.1741 2+ for C58H48N6O9 0.03 
 
Treatment of Complexation Solid 
Table 2.6: ESI-MS results for the solid produced following treatment of the complexation solid 
with EDTA in Section 2.2.6.3. The desired ligand compound is highlighted in green. 
Species Identity m/z Predicted m/z Relative Intensity 
2.1 
[M +2H+] 2+ 297.1467 2+ 297.1477 2+ for C34H38N6O4 
1.0 
[M +H+] 1+ 593.2859 1+ 593.2876 1+ for C34H37N6O4 
2.3 [M +2H+] 2+ 387.1561 2+ 387.1583 2+ for C46H42N6O6 0.65 
2.4 [M +2H+] 2+ 310 310.1556 2+ for C36H40N6O4 0.40 
2.20 [M +2H+] 2+ 408.6765 2+ 408.6794 2+ for C48H47N7O6 0.26 
2.5 [M +2H+] 2+ 396 396.1636 2+ for C46H44N6O7 0.19 
2.19 [M +2H+] 2+ 318 318.6688 2+ for C36H43N7O4 0.07 
2.12 [M +2H+] 2+ 370 370.2243 1+ for C20H28N5O2 0.06 
2.13 [M +2H+] 2+ 275.6256 275.6266 2+ for C32H33N5O4 0.05 
2.30 [M +H+] 1+ 199.0396 199.0395 1+ for C12H7O3 0.02 
Cu(2.1) [M]2+ 327 327.6047 2+ for [Cu(C34H36N6O4)]2+ 0.01 
 







Table 2.7: ESI-MS results for the solution produced following treatment of the complexation solid 
with EDTA in Section 2.2.6.3. The desired ligand compound is highlighted in green. 
Species Identity m/z Predicted m/z Relative Intensity 
2.1 
[M +2H+] 2+ 297.1469 2+ 297.1477 2+ for C34H38N6O4 
1.0 
[M +H+] 1+ 593.2861 1+ 593.2876 1+ for C34H37N6O4 
2.4 [M +2H+] 2+ 310 310.1556 2+ for C36H40N6O4 0.95 
2.5 [M +2H+] 2+ 396 396.1636 2+ for C46H44N6O7 0.32 
2.22 [M +2H+] 2+ 331.6749 2+ 331.6767 2+ for C38H45N7O4 0.19 
2.13 [M +2H+] 2+ 275.6256 2+ 275.6266 2+ for C32H33N5O4 0.15 
2.19 [M +2H+] 2+ 318 318.6688 2+ for C36H43N7O4 0.13 
2.12 [M +2H+] 2+ 370.2230 370.2243 1+ for C20H28N5O2 0.06 
2.18 [M +2H+] 2+ 288 288.6345 2+ for C34H35N5O4 0.04 
2.17 [M +2H+] 2+ 198.6233 198.6239 2+ for C22H31N5O2 0.02 
 
Treatment of Complexation Liquor 
Table 2.8: ESI-MS results for the solution produced following treatment of the complexation 
liquor with EDTA as described in Section 2.2.6.4. The desired ligand compound is highlighted in 
green. 
Species Identity m/z Predicted m/z Relative Intensity 
2.4 [M +2H+] 2+ 310.1552 2+ 310.1556 2+ for C36H40N6O4 1.0 
2.3 [M +2H+] 2+ 387.1570 2+ 387.1583 2+ for C46H42N6O6 1.0 
2.6 [M +2H+] 2+ 409.1717 2+ 409.1714 2+ for C48H46N6O7 0.53 
2.5 [M +2H+] 2+ 396 396.1636 2+ for C46H44N6O7 0.33 
2.1 [M +2H+] 2+ 297.1474 2+ 297.1477 2+ for C34H38N6O4 0.30 
2.30 [M +1H+] 1+ 199.0400 1+ 199.0395 1+ for C12H7O3 0.27 
2.22 [M +2H+] 2+ 331.6753 2+ 331.6767 2+ for C38H45N7O4 0.16 
2.13 [M +2H+] 2+ 275.6262 2+ 275.6266 2+ for C32H33N5O4 0.11 
Unknown 1+ 354.0115 Unknown 0.07 
2.16 [M +2H+] 2+ 374.6408 374.6425 2+ for C44H39N5O7 0.07 
 
  





ESI-MS of Complexation Liquor Post EDTA Solid: 
Table 2.9: ESI-MS results for the solid produced following treatment of the complexation liquor 
with EDTA as described in Section 2.2.6.4. The desired ligand compound is highlighted in green. 
Species Identity m/z Predicted m/z Relative Intensity 
Unknown 1+ 293.0985 1+ Unknown 1.0 
2.3 
[M +2H+] 2+ 387.1562 2+ 387.1583 2+ for C46H42N6O6 
0.73 
[M +H+] 1+ 773.3091 1+ 773.3088 1+ for C46H41N6O6 
2.4 [M +2H+] 2+ 310 310.1556 2+ for C36H40N6O4 0.27 
2.6 [M +2H+] 2+ 409.1707 2+ 409.1714 2+ for C48H46N6O7 0.19 
2.5 [M +2H+] 2+ 396 396.1636 2+ for C46H44N6O7 0.14 
2.1 [M +2H+] 2+ 297 297.1477 2+ for C34H38N6O4 0.10 
2.9 [M +2H+] 2+ 486.1702 486.1741 2+ for C58H48N6O9 0.08 
2.30 [M +H+] 1+ 199.0394 199.0395 1+ for C12H7O3 0.05 
2.13 [M +2H+] 2+ 275.6256 275.6266 2+ for C32H33N5O4 0.05 
2.18 [M +2H+] 2+ 288 288.6345 2+ for C34H35N5O4 0.03 
 
Chloroform Extraction of Complexation Solid Post EDTA Solution  
Table 2.10: ESI-MS results for the chloroform extract from the solution produced following 
treatment of the complexation solid with EDTA as described in Section 2.2.6.4 and 2.2.6.5. The 
desired ligand compound is highlighted in green. 
Species Identity m/z Predicted m/z Relative Intensity 
2.3 [M +2H+] 2+ 387.1564 2+ 387.1583 2+ for C46H42N6O6 1.0 
2.5 [M +2H+] 2+ 396 396.1636 2+ for C46H44N6O7 0.18 
2.30 [M +H+] 1+ 199.0395 199.0395 1+ for C12H7O3 0.15 
2.9 [M +2H+] 2+ 486.1714 2+ 486.1741 2+ for C58H48N6O9 0.14 
2.18 [M +2H+] 2+ 288.6332 2+ 288.6345 2+ for C34H35N5O4 0.11 
2.1 [M +2H+] 2+ 297 297.1477 2+ for C34H38N6O4 0.08 
2.6 [M +2H+] 2+ 409 409.1714 2+ for C48H46N6O7 0.07 
2.4 [M +2H+] 2+ 310 310.1556 2+ for C36H40N6O4 0.05 
2.20 [M +2H+] 2+ 408 408.6794 2+ for C48H47N7O6 0.05 
2.13 [M +2H+] 2+ 275 275.6266 2+ for C32H33N5O4 0.04 
 
  




Table 2.11: ESI-MS results for the solution following chloroform extraction of the solution 
produced following treatment of the complexation solid with EDTA as described in Section 2.2.6.4 
and 2.2.6.5. The desired ligand is highlighted in green. 
Species Identity m/z Predicted m/z Relative Intensity 
2.1 
[M +2H+] 2+ 297.1460 2+ 297.1477 2+ for C34H38N6O4 
1.0 
[M +1H+] 1+ 593.2841 1+ 593.2876 1+ for C34H37N6O4 
2.4 [M +2H+] 2+ 310.1536 2+ 310.1556 2+ for C36H40N6O4 0.86 
2.5 [M +2H+] 2+ 396.1601 2+ 396.1636 2+ for C46H44N6O7 0.41 
2.22 [M +2H+] 2+ 331.6738 2+ 331.6767 2+ for C38H45N7O4 0.20 
Unknown 1+ 354.0107 1+ Unknown 0.15 
2.13 [M +2H+] 2+ 275.6248 275.6266 2+ for C32H33N5O4 0.10 
2.12 [M +2H+] 2+ 370.2220 370.2243 1+ for C20H28N5O2 0.08 
2.17 [M +2H+] 2+ 198.6228 198.6239 2+ for C22H31N5O2 0.04 
 
Table 2.12: ESI-MS results for the precipitate produced from the solution following chloroform 
extraction as described in Section 2.2.6.4 and 2.2.6.5. The desired ligand is highlighted in green. 
Species Identity m/z Predicted m/z Relative Intensity 
2.1 
[M +2H+] 2+ 297.1465 2+ 297.1477 2+ for C34H38N6O4 
1.0 
[M +1H+] 1+ 593.2863 1+ 593.2876 1+ for C34H37N6O4 
2.4 [M +2H+] 2+ 310.1538 2+ 310.1556 2+ for C36H40N6O4 0.12 
2.12 [M +H+] 1+ 370.2232 370.2243 1+ for C20H28N5O2 0.09 
 
Column of Complexation Solid Post EDTA Solution Post Chloroform Extraction 
 
Table 2.13: ESI-MS results for Fraction 1 of the anion exchange column of the solution remaining 
following chloroform extraction as described in Section 2.2.6.4 and 2.2.6.5. The desired ligand is 
highlighted in green. 




[M +2H+] 2+ 297.1468 2+ 297.1477 2+ for C34H38N6O4 
1.0 
[M +1H+] 1+ 593.2859 1+ 593.2876 1+ for C34H37N6O4 
2.4 
[M +2H+] 2+ 310.1543 2+ 310.1556 2+ for C36H40N6O4 
0.79 
[M +1H+] 1+ 619.3019 1+ 619.3033 1+ for C36H39N6O4 
2.5 [M +2H+] 2+ 396.1611 2+ 396.1636 2+ for C46H44N6O7 0.28 
2.22 [M +2H+] 2+ 331.6747 2+ 331.6767 2+ for C38H45N7O4 0.27 
Cu(2.12.1) [M]2+ 327 327.6047 2+ for [Cu(C34H36N6O4)]2+ 0.26 
2.13 
[M +2H+] 2+ 275.6255 2+ 275.6266 2+ for C32H33N5O4 
0.16 
[M +1H+] 1+ 550.2430 1+ 550.2455 1+ for C32H32N5O4 
2.12 [M +H+] 1+ 370.2231 370.2243 1+ for C20H28N5O2 0.08 
Cu(2.19) [M]2+ 349.1239 349.1257 2+ for [Cu(C36H41N7O4)]2+ 0.06 
Cu(2.20) [M]2+ 439.2802 2+ 439.1363 2+ for [Cu(C48H47N7O6)]2+ 0.07 
2.17 [M +2H+] 2+ 198.6234 2+ 198.6239 2+ for C22H31N5O2 0.05 





Table 2.14: ESI-MS results for Fraction 2 of the anion exchange column of the solution remaining 
following chloroform extraction of the solution produced following treatment of the 
complexation solid with EDTA as described in Section 2.2.6.4 and 2.2.6.5. The desired ligand 
compound is highlighted in green. 
Species Identity m/z Predicted m/z Relative Intensity 
2.4 
[M +2H+] 2+ 310.1538 2+ 310.1556 2+ for C36H40N6O4 
1.0 
[M +1H+] 1+ 619.3009 1+ 619.3033 1+ for C36H39N6O4 
2.1 
[M +2H+] 2+ 297.1462 2+ 297.1477 2+ for C34H38N6O4 
0.95 
[M +1H+] 1+ 593.2849 1+ 593.2876 1+ for C34H37N6O4 
2.5 [M +2H+] 2+ 396.1604 2+ 396.1636 2+ for C46H44N6O7 0.39 
Cu(2.1) [M]2+ 327.6027 
327.6047 2+ for 
[Cu(C34H36N6O4)]2+ 
0.29 
2.22 [M +2H+] 2+ 331.6748 2+ 331.6767 2+ for C38H45N7O4 0.28 
2.13 
[M +2H+] 2+ 275.6255 2+ 275.6266 2+ for C32H33N5O4 
0.15 
[M +1H+] 1+ 550.2437 1+ 550.2455 1+ for C32H32N5O4 
Cu(2.19) [M]2+ 349.1233 
349.1257 2+ for 
[Cu(C36H41N7O4)]2+ 
0.07 
2.12 [M +H+] 1+ 370.2232 370.2243 1+ for C20H28N5O2 0.07 
Cu(2.20) [M]2+ 439.2792 
439.1363 2+ for 
[Cu(C48H47N7O6)]2+ 
0.06 
2.17 [M +2H+] 2+ 198.6230 2+ 198.6239 2+ for C22H31N5O2 0.05 
  





Table 2.15: Summarised ESI-MS results from the reaction fractions of the purification by complexation shown in Section 2.2.6. The values are expressed as relative intensities 
for the species of interest compared to the largest peak in that spectrum. The final row percentages for the desired compound was calculated by the desired product divided 
by the sum of the most common side products. 2.1, 2.4, Cu(2.1), 2.3 and 2.5. The desired compound was 2.1 except where Cu(2.1) was the desired compound, as highlighted, 
with free ligand highlighted green and complex highlighted blue. The columns in this table correspond to the boxes of the flowcharts in Figure 2.2 and Figure 2.4. 


































[2.17+2H+] 2+ 198.6234 2+ 198.6239 2+ for C22H31N5O2      0.02  0.04  0.05 0.05   
[2.30 +1H+] 1+ 199.0391 1+ 199.0395 1+ for C12H7O3 0.21 0.08 0.47 0.02 0.02  0.15     0.05 0.27 
[2.2+2H+] 2+ 207.1362 2+ 207.1372 2+ for C22H40N6O2 0.13             
[2.13+2H+] 2+ 275.6256 2+ 275.6266 2+ for C32H33N5O4 0.09 0.13 0.20 0.02 0.05 0.15 0.04 0.10  0.16 0.15 0.05 0.11 
[2.18+2H+] 2+ 288.6332 2+ 288.6345 2+ for C34H35N5O4 0.05 0.07 0.13   0.04 0.11     0.03  
[2.1+2H+] 2+ 297.1471 2+ 297.1477 2+ for C34H38N6O4 1.0 0.09 0.28 0.12 1.0 1.0 0.08 1.0 1.0 1.0 0.95 0.10 0.30 
[2.7+2H+] 2+ 306.1520 2+ 306.1558 2+ for C34H40N6O4 0.25             
[2.4+2H+] 2+ 310.1550 2+ 310.1556 2+ for C36H40N6O4 0.90 0.41 1.0 0.14 0.40 0.95 0.05 0.86 0.12 0.79 1.0 0.27 1.0 
[2.19 +2H+] 2+ 318.6673 2+ 318.6688 2+ for C36H43N7O4 0.20    0.07 0.13        
[Cu(2.1)]2+ 327.6026 2+ 327.6047 2+ for [Cu(C34H36N6O4)]2+  0.43 0.87 1.0 0.01     0.26 0.29   
[2.22+2H+] 2+ 331.6754 2+ 331.6767 2+ for C38H45N7O4 0.11  0.16   0.19  0.20  0.27 0.28  0.16 
[Cu(2.19)]2+ 349.1226 2+ 349.1257 2+ for [Cu(C36H41N7O4)]2+  0.10 0.29 0.04      0.06 0.07   
[2.12+1H+] 1+ 370.2239 2+ 370.2243 1+ for C20H28N5O2 0.08    0.06 0.06  0.08 0.09 0.08 0.07   
[2.16+2H+] 2+ 374.6400 374.6425 2+ for C44H39N5O7            0.04 0.07 
[2.3 +2H+] 2+ 387.1577 2+ 387.1583 2+ for C46H42N6O6 0.46 1.0 0.95 0.23 0.65  1.0     0.73 1.0 
[2.5+2H+] 2+ 396.1628 2+ 396.1636 2+ for C46H44N6O7 0.29 0.07 0.09  0.19 0.32 0.18 0.41  0.28 0.39 0.14 0.33 
[2.20+2H+] 2+ 408.6782 2+ 408.6794 2+ for C48H47N7O6 0.17 0.10  0.14 0.26  0.05       
[2.6+2H+] 2+ 409.1717 2+ 409.1714 2+ for C48H46N6O7  0.13 0.35    0.07     0.19 0.53 
[2.21+2H+] 2+ 417.6834 2+ 417.6847 2+ for C48H49N7O7 0.10             
[2.23+2H+] 2+ 421.6849 2+ 421.6872 2+ for C50H49N7O6  0.06 0.08           
[2.24+2H+] 2+ 430.6902 430.6925 2+ for C50H51N7O7   0.04           
[Cu(2.20)]2+ 439.1320 2+ 439.1363 2+ for [Cu(C48H47N7O6)]2+  0.08 0.04 0.05      0.07 0.06   
[2.9+ 2H+] 2+ 486.1714 2+ 486.1741 2+ for C58H48N6O9  0.04 0.03    0.14     0.08  
Percentage of desired compound (compared to major side products) 38% 22% 27% 67% 44% 44% 6% 44% 89% 43% 36% 8% 11% 




2.3.3. Summary of Results 
The intention of this work was to purify the desired ligand, 2.1, through complexation to copper 
followed by recovery of the ligand. Iterations of the reaction was performed in an attempt to 
refine the reaction conditions towards purifying the desired ligand following the steps of the 
reaction. The criterion for judging enrichment was made on the basis ESI-MS results, where 
relative intensities for various compounds were compared to trace the increased or decreased 
presence of a compound before and after a reaction step. From the flowcharts and tables of ESI-
MS results, (See Appendix A and B for more) it can be seen that the complexation reaction 
generally produced a blue oily solid and a blue liquor, of which the desired compound exists 
predominantly in the solid. The reaction of the solid with aqueous EDTA produced a brown oily 
solid and bright blue liquor, of which the greatest relative intensity of the desired compound 2.1 
was observed in the liquor. Both the solid and the liquor show an enrichment of 2.1 compared to 
crude material. 
The modifications to the reaction, increasing the ratio of copper, changing the addition of 
copper from aqueous to methanolic and use of anhydrous copper sulfate led to the method 
using 40% stoichiometric pentahydrate copper added as a methanolic solution. This method can 
be observed to give the greatest enrichment of 2.1 with the least waste of this compound to the 
fractions where lower detection was observed. 
  





2.4.1. Amine Starting Material 
It became evident early in the project that the amine starting material used contained 
substantial impurities. These impurities were detected by ESI-MS where species with additional 
or fewer -CH2CH2NH- groups were detected, and by 13C NMR. The 13C NMR spectrum allowed for 
identification of carbon atoms in different environments with respect to the amine group they 
are connected to. Carbon atoms bonded to primary amines tend to have signals between 35 and 
45 ppm, carbon atoms next to secondary amines between 45 and 55 ppm and carbon atoms 
next to tertiary amines between 50 and 60 ppm.38, 76 
 
Figure 2.5: 13C NMR spectrum of the amine, highlighting the peaks in the regions of the NMR 
spectrum where carbon atoms adjacent to primary, secondary, and tertiary amines are 
typically observed. 
In the 13C NMR spectrum (Figure 2.5) there was evidence of carbon atoms next to tertiary 
amines. The desired compound should have had no tertiary amines, so this information 
indicated that branched isomers or piperazines must be present in the mixture (Figure 2.6).  
Peak picking the 13C NMR spectrum gave 30 individual peaks, including some possible 
multiplets/overlaps (so the number would increase if these peaks are not multiplets or are 
separated from each other). The maximum realistic number of peaks expected for the four 
isomers was 22, showing that there were other unknown compounds present in the mixture. 
This coupled with the overall complexity of the peaks and integral uncertainty (due to the fact 
Tertiary Secondary Primary 




that the relaxation times were not known) has meant that assignment was not achievable. 
However, integration of the relevant sections of the 13C NMR allowed for an estimate as to the 
degree of branching (Table 2.16) 
 
 
Linear polyamine (desired compound) Asymmetric monobranched 
 
 
Symmetric monobranched Dibranched 
Figure 2.6: Polyamine isomers of 3,6,9,12-tetraazatetradecane-1,14-diamine (C10H28N6) 
 
 
Table 2.16: Ratio of carbon atoms adjacent to primary, secondary and tertiary amines for each of the 
probable 3,6,9,12-tetraazatetradecane-1,14-diamine isomers present in the starting material 
Isomer C next to 1° N C next to 2° N C next to 3° N Ratio 
 




3 4 3 3:4:3 
 
3 4 3 3:4:3 
 








Arbitrarily, if the mixture was assumed to be composed of a 1:1:1:1 mixture of each isomer, the 
ratio of carbon atoms next to primary, secondary and tertiary amines would be 12:16:12 
(primary:secondary:tertiary), or 0.75:1.00:0.75. Integration of the 13C spectrum gave a ratio of 
0.50:1.00:0.78, suggesting more secondary and tertiary amines were present than for a 1:1:1:1 
mixture. Multiple attempts were made to assign this spectrum and to determine the true ratio 
based on the integrals, including using excel to create and then solve equations to fit the data, to 
no success. 
ESI-MS evidence was especially indicative of the impurities observed in the amine starting 
material. The major peak observed in the ESI-MS spectrum corresponds to the desired mass for 
the named amine, which could correspond to both the desired linear amine as well as any 
branched isomers. Peaks were also evident for the amines with additional or fewer -CH2-CH2-NH- 
units (Figure 2.7, Figure 2.8) which again were likely composed of linear and branched isomers. 
In addition to this, signals consistent with piperazine compounds were also able to be detected. 
These originated from the reaction to form the polyamine and formed as a by-product, more 
detail of which can be seen in Figure 2.9, Figure 2.10 and Figure 2.11 below. The piperazine 
compounds formed during the synthesis of the polyamine would have had a different molecular 
mass to the equivalent polyamine compound by 28 gmol-1, and many such signals were located 
in the mass spectrum for the amine starting material (Figure 2.7). 
Terminal piperazines would reduce the number of primary amines while increasing the number 
of tertiary amines, while central piperazines decrease the number of secondary amines in favour 
of tertiary amines. Presence of these compounds would also explain the complexity of the NMR 
spectrum as there are multiple isomers depending on the position of the piperazine moiety. 
A final class of side products may be present in the reaction mixture, adding further complexity 
to the starting material. Cyclic versions of the polyamines may have also been present in the 
reaction however, their presence was difficult to determine as the cyclic compounds of the 
linear amines are isomers of the piperazine compounds. The linear piperazine compounds were 
assumed to be present as piperazine compounds with multiple piperazine groups or the isomeric 
cyclic piperazine compounds were detected, showing that piperazines can be formed. 
Additionally, in later sections, the compounds of piperazine masses were seen to react with 
naphthalic anhydride which was not likely to be possible if the mass was entirely composed of 
cyclic compounds unless they contained multiple branches. 
 








Figure 2.7: ESI-MS spectrum of the starting material amine, with peaks colour coded to correspond 
to the species identified in Figure 2.8. The peaks that are not labelled on this spectrum for clarity 
have been identified and their assignment given in Figure 2.8. 
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Figure 2.8: The top rows show the masses and formulae of identified compounds present in the 
reaction mixture, with the observed mass in bold and colour coded and the predicted mass and 
relative intensity (compared to the desired mass) in brackets. The isomers matching that mass and 
formula is then shown in the columns beneath the mass. Note: the isomers shown may not be 
exhaustive of all the isomeric possibilities. Cyclic species including improbable larger macrocycles 
are not shown.  




The peaks corresponding to the masses of free amines were not normally detected following 
reaction, indicating the presence of cyclic compounds may be unlikely. Additional expansion of 
the ESI-MS results for the crude ligand synthesis, focussing on the 0-250 m/z region, would 
potentially identify any trace amine corresponding to the cyclic species following reaction. 
Branched cyclic species on the other hand would have had the potential to react with naphthalic 
anhydride so presence or lack of masses corresponding to the free amine in the spectrum would 
not be able to confirm whether these cyclic compounds exist. 
The relative intensities assigned to the piperazine compounds above therefore cannot be 
identified as corresponding entirely to the piperazines nor to the cyclic compounds, however, 
due to the inability for cyclic compounds to react as observed and the presence of cyclic 
piperazines these peaks were assigned as piperazines for simplicity. This was not an assumption 
that the entire peak was composed of the piperazines, but rather a way to highlight the 
compounds that were able to react in the reactions performed in this work and were therefore 
of interest to this study. ESI-MS peaks corresponding to compounds potentially containing either 
a piperazine moiety and cyclic character or multiple piperazine moieties indicated that the 
piperazine compounds existed in the mixture (Table 2.17).  
Table 2.17: Cyclic piperazine derivatives detected in the ESI-MS spectrum of the amine starting material. 
These may also correspond to linear molecules containing two or three piperazine groups, respectively. 





with one piperazine 
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The amine chosen, 3,6,9,12-tetraazatetradecane-1,14-diamine, was identified by both NMR and 
ESI-MS as having many impurities present. To understand where these impurities may have 
originated from, the method of producing this amine was researched in the literature. The 
amine was likely produced through one of the following methods, as the majority of commercial 
ethyleneamines were produced in this way (in 2005 it was reported that 65% of commercial 
amines were produced using the EDC method)77-78: 
1. EDC (ethylene dichloride) method (Figure 2.9). This method involves reacting 1,2-
dichloroethane with ammonia, producing 1,2-disubstitutedalkanes of varying lengths via 
a nucleophilic substitution. The more 1,2-dichloroethane that is added, the greater the 
number of -CH2CH2NH- units in the final molecules. The mixture that is produced will 
contain a large mix of amines of different molecular weights based on the number of 
repeated units. The reaction also produces HCl as a side product which is neutralised 
with NaOH. The nucleophilic substitution unfortunately favours formation of both linear 
and branched products as the nucleophilicity of primary and secondary and amines are 
similar, with the trend generally being that secondary amines are more nucleophilic than 
primary unless they are substantially sterically hindered. Therefore, branched products 
are likely to form. As these have the same molecular mass, they will be difficult to 
separate from each other, as well as from the similar mass compounds with extra 
units.79 
 
Figure 2.9: Summary of the EDC method for production of ethylene amines, showing common 
products and their subsequent reaction products, including piperazine and branched side 
products. 
2. MEA/RA (monoethanolamine reductive amination) method (Figure 2.10). 2-
Aminoethan-1-ol is oxidised using a nickel hydrogenation/dehydrogenation catalyst to 
give 2-aminoethanal. This then reacts with either ammonia or existing amines to 
produce an amine which then undergoes hydrogenation to give the product amine. 




Again, this method is capable of producing various longer amines including branched 
compounds.80 
 
Figure 2.10: Summary of the MEA/RA method for production of ethylene amines, showing 
common products and their subsequent reaction products, including piperazine and branched 
side products. 
3. Ethylene oxide method (Figure 2.11). This method is less commonly used, however, 
reacts following a similar process to the MEA/RA method. Ethylene oxide is reacted with 
ammonia to produce 2-aminoethan-1-ol, which then reacts further to give 
ethyleneamines77. This also produces 2,2’-azanediylbis(ethan-1-ol) and 2,2’,2’’-
nitrilotris(ethan-1-ol), along with the branched side products. 
 
Figure 2.11: Summary of the ethylene oxide method for production of ethylene amines, 
showing common products and their subsequent reaction products, including piperazine and 
branched side products. 
In these syntheses and in the syntheses using other less common methods, the resulting mixture 
is then fractionally distilled in attempt to isolate the amines of different molecular weights from 
each other.78, 81 
All three methods involve reacting ethyleneamine compounds with additional units, essentially 
building the amines from -CH2CH2NH- units. For an amine composed of five of these units, as for 
the desired compound, there are four possible isomers: a linear polyamine, an asymmetric 




monobranched polyamine, a symmetric monobranched polyamine, and a dibranched 
polyamine. The method used to produce the ethyleneamines is also used to produce piperazine 
which is a common side product in the reaction to produce linear polyamines.78 Piperazine forms 
when two molecules of 1,2-dichloroethane react with one molecule of ammonia each as well as 
reacting together to form a ring. The piperazine product can then react further to become longer 
chain piperazine derivatives. 
The fractional distillation process to separate the resulting mixture into different components 
was not completely effective, leaving many of the compounds of different masses in the fraction 
containing the desired compound along with isomers of the same mass. Synthesis of the ligand 
based on this polyamine mixture was likely to produce a similarly broad range of compounds. 
Attempts have been made to purify this amine outside of the direct scope of this work, including 
silica column chromatography using triethylamine to prevent smearing by deactivating the silica. 
The column was then run using DCM:Methanol 9:1 through to 4:1. Some separation into a 
number of bands was observed on TLC yet the NMR spectra of fractions showed separation was 
incomplete. Direct complexation to copper followed by Sephadex column chromatography was 
also attempted by mixing the amine starting material with copper sulfate and loading this onto a 
Sephadex column. Elution gave some appearance of banding with a large amount of smearing. 
This again resulted in a mixture of compounds in the fractions collected. 
Given the complexity of the mixture, any attempt to purify the amine will be difficult and it was 
unsurprising that these attempts were unsuccessful. Future work surrounding purification of this 
amine could include further distillation of the amine or synthesis of the naphthalimide directly. 
Direct synthesis of the desired linear amine has not been attempted to date due to the prospect 
of generating a similarly complicated mixture of compounds to the purchased chemical. If the 
synthesis were attempted it could be performed using aminoethane-1-ol, reacting with 
naphthalic anhydride, activating the alcohol and reacting this with pure 3,6-diazaoctane-1,8-
diamine (Figure 2.12). This may still result in branched molecules forming which may be able to 
be separated based on their large difference in mass from the naphthalimide groups. 
 
Figure 2.12: Future work proposal. Isomeric possibilities and side products not shown. 
  




2.4.2. Crude Ligand Material 
After attempts to purify the amine were unsuccessful, effort was focussed instead on separating 
the desired naphthalimide compound 2.1 from the crude ligand mixture following the reaction 
of the amine with naphthalic anhydride. This was a logical approach not only because of the 
inability to separate free amine, but also due to the observation that mononaphthalimide, 
dinaphthalimide and trinaphthalimide products can all form simultaneously from the synthesis 
and purification would therefore be required anyway.  
The mechanochemical procedure was an adaption of one described by Arya et al and involves 
directly grinding aromatic anhydrides with primary amines in a mortar and pestle for ten 
minutes, achieving a yield of approximately 90%.82 The method by Arya et al was performed to 
synthesise mono- and diimides from primary amines and 9,10-dihydroanthracene-9,10-a,b-
succinic anhydride, a reaction similar to that described in this work in that the primary amine 
was reacted with a bulky anhydride to form imides. This method was preferred over the solvent-
reflux method described by Braña et al in their synthesis of compound 2.1 as the 
mechanochemical procedure can be performed in greater quantities, in shorter time scales and 
was a greener chemistry approach with less work up than the solution-based method. This was 
because the lack of solvent allows for easy handling of greater amounts of starting materials 
without the added hazard of the bulk solvent. The reaction duration was shorter, going from 
hours at reflux to minutes of mechanochemistry. Additionally, the work up involved was quick 
drying of the powdery sample rather than concentration in vacuo, recovery from the vessel and 
subsequent drying of the oily product that resulted when the reaction was performed in this 
fashion. Reactions at reflux were attempted and the range of impurities was not observed to 
decrease by ESI-MS (with emphasis placed on the presence of the mononaphthalimide species) 
and therefore the solvated procedure was abandoned.  
A series of experiments were conducted in which the stoichiometry of the starting materials was 
varied in attempts to obtain product richer in the desired compound. It was found that side 
products were always a substantial contaminant of the desired product, however, the nature of 
these side products varied with the stoichiometric ratio. The method was adjusted to use a slight 
excess of naphthalic anhydride, approximately a 1:3 molar ratio as opposed to the 
stoichiometric 1:2. The method was also adjusted to include the use of a small volume of 
chloroform to aid mixing.  
The stoichiometry of the reaction was tailored to prevent the formation of the 
mononaphthalimide product 2.2 even though this increased production of the product where a 




third naphthalic anhydride group had reacted (Figure 2.16). This was because the impurity 
produced with an additional naphthalene moiety was likely to be more easily separated from the 
others through their poorer complexation with copper (See Section 2.4.3). As the 
mononaphthalimide was likely to be a good ligand it would not be separated from the desired 
compound during the copper complexation technique used to purify, while the molecules with 
additional naphthalimides potentially could be.  
The mass of crude material gained from this reaction was generally slightly greater than the 
mass of the starting materials used. The material was allowed to dry before weighing and use to 
allow evaporation of the chloroform used and the water generated in the synthesis, however, 
the increased mass suggests that the water was retained by the material and that the material 
may be hygroscopic despite its low solubility in water. Further possibilities include reactions with 
carbon dioxide in the air. Products from such reactions were not observed. 
Multiple different compounds were detected by ESI-MS (Figure 2.13), and of these compounds, 
all had multiple possible isomers. As a result, the complexity of the mixture cannot be fully 
determined by ESI-MS. The discussion will focus instead on the group of isomers described by 
the mass detected, with some discussion surrounding the isomers that may be present. The 
compounds detected include mono-, di- and trinaphthalimide and naphthalamide products of 
the piperazine tetramine, pentaamine, piperazine pentaamine, hexamine, piperazine hexamine, 
heptamine and piperazine heptamine compounds. The distribution observed was also similar to 
that of the starting material, with the largest peaks corresponding to the hexamines and the 
piperazine derived hexamine products.  
 





Figure 2.13: ESI-MS spectrum showing different compounds detected following reaction of 
the amine with naphthalic anhydride. These compounds have been assigned and labelled 
with both the compound number and the colour of the amine that would yield this 
compound as per Figure 2.7.  
 
The NMR information collected on the crude synthetic product also indicates a complex mixture, 
even in the poor-quality spectra which were able to be obtained. There were peaks in the 13C 
NMR spectrum (Figure 2.14) characteristic of carbon atoms adjacent to primary (36-38 ppm), 
secondary (44-47 ppm) and tertiary (51-54 ppm) nitrogen atoms. The peaks were in different 
locations to the free amine, which may be due to the solvent difference or the peaks of the 




aromatic carbons but was likely due to the different environments of the nitrogen atoms 
(including both the addition of naphthalimides and their electronic effects as well as changes to 
overall symmetry). The aromatic carbon atoms would likely show as peaks past 100 ppm. Of 
note was the presence of peaks that may correspond to carbon atoms next to primary nitrogen 
atoms, as this would imply that there were branched isomers that did not have naphthalimide 
attached to every terminal nitrogen atom. 
 
Figure 2.14: 13C NMR spectrum of the alkyl region of the crude material alongside the free 
amine (top) and crude ligand mixture (lower). 
The 1H NMR spectrum (Figure 2.15) showed a ratio of 6:18 aromatic:alkyl protons when 
integrated, with 9 protons of these appearing as an amine region and 1 removed for the solvent. 
The expected ratio, based on reaction stoichiometry, would be 6:9.33 for unreacted material, 
6:8 for dinaphthalimide material with unreacted additional anhydride and 6:7.33 for 
trinaphthalimide material. This decrease was due to the loss of protons on the nitrogen atoms as 
imide formation occurred. The ratio from the NMR appeared to be more complex as it did not 
correspond to any ratio above, likely due to overlap of the amine peak with alkyl protons or 
presence of water. 





Figure 2.15: 1H NMR spectrum of the crude ligand material, showing the overlap and 
complexity of the peaks, which were not able to be fully assigned. Integrations of the aromatic 
and alkyl regions of the spectrum are also shown. Spectra of drier material was not able to be 
obtained. 
Despite the issues surrounding the complexity of this mixture, the ESI-MS analyses highlighted 
the presence of the desired compound mass in high amounts. This indicated that the intended 
dinaphthalimide of the hexamine and the related isomers are substantial components of the 
crude reaction material. As observed in Table 2.1, the composition as detected by ESI-MS varies 
between syntheses, suggesting that there is some level of inconsistency in the product even 
when produced identically. 
2.4.3. Purification by Complexation 
The synthesis of the ligand produced a range of compounds due to the low purity of the amine 
starting material. The products of these impurities may have had fewer available donor atoms 
than the desired compound (Figure 2.16). As a result, they would have had a lower coordinative 
ability than the desired compound and would be outcompeted for coordination in the presence 
of limited metal availability. As the chelate theory predicts, the more nitrogen atoms with free 
lone pairs in the molecule, the better the ligand will be. Considering only the molecules derived 
from the linear and mono-branched hexamine, the mononaphthalimide ligand 2.2 will form the 
most thermodynamically favourable complex, followed by the dinaphthalimide 2.1, followed by 
the dinaphthalimide ligand with additional amide substitution 2.5. This means it was possible 
that the mixture where excess anhydride was used will be able to be purified by complexation. 




This is because the additionally substituted ligands would have been unlikely to coordinate in 
favour of the desired product, and therefore the complex and the residual starting material 
mixture can be separated to yield the copper complex of the desired product. The only better 
ligand depicted (2.2) was unlikely to be present in the crude material due to the excess 
naphthalic anhydride used encouraging its conversion to the dinaphthalimide species.  
 
Figure 2.16: Compounds 2.1, 2.2, 2.3 and 2.5 are shown (left) with their copper complexes 
(right). The figure also shows the number of coordination sites for coordination to metal 
centres and the predicted complexes of these compounds with copper (right). Note that the 
coordination geometry and ligand isomer is shown as a simplification and there are many 









For the piperazine compounds, the piperazine moiety reduces the strength of some donor 
atoms. This is due to the geometry required for the piperazine compound to coordinate. The 
piperazine moiety is a six membered ring and will therefore be most stable in a chair orientation 
(Figure 2.17). In this orientation, the lone pair of electrons on the nitrogen atoms are oriented in 
different directions to each other, meaning that it is not possible for both nitrogen atoms to 
coordinate to the same metal while in the chair geometry. The piperazine group must adopt a 
boat-like conformation to coordinate both nitrogen donors to the metal centre. This of course 
comes with a reduction in stability due to the ring strain of the boat conformation, so the 







Figure 2.17: The most favourable orientation for the piperazine moiety both free (above) 
and coordinated (below). This highlights the difference in the orientation, with the left side 
showing the distortion from chair form to boat upon coordination, and the right showing 
the distortion to the hexagonal shape of the ring when viewed from above the plane of the 
ring. 
Unfortunately, the purification by complexation strategy will not allow for elimination of the 
longer side products as these will be better ligands than the desired compound due to their 
available donor atoms for coordination. None of the purification attempts to date have been 
able to overcome this issue.  




2.4.3.1. Purification by Complexation Reaction Stages 
The process of purification by complexation, as seen in the flowcharts in Sections 2.2.6 and 
Appendix A, involved taking the crude ligand material and reacting it with copper at a less than 
stoichiometric ratio under reflux. The crude ligand mixture of the desired compound and side 
products was dissolved in methanol and the copper salt added as a solution. This was intended 
to produce a complexation product of the copper centre with the best ligands available, ideally 
the desired ligand, and the remaining side products would hopefully stay in solution unchanged. 
Following separation of the complexation product from the unreacted side products, the 
complexation products were reacted with EDTA to remove the copper and leave the free ligand 
behind. It was expected that the complexation product from the previous step would produce 
an aqueous solution of the copper EDTA complex and the desired ligand would precipitate for 
collection. In this way, the desired compound could be separated from the side products.  
The complexation reaction produced a solid and a liquor, with the solid containing the greater 
proportion of the desired complex Cu(2.1), which was detected as up to 68% and an average of 
41% of the complexation solid (Table 2.18; see the table for the explanation on how percentages 
were calculated). This result represents an enrichment compared to the crude product, which 
had a maximum composition of 41% and average of 31% desired ligand, 2.1. This reaction then 
led to further enrichment as this solid was treated with EDTA, leading to a solution that had a 
maximum composition of 69% and mean of 51% desired ligand, 2.1. This aqueous fraction was 
still contaminated with undesired side products, and the attempted extraction with chloroform 
to collect the desired compound led to removal of much of the undesired side products and a 
subsequent enrichment of the desired compound 2.1. This enrichment in the remaining solution 
following extraction was observed as a maximum composition of 85% and a mean of 63%. It was 
evident that the desired compound can be enriched during this process by comparison to the 
crude material. 
Unfortunately, the phase in which the greatest enrichment was observed by ESI-MS (aqueous 
phase in Section 2.2.6.3) contained substantial Cu(EDTA) presence, meaning the true enrichment 
is not known. Attempts to separate these species through anion exchange chromatography led 
to some separation, yet the fractions collected retained some blue colour indicating that 
complex was still present. The purity of the recovered fractions also appeared to decrease, with 
a lower percentage composition for the desired compound once the solution had been run 
through the column (Table 2.11 and Table 2.13). The reason for this is unknown. 
The solid produced during the same reaction (Section 2.2.6.3) as the aqueous phase just 
described also demonstrated an increased enrichment compared to crude material. While this 




increase was overall not as substantial, increasing by only a few percent, in the reaction 
described in Section 2.2.6.3 the increase in enrichment was the same for both the solid and the 
aqueous phases. This suggests that the solid could also be used as although the enrichment was 
not as great, the bulk of the material ended up in this phase. Additionally, even though the 
enrichment was not as great in some cases, the phase considered more enriched was 
determined to be so based on numbers which excluded the substantial Cu(EDTA) side product 
present within that phase. As such, the enrichment is likely much lower than calculated. 
A discussion around each fraction of the reaction following the purification by complexation 
protocol as discussed in the experimental section, followed by a discussion on the individual 
variations made to the method and their consequences, can be found in Appendices C and D.  
Table 2.18: Summary of results tables, showing the percentage composition values of the desired 
compound, based on relative intensities by ESI-MS as per the results tables. The columns show 
the percentage composition for the desired compound in each fraction, and the rows show the 
iteration of the reaction. The penultimate row shows the mean value of the percentage 
compositions and the final row shows the range. Where the desired compound was the free 
ligand, the mean is highlighted in green, and where the desired compound was the copper 































33% Aqueous Copper (Appendix B.1) 41 12 9 16 4 23 39 2   
33% Methanolic Copper (Appendix B.2) 27 61 12 10 7 54 6 4   
33% Methanolic Copper Repetition (Appendix B.3) 29 38 14 14 14 38 15 9 21 50 
40% Methanolic Copper (Appendix B.4) 29 44 14 20 25 69 7 14 10 52 
40% Methanolic Anhydrous Copper (Appendix B.5) 19 68 14  17 61 3 4 21 84 
40% Methanolic Copper 3.5x Scale (Appendix B.6) 19 39 16  23 67 15 10 11 85 
40% Methanolic Copper 7.5x Scale (Table 2.15) 38 22 27 67 44 44 8 11 6 44 
Mean 31* 41 15 25 19 51 13 8 14 63 
Maximum and Minimum values 
(range) 
19 to 41 
(22) 
12 to 68 
(56) 
9 to 27 
(18) 
10 to 67 
(57) 
4 to 44 
(40) 
23 to 69 
(46) 
3 to 39 
(36) 
2 to 14 
(12) 
6 to 21 
(15) 
44 to 85 
(41) 
 *As this column includes duplicates from experiments that used the same starting material, the 
mean value excludes these duplicates, taking each value once.  
2.4.3.2. Variations to the Purification by Complexation method 
Many variations to the method were made in attempts to refine the process towards fractions 
with the greatest enrichment of the desired ligand. The method described in this chapter was 




the final method used during this work and appeared to give the greatest enrichment of the 
desired compound.  
From the results obtained from these experiments, it appeared that using aqueous copper 
sulfate resulted in little to no enrichment when compared to crude material by ESI-MS, while 
switching to methanolic addition of copper sulfate increased the enrichment. Additionally, 
switching from 33% stoichiometric to 40% stoichiometric copper also resulted in an increased 
enrichment to the desired compound in various reaction fractions. The use of anhydrous copper 
as opposed to the pentahydrate appeared to have increased the enrichment, but the poor 
solubility of the anhydrous copper in methanol made this method substantially more difficult to 
accurately perform and reproduce. Future work surrounding the use of the pentahydrate in a 
larger reaction volume to recreate the concentration of the anhydrous reaction may produce 
interesting results as the increased reaction volume may have been the true reason for this 
increased enrichment (See the Appendix D subsection on the pentahydrate versus anhydrous 
copper for more). 
The results from this process show that, while enrichment of the desired compound was 
achieved, this was at the substantial detriment of the yield. As such, it was difficult to determine 
which of the variations described was most successful and further work around repetition of the 
methods would need to be performed. The greatest overall enrichment of the desired 
compound was observed in the post chloroform extraction solution of the EDTA treated 
complexation solid from the 40% methanolic copper reaction performed on 3.5x scale (Appendix 
B.6), however, as identified above this aqueous fraction contained predominantly the Cu(EDTA) 
complex and so the true enrichment is unknown. Additionally, lack of repetitions makes it 
difficult to comment fully on which method was best. 
The methods and results for these variations can be found in Appendix A, and a further 
discussion surrounding the impact of the variations can be found in Appendix D. 
2.4.4. Conclusions 
During this study, a polyamine mixture containing a multitude of related ethyleneamines was 
reacted with naphthalic anhydride in the attempt to synthesise a dinaphthalimide tetradentate 
ligand for use in dinuclear complex syntheses. While this compound was synthesised, a range of 
other compounds were also detected due to the other amines present in the starting material. 
Purification by complexation was applied to attempt to separate out the desired compound 
from the by-products. This strategy was approached as the various naphthalimide side products 
were likely to have different properties which might allow them to be separated. This included 




the theory that the majority of the side products were likely to be poorer ligands than the 
desired compound. 
During this study enrichment and isolation of the desired complex was achieved to a much 
greater enrichment than in the crude material. This occurred through the collection of the solid 
precipitate following complexation and subsequent treatment with EDTA (Figure 2.18). The 
enriched compound was detected in the solution following the EDTA treatment. While this then 
gave reasonably enriched material (as judged by ESI-MS) through both anion exchange 
chromatography and through precipitation from water, the reaction was very low yielding and 
much of the desired compound was lost to other fractions during the work up. As such, future 
work should be attempted to optimise the quantity of the material recovered, not just the 
quality. 
 
Figure 2.18: The flowchart from Figure 2.4 modified to highlight the path to the material that 
showed the greatest enrichment of the desired compound 2.1. 
Through the experiments where variables surrounding the copper were altered, the reaction 
conditions were able to be somewhat refined. It became evident that methanolic addition of a 
40% stoichiometric solution of copper sulfate pentahydrate was the best set of conditions 
trialled for this reaction and resulted in the greatest enrichment of the compound compared to 
the side products. Repeated experimentation showed that the process was fairly reproducible 





 Cobalt Complexes 
 
3.1. Introduction 
The intention of this project was to synthesise a heterodinuclear anticancer drug by coupling 
cobalt(III) and platinum(II) centres. As described in Section 1.3, the dinuclear complex was 
designed to act as a prodrug of cisplatin, retaining its anticancer efficacy once activated. The 
cobalt centre, as in Sections 1.4 and 1.5, is to be coupled to the platinum centre to give the 
platinum anticancer centre increased selectivity. The desired ligand 2.1 was designed to 
physically block the interactions on the platinum centre that. Led to complex degradation.  
The tetradentate ligand synthesised in Chapter 2 would form a complex with cobalt(III) that 
leaves two vacant coordination sites. To allow for the water ligands ultimately required for 
dinuclear complex synthesis, carbonate and nitrite ligands were chosen as candidates for this 
work (as seen in Section 1.5). Literature examples of tetradentate amine complexes of cobalt(III) 
with both nitrite and carbonate ligands are known, as are studies where these ligands are 
subsequently replaced by other ligands. 83, 84, 85, 86, 87, 88 
To form these complexes the cobalt centre must first be complexed to nitrite or carbonate 
ligands, forming [Co(NO2)6]3- or [Co(CO3)3]3- complexes, which are then reacted with the 
tetradentate ligand. Many tetradentate amine ligand complexes have been synthesised in this 
manner, such as in the syntheses of complexes [Co(cyclam)(NO2)2]+, [Co(dimethylcyclam)OCO2]+, 
[Co(trpyn)OCO2]+, [Co(pmea)OCO2]+, [Co(abap)OCO2]+ and [Co(trien)(NO2)2]+ (Figure 3.1). In 
these syntheses, the cobalt(III) complex is first formed followed by ligand exchange of either 
NO2- or CO32- ligands for the tetradentate amines. The yields of these complexes range from 18% 
to 81%, with the lowest percentage corresponding to formation of crystals of a compound that 
turned out to be a dinuclear complex. In general, these syntheses appear to be relatively high 
yielding, producing sufficient material to allow for further reaction steps as desired. As a result, 
similar strategies were employed within this work. 
 
(dimethylcyclam = meso-5,12-dimethyl-1,4,8,11-tetraazacyclotetradecane; trpyn = tris(2-(1-
pyrazolyl)ethyl)amine); pmea = bis(2-pyridylmethyl)-2-(2-pyridylethyl)amine; abap = N-(2-















Yield: Not given 
[Co(dimethylcyclam)OCO2]+ 84, 85 
Yield: 65% 












Figure 3.1: Tetramine complexes of cobalt(III), synthesised by displacement of NO2- or CO32- 







Cobalt starting materials were purchased and used directly. The ligands used were synthesised 
as previously described. General methods and procedures can be found in Sections 2.2.1-2.2.5. 






Following the method by Mori and Douglas89, cobalt chloride ([Co(OH2)6]Cl2, 3.2 g 13.4 mmol) 
was dissolved in distilled water (3.2 mL) and hydrogen peroxide (2 mL, 30 %) added. A separate 
solution of potassium bicarbonate (KHCO3, 6.4 g 63.9 mmol) in distilled water (6.4 mL) was 
placed on a magnetic stirrer in a beaker and the cobalt chloride solution added dropwise with 
stirring over the course of thirty minutes. The colour change observed was from pink to a deep 
green solution immediately with formation of a deep green precipitate over time. 
While the cobalt solution was being added to the potassium bicarbonate solution, crude 
tetradentate ligand 2.1 (C34H36N6O4, 8.0 g 13.5 mmol) was added to methanol (125 mL) in a 250 
mL round bottom flask and brought to reflux by placing on a hot plate stirrer. Once at reflux, and 
the addition of cobalt solution to potassium bicarbonate solution was completed, the resulting 
green mixture was added to the methanolic ligand solution. The beaker was rinsed with distilled 
water (2 mL) which was also added to the mixture at reflux. The resulting mixture was then 
heated with stirring for 20 hours to give a burgundy solution with some deep green solid. The 
solid was then removed by filtration while the mixture was still warm. Upon cooling, the liquor 
produced an oily burgundy solid (m.p. 89-96 °C) with the liquor remaining burgundy. The liquor 






Analysis of Solid: 
Mass: [M +H+] 1+: m/z 711.1986 1+ (Predicted 711.1977). Not the major peak, major peaks 
assigned to side products from the ligand material (including 387.1570 2+, assigned as 2.3 
predicted 387.1583 2+ for C46H42N6O6). 
IR: 1696 (m), 1655 (s), 1621 (m), 1586 (s), 1512 (w), 1437 (w) 1377 (m), 1343 (s), 1290 (w), 1234 
(s), 1170 (m). 
See results for analysis of other phases (Section 3.3.1, Appendix E). 
3.2.2. [Co(C34H36N6O4)(CO3)]+ using enriched ligand material from Section 
2.2.6.5 
This reaction was performed as per Section 3.2.1 with the following amendments: 
- [Co(OH2)6]Cl2 (0.1 g, 0.42 mmol) was dissolved in distilled water (0.5 mL) and 30% hydrogen 
peroxide (0.25 mL) added.  
- Potassium bicarbonate (KHCO3 0.2 g) was dissolved in distilled water (0.5 mL)  
- The cobalt chloride solution added dropwise with stirring over the course of five minutes 
- enriched tetradentate ligand 2.1 (C34H36N6O4, 0.25 g 0.42 mmol) was added to methanol (25 
mL) in a 50 mL round bottom flask 
- The beaker from the cobalt carbonato synthesis was rinsed with distilled water (0.5 mL) which 
was also added to the refluxing solution.  
Difference in the results obtained between the methods include the substantially reduced 
detection of ligand side products and lack of formation of an oil following cooling of the reaction 
liquor.  
Analysis of Solid: 
Mass: [M +H+] 1+: m/z 711.1986 1+ (Predicted 711.1977 for [Co(C34H36N6O4)(CO3)]+). Not the 
major peak, major peak 325.1013 2+ (assigned as 3.3, predicted 325.1026 2+ for 
[Co(C34H35N6O4)]2+) 
 






3.2.3. [Co(C34H36N6O4)(NO2)2]+ from crude ligand material produced as in 





Cobalt nitrate (Co(NO3)2∙6H2O, 1.00 g 3.5 mmol) was dissolved in water (10 mL) and stirred into a 
solution of potassium nitrite (KNO2, 2.00 g, 24.4 mmol) dissolved in water (15 mL). The resulting 
solution was stirred for 30 minutes at 70°C. Acetic acid (50 % v/v, 3.25 mL 27 mmol) was added 
and the slurry allowed to settle overnight. This slurry was then filtered and the solid collected.  
A solution of crude tetradentate ligand 2.1 (C34H36N6O4, 1.00 g 1.7 mmol) dissolved in methanol 
(20 mL) was brought to reflux using a hotplate stirrer. This recovered solid (mass unknown as 
solid was used directly) was added to the solution in a single addition. The resulting mixture was 
heated at reflux and stirred overnight. Alternatively, sodium cobaltinitrite (Na3[Co(NO2)6] 1.9 g, 
4.7 mmol) was dissolved in methanol used in place of the filtered product and reaction 
continued analogously. The reaction resulted in production of a yellowish precipitate and orange 
solution which was warm filtered to give bright yellow orange solid material that was visually 
indistinguishable from the [Co(NO2)6]3- starting material and was similarly soluble in water. ESI-
MS analysis of this solid gave no assignable peaks, which was the same as was observed for the 
starting material. The filtrate yielded an orange-brown precipitate (0.1 g) once cooled in the 
fridge, which was then further characterised by IR, ESI-MS, and melting point. (m.p. 101-104 °C). 
Analysis of solid from cooling overnight: 
Mass: [M +H+] 1+: m/z 743.1990 1+ (Predicted 743.1983 1+ for [Co(C34H36N6O4)(NO2)2]+ major 
peak) 
IR: 1694 (m), 1651 (s), 1624 (m), 1587 (s), 1512 (w), 1460 (w), 1438 (w), 1412 (m, br), 1360 (m), 





See results for analysis of other phases (Section 3.3.1, Appendix E). 
3.2.4. [Co(C34H36N6O4)(NO2)2]+ from crude ligand material produced as in 
Section 2.2.6.1 (stoichiometric) 
Sodium cobaltinitrite (Na3[Co(NO2)6] 5.45 g, 13.5 mmol) was added to a refluxing solution of 
tetradentate ligand 2.1 (C34H36N6O4, 8 g 13.5 mmol) dissolved in methanol (125 mL). This mixture 
was then heated at reflux and stirred for 19 hours. The reaction resulted in production of a 
brown, beige and orange precipitate and an orange solution which was warm filtered and 
refrigerated overnight to produce an orange oily solid.  
Analysis of Oily Solid: 
Mass: [M +H+] 1+: m/z 743.1993 1+ (Predicted 743.1983 1+ for [Co(C34H36N6O4)(NO2)2]+ minor 
peak, major peak was 387.1579 2+, assigned as 2.3 predicted 387.1583 2+ for C46H42N6O6) 
See results for analysis of other phases (Section 3.3.1, Appendix E). 
3.2.5. [Co(C34H36N6O4)(NO2)2]+ using enriched ligand material from Section 
2.2.6.5 (stoichiometric) 
Purified tetradentate ligand 2.1 (C34H36N6O4, 0.25 g 0.42 mmol) was dissolved in methanol (25 
mL) in a 50 mL round bottom flask and brought to reflux. Sodium cobaltinitrite (Na3[Co(NO2)6] 
0.17 g, 0.42 mmol) was added as a solid and washed into the solution using methanol. The 
orange mixture was heated for 19 hours and resulted in production of a pale blue precipitate, a 
yellow orange precipitate and orange solution which was warm filtered. 
Analysis of Orange Solid: 
Mass: [M +H+] 1+: m/z 743.1991 1+ (Predicted 743.1983 1+ for [Co(C34H36N6O4)(NO2)2]+ minor 
peak, major peak was 325.1031 2+, assigned as 3.3 predicted 325.1026 2+ for [Co(C34H35N6O4)]2+) 






3.3.  Results 
Figure 3.2 shows the cobalt complexes discussed further in this chapter. 
 
3.1: [Co(2.1)CO3]+ complex, 711.1984 1+ (predicted 711.1977 1+ for [Co(C34H36N6O4)CO3]+) 
 
3.2: [Co(2.1)NO2]+ complex, 743.1991 1+ (predicted 743.1989 1+ for [Co(C34H36N6O4)(NO2)2]+) 
 
3.3: [Co(2.1 -2H+)]2+ complex, 325.1009 2+ (predicted 325.1026 2+ for [Co(C34H35N6O4)]2+) 
Figure 3.2: These structures correspond to the structures discussed in this chapter. The 
structures are deliberately shown without geometry and as only one isomeric possibility, both 





3.3.1. [Co(C34H36N6O4)(CO3)]+ Syntheses 
3.3.1.1. ESI-MS of Synthesis using Crude Ligand 
The following table summarises the ESI-MS results from the synthesis of [Co(2.1)CO3]+ using 
crude ligand material, as described in Section 3.2.1. The ESI-MS results are quoted as relative 
intensities which were calculated as per Chapter 2; by measuring the peaks and dividing each 
peak height by that of the major peak in the mixture. The percentage compositions of each 
fraction are given in the final row. The percentage composition was calculated as the percentage 
of the desired compound (2.1 in the first column, [Co(2.1)CO3]+ in the following three columns) 
compared to the major products of the reaction, 2.1, 2.3, 2.4, 2.5 and [Co(2.1)CO3]+. The free 
ligand 2.1 is highlighted in green, and the [Co(2.1)CO3]+ complex is highlighted in lavender. 
 
 
Table 3.1: ESI-MS results for the synthesis of [Co(C34H36N6O4)(CO3)]+ using crude ligand material.  







[2.30+1H+] 1+ 199.0394 1+ 199.0395 1+ for C12H7O3 0.31  0.12  
[2.2+2H+] 2+ 207. 2+ 207.1372 2+ for C22H40N6O2 0.15    
[2.25+2H+] 2+ 254.1036 2+ 254.1055 2+ for C30H28N4O4  0.01   
[2.13+2H+] 2+ 275.6259 2+ 275.6266 2+ for C32H33N5O4 0.10 0.02  0.03 
[2.18+2H+] 2+ 288.6330 2+ 288.6345 2+ for C34H35N5O4    0.03 
[2.1+2H+] 2+ 297.1470 2+ 297.1477 2+ for C34H38N6O4 1.0  0.05  
[2.4+2H+] 2+ 310.1549 2+ 310.1556 2+ for C36H40N6O4 0.93 0.20 1.0 0.23 
[2.7+2H+] 2+ 306.1520 2+ 306.1558 2+ for C34H40N6O4 0.59    
[Co(2.1)]+ -H+ 325.1011 2+ 325.1026 2+ for [Co(C34H35N6O4)]2+  0.05  0.06 
[2.15+2H+] 2+ 365.6359 1+ 365.6372 2+ for C44H35N5O6    0.02 
[2.12+1H+] 1+ 370.2235 2+ 370.2243 1+ for C20H28N5O2 0.07    
[2.3 +2H+] 2+ 387.1568 2+ 387.1583 2+ for C46H42N6O6 0.71 1.0 0.37 1.0 
[2.5+2H+] 2+ 396.1623 2+ 396.1636 2+ for C46H44N6O7 0.77 0.12 0.07  
[2.20+2H+] 2+ 408.6776 2+ 408.6794 2+ for C48H47N7O6 ?0.37?  0.12 0.14 
[2.21+2H+] 2+ 417.6829 2+ 417.6847 2+ for C48H49N7O7 0.28    
[2.23+2H+] 2+ 421.6852 2+ 421.6872 2+ for C50H49N7O6  0.09   
[Co(2.1)CO3]+ 711.1974 1+ 711.1977 1+ for [Co(C34H36N6O4)CO3]+  0.01 0.05 0.03 






3.3.1.2. ESI-MS of Synthesis using Enriched Ligand 
The following table summarises the ESI-MS results from the synthesis of [Co(2.1)CO3]+ using 
crude ligand material, as described in Section 3.2.2. The ESI-MS results are quoted as relative 
intensities which were calculated as per Chapter 2; by measuring the peaks and dividing each 
peak height by that of the major peak in the mixture. The percentage compositions of each 
fraction are given in the final row. The percentage composition was calculated as the percentage 
of the desired compound (2.1 in the first column, [Co(2.1)CO3]+ in the following two columns) 
compared to the major products of the reaction, 2.1, 2.3, 2.4, 2.5 and [Co(2.1)CO3]+. The free 






Table 3.2 ESI-MS results for the synthesis of [Co(C34H36N6O4)(CO3)]+ using enriched ligand 
material.  





[2.1+2H+] 2+ 297.1465 2+ 297.1477 2+ for C34H38N6O4 1.0 0.04 1.0 
[2.4+2H+] 2+ 310.1538 2+ 310.1556 2+ for C36H40N6O4 0.12 0.05 0.88 
[Co(2.1)]+ -H+ 325.1013 2+ 325.1026 2+ for [Co(C34H35N6O4)]2+  1.0 0.07 
[Co(2.1)(OH)]2+ 334.1068 2+ 334.1079 2+ for [Co(C34H36N6O4)(OH)]2+  0.37  
[2.12+1H+] 1+ 370.2232 2+ 370.2243 1+ for C20H28N5O2 0.09   
[2.5+2H+] 2+ 396.2388 2+ 396.1636 2+ for C46H44N6O7   0.05 
[Co(2.1)CO3]+ 711.1981 1+ 711.1977 1+ for [Co(C34H36N6O4)CO3]+  0.21 0.02 
[Co(2.1)CO3OH2]+ 729.2101 1+ 729.2083 1+ for [Co(C34H36N6O4)(CO3)(OH2)]+  0.05  







3.3.2. [Co(C34H36N6O4)(NO2)2]+ Syntheses 
3.3.2.1. ESI-MS Results of the Synthesis using Crude Ligand Material 
(Excess Cobalt) 
The following table summarises the ESI-MS results from the synthesis of [Co(2.1)(NO2)2]+ using 
crude ligand material, as described in Section 3.2.3. The ESI-MS results are quoted as relative 
intensities which were calculated as per Chapter 2; by measuring the peaks and dividing each 
peak height by that of the major peak in the mixture. The percentage compositions of each 
fraction are given in the final row. The percentage composition was calculated as the percentage 
of the desired compound (2.1 in the first column, [Co(2.1)(NO2)2]+ in the following three 
columns) compared to the major products of the reaction, 2.1, 2.3, 2.4, 2.5 and [Co(2.1)(NO2)2]+. 
The free ligand 2.1 is highlighted in green, and the [Co(2.1)(NO2)2]+ complex is highlighted in 
orange. See Figure 3.3 for a detailed analysis of the peak corresponding to [Co(2.1)(NO2)2]+ in the 
ESI-MS spectrum. 
Table 3.3: ESI-MS results for the synthesis of [Co(C34H36N6O4)(NO2)2]+ using crude ligand material 
and excess cobalt. 







[2.17+2H+] 2+ 198.6229 2+ 198.6239 2+ for C22H31N5O2 0.40    
[2.25+2H+] 2+ 254.1030 2+ 254.1055 2+ for C30H28N4O4 0.29    
[2.13+2H+] 2+ 275.6254 2+ 275.6266 2+ for C32H33N5O4 0.55    
[2.18+2H+] 2+ 288.6335 2+ 288.6345 2+ for C34H35N5O4 0.14    
[2.1+2H+] 2+ 297.1464 2+ 297.1477 2+ for C34H38N6O4 0.92    
[2.4+2H+] 2+ 310.1539 2+ 310.1556 2+ for C36H40N6O4 1.0    
[2.19+2H+] 2+ 318.6673 2+ 318.6688 2+ for C36H43N7O4 0.57    
[Co(2.1)]+ -H+ 325.1020 2+ 325.1026 2+ for [Co(C34H35N6O4)]2+  1.0   
[2.3 +2H+] 2+ 387.1565 2+ 387.1583 2+ for C46H42N6O6 0.07    
[2.5+2H+] 2+ 396.2387 2+ 396.1636 2+ for C46H44N6O7 0.15    
[2.11+2H+] 2+ 439.2807 1+ 439.2822 1+ for C24H35N6O2 0.11    
[Co(2.12)(NO2)2]+ 520.1346 1+ 520.1355 1+ for [Co(C20H28N5O2)(NO2)2]+   0.13  
Unknown 605.2519 1+ Unknown  0.32 0.19 0.14 
Unknown 677.2844 1+ Unknown  0.82 0.23 0.25 
[Co(2.1)CO3]+ 711.1984 1+ 711.1977 1+ for [Co(C34H36N6O4)CO3]+  0.56   
[Co(2.1)(NO2)2]+ 743.1987 1+ 743.1989 1+ for [Co(C34H36N6O4)(NO2)2]+  
Not 
Detected 1.0 1.0 







Oily Solid IR: 1694 (m), 1651 (s), 1624 (m), 1587 (s), 1512 (w), 1460 (w), 1438 (w), 1412 (m, br), 
1360 (m), 1342 (m), 1305 (m), 1235 (s) 
Crude Ligand IR: 1694 (m), 1650 (s), 1621 (m), 1587 (s), 1513 (w), 1439 (m), 1375 (m), 1346 (s, 
br), 1237 (s) 
The two IR spectra peaks indicate that while the complexation material contains peaks 
corresponding to the naphthalimide moiety of the free ligand, there were differences between 
the two spectra. Common peaks have been left as plain text while the peaks that exist in only 
one of the two spectra are bolded. This indicated that some new peaks were present, and some 
existing peaks had disappeared, in the non-fingerprint region of the complex IR spectra.  
 
Figure 3.3: ESI-MS spectra showing the result of the synthesis of [Co(C34H36N6O4)(NO2)2] 
(743.1990 1+, predicted 743.1993, top spectrum). The sample isotope pattern and mass 






3.3.2.2. ESI-MS Results of the Synthesis using Crude Ligand Material (Stoichiometric) 
The following table summarises the ESI-MS results from the synthesis of [Co(2.1)(NO2)2]+ using crude ligand material, as described in Section 3.2.4. The ESI-
MS results are quoted as relative intensities which were calculated as per Chapter 2; by measuring the peaks and dividing each peak height by that of the 
major peak in the mixture. The percentage compositions of each fraction are given in the final row. The free ligand 2.1 is highlighted in green, and the 
[Co(2.1)(NO2)2]+ complex is highlighted in orange. 
Table 3.4: ESI-MS results for the synthesis of [Co(C34H36N6O4)(NO2)2]+ using crude ligand material and stoichiometric cobalt. 















[2.30 +1H+] 1+ 199.0394 1+ 199.0395 1+ for C12H7O3 0.31 0.11 0.53 0.02 0.04   
[2.2+2H+] 2+ 207 2+ 207.1372 2+ for C22H40N6O2 0.15       
[2.13+2H+] 2+ 275.6259 2+ 275.6266 2+ for C32H33N5O4 0.10   0.02 0.13   
[2.18+2H+] 2+ 288.6329 2+ 288.6345 2+ for C34H35N5O4    0.05  0.09  
[2.1+2H+] 2+ 297.1470 2+ 297.1477 2+ for C34H38N6O4 1.0    0.18   
[2.7+2H+] 2+ 306.1520 2+ 306.1558 2+ for C34H40N6O4 0.59       
[2.4+2H+] 2+ 310.1549 2+ 310.1556 2+ for C36H40N6O4 0.93 0.25 0.27 0.45  1.0 0.13 
[Co(2.1)]+ -H+ 325.1013 2+ 325.1026 2+ for [Co(C34H35N6O4)]2+  0.43 0.09  0.21   
[2.12+1H+] 1+ 370.2235 2+ 370.2243 1+ for C20H28N5O2 0.07       
[2.3 +2H+] 2+ 387.1565 2+ 387.1583 2+ for C46H42N6O6 0.71 1.0 0.34 1.0 1.0 0.86 1.0 
[2.5+2H+] 2+ 396.1623 2+ 396.1636 2+ for C46H44N6O7 0.77  0.39 0.19 0.32 0.24  
[2.20+2H+] 2+ 408.6775 2+ 408.6794 2+ for C48H47N7O6 ?0.37?    0.45 0.15  
[2.21+2H+] 2+ 417.6829 2+ 417.6847 2+ for C48H49N7O7 0.28       
[2.9+2H+] 2+ 486.1727 2+ 486.1741 2+ for C58H48N6O9  0.10 0.09     
[Co(2.1)CO3]+ 711.1984 1+ 711.1977 1+ for [Co(C34H36N6O4)CO3]+  0.11  0.09  0.08 0.36 














3.3.2.3. ESI-MS Results of the Synthesis using Enriched Ligand Material 
(Stoichiometric) 
The following table summarises the ESI-MS results from the synthesis of [Co(2.1)(NO2)2]+ using 
crude ligand material, as described in Section 3.2.5. The ESI-MS results are quoted as relative 
intensities which were calculated as per Chapter 2; by measuring the peaks and dividing each 
peak height by that of the major peak in the mixture. The percentage compositions of each 
fraction are given in the final row. The percentage composition was calculated as the percentage 
of the desired compound (2.1 in the first column, [Co(2.1)(NO2)2]+ in the following columns) 
compared to the major products of the reaction, 2.1, 2.3, 2.4, 2.5 and [Co(2.1)(NO2)2]+. The free 
ligand 2.1 is highlighted in green, and the [Co(2.1)(NO2)2]+ complex is highlighted in orange. 
Table 3.5: ESI-MS results for the synthesis of [Co(C34H36N6O4)(NO2)2]+ using enriched ligand 
material and stoichiometric cobalt.  









[2.18+2H+] 2+ 288.2903 2+ 288.6345 2+ for C34H35N5O4  0.15   
[2.1+2H+] 2+ 297.1465 2+ 297.1477 2+ for C34H38N6O4 1.0   0.32 
[2.4+2H+] 2+ 310.1538 2+ 310.1556 2+ for C36H40N6O4 0.12 0.43 0.39 0.24 
[Co(2.1)]+ -H+ 325.1009 2+ 325.1026 2+ for [Co(C34H35N6O4)]2+  1.0 1.0 1.0 
[2.12+1H+] 1+ 370.2232 2+ 370.2243 1+ for C20H28N5O2 0.09    
[Co(2.1)CO3]+ 711.1984 1+ 711.1977 1+ for [Co(C34H36N6O4)CO3]+  0.13 0.23 0.27 
[Co(2.1)(NO2)2]+ 743.1991. 1+ 743.1989 1+ for [Co(C34H36N6O4)(NO2)2]+  
Not 
Detected 0.03 0.08 
Percentage of desired compound in the fraction composition 83% 0% 2% 4% 
 
3.3.3 Summary of Results 
This chapter explores the synthesis and analysis of cobalt complexes of the tetradentate ligand 
2.1, synthesised from both crude and enriched starting materials. The results have shown 
through the detection of the desired mass by ESI-MS that the desired complexes were 
synthesised. The [Co(2.1)CO3]+ complex, 3.1, was detected in all corresponding syntheses by ESI-
MS as 711.1984 1+ (predicted 711.1977 1+ for [Co(C34H36N6O4)CO3]+), and the [Co(2.1)(NO2)2]+ 
complex, 3.2, was detected in all corresponding syntheses as 743.1991 1+ (predicted 743.1989 
1+ for [Co(C34H36N6O4)(NO2)2]+).  
While these compounds were detected, they were present in low amounts. Complexes were 
synthesised using both enriched and crude material to afford the desired product. Interestingly, 
the use of enriched material yielded purer complexes (as the crude ligand syntheses predictably 
resulted in the detection of ligand side products in the complexation mixture) yet the relative 
intensity of the desired complexes were still low. This was partially due to a substantial 





ligand after it had undergone a deprotonation; [Co(2.1)]+ -H+, 325.1026 2+ for [Co(C34H35N6O4)]2+. 
This side product was discussed in more depth throughout the discussion and in Appendix F. The 
large peak of the 325 2+ mass in many spectra results in the desired complex peak appearing as 
a small peak relative to it, which indicated that the presence of the 325 2+ peak may be giving 
the desired compound peak a diminished appearance.  
The appearance of free ligand in the complex syntheses, both using crude and enriched material, 
reinforces that the ligand may have had issues complexing whether it be due to the differing 
solubilities of the metal centre and the ligand or due to the steric effects of the pendant 
naphthalimide groups. This was not a surprising finding given that many syntheses were 
attempted before these complexes were successfully detected by ESI-MS. Further work into the 
optimisation of the complexation conditions should be pursued to encourage full ligand 
complexation. The excess free ligand indicated that further complexation may be possible, and 
increasing the cobalt content is one area in which optimisation could focus. Given that the best 
sample of any complex came from a synthesis with “excess” cobalt (Section 3.2.2), and only 
trace amounts of free ligand were detected in any of the phases by ESI-MS, this avenue should 
be the first to be explored further. Additional future work into complexes that have either 
smaller pendant groups or greater aqueous solubility is also desirable to pursue greater yields. 
The following discussion around formation of these complexes will include relative intensity and 
percentage composition values as for the discussion of Chapter 2. As in Chapter 2, these values 
should be treated as a guide only as ESI-MS is a non-quantitative technique. Changes of relative 
intensity of two compounds relative to each other can be used to determine the conversion of 
starting material to product or purification of the desired compound. The differing abilities of 
compounds to ionise by ESI means that the percentage compositions cannot be taken as exact 
but rather must only be used to compare the difference fractions to determine which had the 
greatest presence of the desired compound versus side products. The percentage compositions 
were found from relative intensities, and therefore were calculated in the same way for each 
reaction fraction. In this way, a fraction with 10% of the composition identified as the desired 
complex can be compared to one with 5% composition to determine that the former contains a 








3.4.1. Cobalt Carbonate Syntheses 
Mass spectrometry showed presence of a peak corresponding to complex formation, 711.1984 
1+ (predicted 711.1977 for [Co(C34H36N6O4)CO3]+); however, this was not a major peak. The 
predicted isotope pattern for this structure matched that seen in the native spectrum well 
(Figure 3.3). The highest relative intensity found during the reported work here was 0.21, 
corresponding to 16% of the composition being the complex (Table 3.1). 
This solid was separated from the reaction liquor by hot filtration. The liquor itself was a clear 
burgundy solution that gradually became slightly opaque and forms an oil upon cooling. The 
liquor and the oil it produced were largely very similar, containing the desired compound along 
with side products from the crude ligand reaction. The oil had a slightly higher relative intensity 
of cobalt complexes when compared to the liquor. In both cases, side products from the ligand 
material represented the major peaks in the ESI-MS spectra. 
The syntheses performed using crude ligand material produced the corresponding contaminated 
products, wherein the ligand side products were found in all phases of the reaction mixture. The 
synthesis using the enriched ligand material produced a less complicated ESI-MS spectra for 
each phase, however, free ligand remained in the solution indicating completion was 
incomplete. 
There was also evidence of another complex in the fractions with the mass 325.1020 2+ and its 
pair at 649.1982 1+. This mass corresponds to [Co(C34H35N6O4)]2+ and [Co(C34H34N6O4)]+, which 
would be a complex of the desired compound to cobalt without additional ligands and 
deprotonated once and twice respectively (3.3). This complex was unexpected given the ESI-MS 
was run in positive ion mode which should favour protonation, yet the ESI-MS peak matched 
well to the assigned formula with the isotope pattern of the simulated and native spectra 
correlating well (Figure 3.4). Prediction software for this mass was also unable to find any other 






Figure 3.4: Native (above) and simulated (below) spectra for the 325.1013 2+ peak, showing 
the isotopic pattern match. 
To form a complex with this structure, it was possible that the amines within the molecule had 
become deprotonated. This could either be due to the other amines present in solution acting as 
bases, or due to the ESI process required to analyse the samples. It was unclear as to whether 
this species existed in solution or whether it formed in the process of analysing the sample. The 
structure of this species is difficult to determine as there are a few potential binding modes. The 
first involves the nitrogen atom of the imide acting as a donor atom, which is unlikely due to 
both the resonance of the naphthalimide and the steric bulk preventing the metal to be 








Figure 3.5: One proposed binding modes for the deprotonated ligand cobalt complex, 
showing coordination through the oxygen donor atoms in 3D (left) as an iminolate (upper 
2D) or through lone pairs (lower 2D). Note that the deprotonation is not displayed in the 
lower 2D structure here as it is unclear where this would occur but is assumed to be an 
amine proton. 
A second option is through coordination to the lone pairs on the imide carbonyl groups, possibly 
as an iminolate (Figure 3.5). This would form a seven membered ring, and as such may be a 
poorer coordination mode. A naphthalimide structure bound through the oxygen donor atom is 
known, and the literature example forms an eight membered chelate ring indicating that the 
structure proposed here is feasible (Figure 3.6).  
Another option would be a combination of these two binding modes with five total nitrogen 
donor atoms and one oxygen. Finally, it is possible but unlikely that the cobalt(III) centre was 
four coordinate. Such structures are known90 and were formed through reactions in non-
coordinating solvents with tetradentate ligands. The reaction solvent in this reaction contained 
both coordinating ions and was weakly coordinating so this is not as likely to have occurred in 
solution, but may have occurred in the largely solvent free environment of ESI-MS. It would be 
difficult to distinguish this compound from the desired complex visually as it would likely be pink 
or red if it contains a cobalt coordination sphere of four or five nitrogen donor atoms and one or 








Figure 3.6: Literature structures 636006 and 636004 demonstrating an oxygen bound 
naphthalimide moiety, forming an eight membered chelate ring.91 Bond determined by Olex2. 
This bond was shown in Olex2 and had a length of 2.8 Å in the first structure and 3.2 Å in the 
second structure, which is a long but plausible bond length. 
 
3.4.2. Cobaltinitrite Syntheses 
As for Section 3.4.1, both crude and enriched ligand syntheses resulted in the production of 
complex 3.2. This was detected in low amounts in many phases of the reaction, and as the major 
component in one fraction. This was the reaction involving crude ligand and excess cobalt, which 
produced an oil upon cooling of the reaction liquor that contained close to 100% complex 3.2 
(Table 3.3). 
The synthetic procedure for production of the dinitrite complex was adapted from Werner’s 





cobalt nitrite and tetradentate ligand, which was dissolved in methanol, were heated until the 
reaction was observed by production of solid. In the original method this only required three 
minutes; in the current adaptation the reaction was allowed to proceed overnight due to the 
increased complexity and lower solubility of the ligand. The solution was then filtered to remove 
unreacted potassium cobaltinitrite and the filtrate cooled to allow for precipitation of brown-
yellow powder. The potassium cobaltinitrite species required for this synthesis was produced 
using the second method described by Vendilo et al.93  
The reaction of the ligand material with the cobaltinitrite starting material produced solid 
material and an orange liquor, which upon cooling produced an orange-brown oil. The solid that 
was produced immediately during the reaction can be separated into two primary categories: 
cobaltinitrite starting material and other products. The cobaltinitrite starting material has low 
solubility in methanol and was either added to the methanolic ligand solution as a methanol 
slurry or as a solid. The addition of the material to the refluxing methanolic ligand solution 
resulted in solid remaining in the mixture. At the end of the reaction, the orange solid could be 
separated from the other solids and showed the same solubility and intense yellow colouring in 
water as the starting material. ESI-MS in positive and negative ion mode (as the complex would 
be expected to be 3-) of this solid did not detect the compound, which was in keeping with the 
lack of detection of the cobaltinitrite starting material when analysed directly. This did not 
confirm with certainty that the solid was starting material, but the lack of other complex 
detection showed that it was not the desired compound. 
The remainder of the reaction solid from each reaction contains predominantly side products, 
the exact nature of which was discussed in Appendix F.2 as it pertains to each iteration of the 
reaction. The desired compound was detected in the solids in trace amounts. 
The hot filtering followed by cooling and collection of the precipitate formed allowed for 
separation of impurities from the desired compound. The desired compound was detected in 
the purest form in the oil produced after the reaction liquor had been cooled, as determined by 
ESI-MS. In this fraction, the desired complex was the major peak, with side products present at 
less than a quarter of the height (0.25 or less relative intensity) of the desired complex peak. The 
ESI-MS of this precipitate showed a good match of the major peak isotope pattern to a 
simulated pattern for the expected product (Figure 3.3). The starting materials were a mustard 
yellow colour, however, the solid analysed was more orange-brown. The IR data (Section 
3.3.2.1) showed some ligand starting material peaks in the complexation product, indicating that 





very different) not seen in the free ligand spectrum. This indicated that complexation may have 
occurred, and the new cobalt-nitrogen bonds were present in the spectrum. 
Finding the complex in its purest form in this oil was logical based around the structure of this 
complex. With a 1+ charge, the complex was likely to be more polar than the free ligand and as a 
result may show a lower solubility in methanol than the free ligand did, causing it to precipitate 
following cooling. The complex was less charged than the cobalt starting material, which had a 
3- charge, and the separation of these two complexes by hot filtering then allowing the reaction 
to cool thereby reducing the desired complex solubility, was rationale behind the method 
design. The yield of this oil was relatively low with less than 0.1 g of the product formed from 1 g 
of crude ligand, however, the ESI-MS spectrum of this oil appeared to have very few other 
species, indicating that this sample was enriched especially by comparison to the other phases 
(Table 3.3). Unfortunately, during the following repetitions of this method it was difficult to 
reproduce the enrichment demonstrated in the first method described, even when using the 
enriched ligand material. More detail on this can be seen in the discussion for each iteration in 
Appendix F. 
The reaction liquor for this reaction also contained predominantly side products. This was to be 
expected as mentioned above the intended complex and the cobalt starting material were both 
charged and therefore likely less soluble in the methanol of the reaction solvent than the crude 
ligand material was. The exact composition of the liquor again varied by reaction and was 
predominantly composed of the side products with only traces of the desired complex detected 
by ESI-MS (less than 0.05 relative intensity, Table 3.3, Table 3.4). 
Aside from the desired compound, other cobalt complexes were detected in the reaction 
components. Interestingly, this included a 711.1984 1+ peak that matched the predicted mass 
for the carbonate complex. This peak in the carbonate synthesis matched the expected isotope 
pattern for this compound, and the peak masses were very similar (711.1984 1+ here versus 
711.1986 1+ in the previous section). Additionally, the relative intensities of these peaks 
compared to ligand side products was very similar, 0.11 versus 0.05 (Table 3.1 and Table 3.4). 
This was not likely to be caused by cross contamination of the mixture as this peak was 
frequently seen across numerous reaction mixtures in multiple fractions. There was a possibility 
that traces of complex 3.1 could have formed in situ. Dissolution of carbon dioxide into the 
solution would be favoured by the presence of basic amines reacting with the carbonic acid 
formed, producing carbonate and protonated amines. The resulting carbonate anion can bind to 





such as nitrite in a complex. It was possible that following dissolution in methanol94, the reaction 
of carbon dioxide with water proceeds as above, forming carbonate that then complexes cobalt. 
A synthesis of the [Co(CO3)]3- complex involving the bubbling of a stream of carbon dioxide 
through the reaction mixture95 as the source of carbonate is reported in the literature, indicating 
that this is a reliable way to synthesise the carbonate ligand. In the experiments by Fumiyo et al, 
a platinum triethylphosphine complex was reacted with Tl(acac) in methanol under atmospheric 
conditions which produced a platinum triethylphosphine carbonato complex in 3%.96 When 
carbon dioxide was bubbled through the solution, the yield increased to 18%. This indicated that 
the formation of carbonate complexes in methanolic solutions can be performed under standard 
atmospheric conditions. To identify whether this was occurring in this reaction, further reaction 
under a completely inert atmosphere would need to be performed. Additionally, deliberate 
bubbling of CO2 may encourage the carbonate complex to form, indicating that this could be an 
avenue for future synthesis of the carbonate complex.  
An air oxidation synthesis in this work involving a cobalt sulfate starting material and ligand 2.1 
also appeared to have produced the carbonate complex as determined by presence of the 
711.1982 1+ peak in the ESI-MS spectrum of the reaction mixture. During this synthesis air was 
bubbled continuously through the reaction solution, which appeared to have provided the 
oxygen to oxidise the cobalt as expected as well as the carbon dioxide to form carbonate anions.  
The 325.1013 2+ and 649.1963 1+ peak pair assigned to compound 3.3 were also detected in 
these syntheses, numerous times as the major peak. It remains unclear as to whether this 
species existed in solution or was a remnant of the ESI process. As the desired dinitrito species 
had been observed in spectra as the major peak with no evidence of the 325 peak (Table 3.3) it 
seems as though the 325 species was not solely produced by decomposition of the intended 
complexes during the ESI-MS process. This would favour the hypothesis that the 325 peak 
results from complexation of the ligand to cobalt directly, rather than from the degradation of 
the existing complexes. It remains unclear as to whether the deprotonated ligand complex forms 
in solution or during the ESI process.  
The colours of the samples from which the 325 2+ peak was detected were orange in these 
syntheses, which was not the colour expected for a cobalt complex with four nitrogen and two 
oxygen donor atoms, a probable binding mode for this complex. It was possible that this 
complex only forms in the ESI process, or that the binding mode was not as speculated. It was 
also possible that the complex was in low amounts leading to masking of the colour by other 





potential for formation of negatively or neutrally charged complexes which could be the major 
product, masking the 3.3 compound appear to be the major product when detected by ESI-MS 
(discussed further in Appendix F). This product also may show a dramatically better ionisation 
ability than the other complexes, appearing as a larger peak which seems unlikely given that it 
had also been detected in small relative intensities.  
The 325 2+ peak has also been observed in previous cobalt syntheses during this study with 
ligand 2.1, including an attempted complexation with [Co(en)2Cl2]+ and an air oxidation reaction 
using cobalt sulfate as the starting material. In both of these cases, the 325 peak was a major 
peak in the ESI-MS spectrum, reinforcing the observations made in this chapter. Further 
evidence of deprotonated ligands complexing was observed during one of the copper syntheses 
in the previous chapter, where a peak in the ESI-MS spectrum corresponding to the 
deprotonated Cu(2.1) complex was detected (Figure 3.7). The isotope pattern matched between 
the simulated and native peaks, standing as further evidence of the deprotonation of the ligand. 
The reactions performed using stoichiometric cobalt did not show the same level of enrichment 
in any phase as was observed in the synthesis using excess cobalt. Not only did the complex 
appear in these reactions as a trace component of many phases, free ligand material was also 
detected in many fractions indicating that optimisation of the reaction conditions is required to 
obtain a higher yield of the highly enriched material detected in this work. Similarly to the 
previous section, the use of enriched ligand material compared to crude material led to a less 
complicated product mixture, however, the major products from this reaction were the 325 2+ 







Figure 3.7: Peak in the Copper(2.1) synthesis showing the isotope pattern in the native (above) 
and simulated (below) spectra. The peak corresponds to the mass for a complex formed 
between copper and a deprotonated 2.1 ligand. 
3.4.3. Conclusions 
This chapter explored the successful syntheses of cobalt complexes using both crude and 
enriched ligand material. The complexes produced were detected in low amounts in many of the 
fractions, with the highest detection in the oil produced upon cooling of the reaction liquors. The 
crude material produced the correspondingly contaminated products in most cases, and while 
the enriched ligand material did produce material with fewer side products the yield was low 
and utilised a material that was difficult to obtain (from Section 2.2.6.5). As such, there were 
benefits and detriments around employing either strategy to synthesise these complexes.  
The highest observation by ESI-MS in the reaction composition of the [Co(2.1)CO3]+ complex, 3.1, 
was achieved in the solid produced by the reaction with enriched ligand material. Unfortunately, 
this solid was dark green indicating that residual cobalt starting material, which was not 
detected by ESI-MS, was also present so the true composition was unknown. The other 
detections all occurred in trace amounts so determination of an alternative best method would 
require further experimentation. Prior work showed that crude material could produce higher 
relative intensities of the desired complex, but the detection was variable. Interestingly, 





[Co(2.1)(NO2)2]+ syntheses, which is also cause for further experimentation to determine if this 
complex can be formed in other ways.  
The greatest percentage of the reaction composition for [Co(2.1)(NO2)2]+, 3.2, was observed in 
the reaction utilising crude ligand material and excess cobaltinitrite starting material. This 
reaction produced an oil upon cooling of the reaction solution, both fractions of which contained 
a very high fraction of the complex 3.2 with the complex peak being the major peak of the 
reaction fractions. The stoichiometric crude and enriched syntheses also showed production of 
complex, but in much lower yields.  
Across the syntheses the identification of another potential complex was possible. A peak for 
325.1020 2+ (predicted 325.1026 2+ for [Co(C34H35N6O4)]2+) was identified throughout. This peak 
was assigned as a complex of cobalt with a deprotonated ligand 2.1 coordinated without 
additional ligands. The ‘vacant’ cobalt binding sites may be occupied by the ligand naphthalimide 
carbonyls or through formation and complexation of an iminolate. It is unclear whether the 
complex forms due to the degradation of the desired complexes in the ESI process, complexes 
that exist synthetically or as a remnant of the ESI process in general. This species was identified 
in both crude and enriched ligand syntheses, with a much greater prevalence in the enriched 
ligand syntheses. This may be due to the lack of other species around to mask their presence in 
the enriched syntheses, as it was also detected as the major peak in some crude ligand fractions. 
The presence of this complex could indicate that product formation was higher than previously 
judged if it had degraded to become this compound. Further work surrounding the 
characterisation and attempts to isolate this compound may help to determine how it forms.  
  








This chapter largely focusses on the structure obtained through crystallographic data collection 
and structural elucidation. The crystals formed during the process of complexation of a new 
ligand material to copper and were subsequently analysed by X-ray diffractometry. The 
production of the ligand was performed in the same way as in Chapter 2, using 1,8-naphthalic 
anhydride to produce pendants through mechanochemical reaction conditions. The amine 
starting material, N,N’-bis(3-(2-aminoethylamino)propyl)ethane-1,2-diamine 4.1, was used in 
place of the previously described hexamine, 3,6,9,12-tetraazatetradecane-1,14-diamine. Their 
structures differ in the length of two of the links between nitrogen atoms; the amine focused on 
in this chapter had two propyl chains where the previous amine had five ethylene chains. This 
amine was chosen to both provide a hopefully purer starting material for synthesis, and to 
modify the cobalt coordination environment with two six-membered chelate rings as opposed to 
the previous five membered rings. As five and six membered chelate rings are the most stable 
for a cation in the first transition series, this modification may also encourage complexation.  
The original complex in this chapter was synthesised by myself and my colleague Meghan 
Ricciardi, an undergraduate exchange student whom I supervised and worked alongside through 
a short research project. The crystallographic work was performed by and alongside Dr Matthew 
Polson. 
Figure 4.1 depicts the theoretical and observed compounds discussed in this chapter. 
 
4.1 Intended polyamine starting material 
 
4.2 Branched isomer of polyamine starting material 
Figure 4.1: Structures of the proposed and observed compounds discussed in this chapter. 
 





4.3 Dinaphthalimide ligand formed from 4.1 
 
4.4 Trinaphthalimide ligand formed from 4.2 
 
4.5 Ligand formed from 4.1 with two naphthalimide groups and a naphthalamide group 
 
4.6 Crystal structure formed by complexation of 4.4 
 
4.7 Proposed complex formed with 4.3, not observed during this work 
Figure 4.1 (continued) 





General methods can be found in Sections 2.2.1 - 2.2.5. 
4.2.1. Single Crystal X-Ray Crystallography 
X-ray data was collected on a Supernova instrument with a focused microsource Cu Kα [λ = 
1.54184 Å] radiation and an ATLAS CCD area detector. CrysAlisPro 171.36.28 was used for the 
data collection and data processing. The crystals were mounted on nylon loop using 
polyethylene glycol. All structures were solved using direct methods with SHELXT and refined on 
wF2 using all data by full matrix least square procedures with SHELXL using OLEX-2 for 
visualisation. Graphical presentation of crystallographic data was prepared using OLEX-2 and 
Mercury. 
4.2.2. Amine Starting Material 
1H NMR (CDCl3 400 MHz) δ 2.36 (t, J = 6.0 Hz, 4H, -NH-CH2-CH2-NH2), 2.28 (s, 4H, -NH-CH2-CH2-
NH-) 2.25 – 2.19 (m (dt?), 8H, -NH-CH2-CH2-CH2-NH-), 2.06 (dq, J = 14.2, 7.1 Hz, 4H, -CH2-NH2), 
1.23 (dp, J = 14.1, 6.8 Hz, 4H, -NH-CH2-CH2-CH2-NH-), 0.99 (s, 8H, NH). 
13C NMR (CDCl3 101 MHz) δ 51.81 (2C, -CH2-NH2), 48.67 (2C, -NH-CH2-CH2-NH-), 47.50 (2C, - -
CH2-CH2-CH2-NH-), 47.39 (2C, - -CH2-CH2-CH2-NH-), 40.89 (2C, -NH-CH2-CH2-NH2), 29.59 (2C, - -
CH2-CH2-CH2-NH-) 
Mass: [M +1H+] 1+: m/z 261.2695 1+ (Predicted 261.2767), major peak 
4.2.3. Synthesis of Naphthalimide Derivatised Amine 
 
1,8-naphthalic anhydride (C12H6O3 5.00 g, 25 mmol) was placed in a 10 cm mortar and ground 
with a pestle until a fine powder was achieved. Chloroform (20 mL) was then added to the 
mortar and mixed with the anhydride to give a paste. To this, 3,7,10,14-tetraazahexadecane-
1,16-diamine (C12H32N6, 2 mL approx. 8 mmol) was added in a single addition and the mixture 
was ground for ten minutes. During this time, the mixture went from a pale beige paste to a very 
sticky brown and then to a crumbly pale brown solid as grinding continued. Grinding ceased 
once the mixture became a sticky pale brown powder. 




1H NMR (D2O, 400 MHz) δ: 8.79 – 8.71 (m, 4H, ArCH), 8.66 – 8.58 (m, 4H, ArCH), 8.08 (m, 4H 
ArCH), 4.38 (t, J = 7.0 Hz, 4H, CH2 next to imide), 4.25 – 4.17 (m, 4H, CH2 outer ethyl next to 2° 
N), 3.12 – 3.02 (m, 4H, outer propyl CH2), 3.02 – 2.86 (m, 4H, inner propyl CH2), 2.11 (s, 4H, inner 
ethyl CH2), 2.09 – 1.92 (m, 4H, central propyl CH2). 
4.2.4. Formation of Copper Complexes 
 
Crude ligand material (C36H42N6O4, 1.6 g, 2.57 mmol) was dissolved in methanol (100 mL) and 
filtered. The filtrate was added to a 500 mL conical flask and warmed on a steam bath. Copper 
sulfate (CuSO4∙5H2O, 0.4 g, 1.6 mmol) dissolved in warm methanol (25 mL) and added to the 
conical flask. The reaction mixture gradually became blue with formation of a blue solid. The 
reaction mixture was heated on the steambath with occasional swirling for 3 hours. The reaction 
resulted in formation of an oily blue solid and a blue liquor. Allowing this to stand resulted in 
formation of bright blue plate-like crystals over the course of two weeks. The mass was not 
obtained to avoid deterioration of the crystals upon drying, however, there were crystals 
scattered across the entire surface of the flask, forming upwards of 100 mg of crystalline 
material. 
Suitable crystals were selected and mounted on nylon loops using perfluoronated PEG on a 
SuperNova, Dual, Cu at zero, Atlas diffractometer. The crystals were kept at 120.01(10) K during 
data collection. Using Olex297, the structures were solved with the ShelXT98 structure solution 
program using Intrinsic Phasing and refined with the ShelXL99 refinement package using Least 
Squares minimisation. 
Numerical face indexed absorption corrections were done on all structures unless otherwise 
noted.  
Unless otherwise stated, hydrogens attached to carbons were inserted in the appropriate 
positions and refined as riding atoms with thermal parameters 1.2 (aromatic carbons) or 1.5 (all 
other carbons) times that of the parent atom. Hydrogens attached to nitrogen or oxygen were 
located in the residual electron density map, the distance to the parent atom was fixed at 0.86 Å 
and the thermal parameter fixed to 1.5 times that of the parent atom. 




Crystal Data for C48H44N6O10SCu (M =960.51 g/mol): Monoclinic, space group P21/c (no. 14), a = 
15.2747(13) Å, b = 22.5822(11) Å, c = 15.3342(13) Å, α = 90°, β = 109.197(9)°, γ = 90°, V = 
4995.2(7) Å3, Z = 4, T = 120.01(10) K, μ(CuKα) = 1.510 mm-1, ρcalc = 1.277 g/cm3, 9908 reflections 
measured (3.626° ≤ 2Θ ≤ 75.831°), 5943 unique (Rint = 0.0682, Rsigma = 0.102) which were used in 
all calculations. The final R1 was 0.0568 (I > 2σ(I)) and wR2 was 0.1557 (all data). 
Mass:  Complex not detected by ESI-MS. Detection corresponds to the free ligand. 
[M +2H+] 2+: m/z 401.1740 2+ (predicted 401.1739 2+ for C48H46N6O6) 
[M +1H+] 1+: m/z 801.3411 1+ (predicted 801.3400 1+ for C48H45N6O6) 
[M +3H+] 3+: m/z 267.7849 3+ (predicted 267.7852 3+ for C48H47N6O6) 
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 311.1634 2+ (predicted 311.1633 2+ for C36H42N6O4)  
Relative Intensity: 0.11 
 
Figure 4.2: ESI-MS spectrum of a sample of the crystals that led to the collected structure 
IR of the crystal material: 1692 (s), 1651 (s), 1640 (m), 1589 (m), 1457 (w, br), 1438 (m), 1407 
(w), 1387 (m), 1339 (s), 1236 (s), 1172 (w), 1106 (w, br), 1059 (w) 
  





4.3.1. [Cu(C48H44N6O6)SO4] Complex Crystal Structure 
Figure 4.3 depicts the structure elucidated from the crystallographic data. The structure shows a 
copper centre bound to a tridentate branched trinaphthalimide ligand and a bidentate sulfate 
anion, forming a neural complex. The crystal parameters for this structure are given in Table 4.1. 
 
  
Figure 4.3: Crystal structure of the copper naphthalimide complex, including a space fill view 
of the naphthalimide pendants and a closer alternative view of the coordination sphere. 
 




Table 4.1: Collection and solution parameters for the crystal structure reported in this work.  
Crystallographic Parameters 
Identification code  SEL01a 
Empirical formula  C48H44CuN6O10S 
Formula weight  960.51 g mol-1 
Temperature/K  120.01(10) K 
Crystal system  Monoclinic 
Space group  P21/c 
a/Å  15.2747(13) 
b/Å  22.5822(11) 
c/Å  15.3342(13) 
α/°  90 
β/°  109.197(9) 
γ/°  90 
Volume/Å3  4995.2(7) 
Z  4 
ρcalcg/cm3  1.277 
μ/mm-1  1.510 
F(000)  1996 
Crystal size/mm3  0.122 x 0.078 x 0.014 
Radiation  CuKα (λ = 1.54184) 
2Θ range for data collection/°  3.626 to 75.831 
Index ranges  -18≤ h ≤13, -27≤ k ≤21, -17≤ l ≤19 
Reflections collected  9908 
Independent reflections  5943 [Rint = 0.0682, I/σ = 0.102]  
Data/restraints/parameters  5943/2/601 
Goodness-of-fit on F2  0.965 
Final R indexes [I>=2σ (I)]  R1=0.0568, wR2=0.1317 
Final R indexes [all data]  R1=0.0984, wR2=0.1557 
Largest diff. peak/hole / e Å-3  0.317, -0.554 
CCDC  TBC 
 
  




The unit cell contained four molecules, with one molecule in the asymmetric unit (Figure 4.4 and 
4.5). The formula of the compound was identified as C48H44CuN6O10S which corresponds to the 
expected formula for a compound containing a copper centre bound to a sulfate and the 
polyamine ligand formed with three naphthalimide pendants. The structure contained three 
molecules of ethanol within the asymmetric structure (to give a total of 12 in the unit cell), 
which failed to refine due to disorder. The electron density associated with these ethanol 
molecules was removed using Olex2’s solvent mask. The amine hydrogens were located in the 
electron difference map with N-H distance restrained to 0.86 Å and the position was allowed to 
refine. The Uiso for the hydrogen atoms were fixed to the atom they were attached to at 1.5x. 
 
 
Figure 4.4: Structure of the Copper Naphthalimide product synthesised in this work, rotated to show 
the orientation of the pendants to each other. The third image is a space fill of the naphthalimide 
pendants to show their relative orientation. 
 
  








Figure 4.4 continued: Side by side ball and stick (left) and spacefill (right) views of the unit cell 
packing of the crystal structure 
 
  




The collected structure showed the copper centre was bound to three nitrogen and two oxygen 
donor atoms. The bond angles of the coordination sphere can be seen in Figure 4.5 and Table 
4.2, while the bond lengths are given in Figure 4.6 and Table 4.3. 
 
  
Figure 4.5: Selected bond angles for the coordination sphere, showing the sphere in context 
of the full structure (top), in isolation (left) and the atom numbering (right). 
  








Figure 4.6: Bond lengths for the collected structure coordination sphere, showing the sphere 
in context of the full structure (top), in isolation (left) and the atom numbering (right). 
 
  





Table 4.2: Coordination Sphere Bond Angles. The first column shows which atoms are being 
considered in the angle. The second column shows the bond angles and error values from the 
crystal structure elucidation. 
 
Table 4.3: Collected Structure Bond Lengths The first column lists the atoms in the bond. The 
second column shows the bond lengths and error values from the crystal structure elucidation. 
 
4.3.2. Repetition of Crystallisation Conditions 
Both the trinaphthalimide ligand synthesised from the amine corresponding to the branched 
species, 4.4, and the dinaphthalimide ligand synthesised from the linear species, 4.3, were again 
detected in the repetition. Attempts to produce crystalline material were unsuccessful. 
4.3.3. Summary of Results 
This chapter focusses on the synthesis and structural elucidation of a copper tridentate 
naphthalimide complex. This complex was formed from a branched impurity in the amine 
starting material that was used to form a tetradentate dinaphthalimide ligand from a linear 
hexamine. The branched impurity lead to the formation of a trinaphthalimide and subsequently 
Atoms forming the bond angle Bond Angle including errors 
N1 – Cu – N3 94.60(12)° 
N1 – Cu – N5 147.10(13)° 
N1 – Cu – O1 93.63(12)° 
N1 – Cu – O2 107.46(12)° 
N3 – Cu – N5 92.29(12)° 
N3 – Cu – O1 156.19(13)° 
N3 – Cu – O2 91.41(12)° 
N5 – Cu – O1 92.84(11)° 
N5 – Cu – O2 104.48(12)° 
O1 – Cu – O2 64.80(11)° 
Bonded Atoms Bond Length including errors 
Cu – N1 2.037(3) Å 
Cu – N3 2.052(3) Å 
Cu – N5 2.031(3) Å 
Cu – O1 1.998(3) Å 
Cu – O2 2.378(3) Å 




tridentate species that formed a complex to copper, with a sulfate anion coordinating to the two 
vacant coordination sites around the copper centre. No complex of the desired dinaphthalimide 
ligand product was observed. The crystal structure complex was not detected by ESI-MS, which 
was possibly due to the neutral charge on the complex. The crystal structure had approximately 
four molecules of disordered solvent per unit cell which were removed by solvent masking to 
obtain the final structure. 
  





4.4.1. Crystal Structure Analysis 
The crystal structure confirmed that at least one branched amine was present in the starting 
material, which was speculated upon based on the ESI-MS results. It also showed that the 
naphthalimide pendant motif was indeed forming during the reactions, which to date had only 
been confirmed by ESI-MS evidence. ESI-MS of the crystal showed the major peak corresponding 
to the free ligand 4.4. The amount of this varies in the ESI-MS spectra between syntheses and 
was detected as a major peak in some reactions. 
4.4.1.1. Coordination Sphere Bond Angles and Geometry 
The geometry of the copper centre was a distorted square based pyramid, with multiple bond 
angles experiencing distortion (Table 4.2, Figure 4.5). The decision to call the geometry more 
square pyramidal was based on the τ5 method outlined by Addison and Rao100. This method uses 




, where τ becomes a number between 0 and 1. 1 corresponds to pure trigonal 
bipyramid (as the difference between the two largest angles was 60°, or the difference between 
the 180° axial and 120° equatorial angles) while 0 corresponds to pure square based pyramidal 
(as the difference between the two largest angles was 0°, as both the longest angles are in the 
base of the pyramid and therefore are both 180°). In this system, the two largest angles were 
147.1° and 156.2°. When the calculation was performed using the values of 156.2° as β and 
147.1° as α, τ=0.15, making the geometry predominantly square pyramidal. τ values as extreme 
as 0.1 and 1.0 are reported in the original paper. It appears likely in this situation that the small 
bidentate sulfate bonding angle distorted the geometry, particularly in angles involving the Cu – 
O1 bond. The six membered chelate rings of the naphthalimide ligand also appear to have 
slightly distorted the geometry. Both of these impacts are discussed further below.  
The geometry consisted of the oxygen atom O2 in an approximately axial position, and one 
oxygen and three nitrogen atoms in equatorial positions (Table 4.3, Figure 4.6). A square based 
pyramid would have 90° and 180° equatorial-equatorial angles and 90° axial-equatorial angles. 
In the collected structure, four bond angles assigned as equatorial-equatorial are 92.3°, 92.8°, 
93.6° and 94.6°, which were all close to the expected 90° angle for a square based pyramid. The 
values are slightly larger than expected due to the N1 – Cu – N5 (147.1°) and N3 – Cu – O1 
(156.2°) angles deviating from the expected 180°. This has led to the equatorial positions sitting 
slightly out of plane, with N1 and N5 sitting slightly below the expected plane and N3 and O1 
sitting slightly above it. The four bond angles designated as axial-equatorial were 64.8°, 91.4°, 




104.5° and 107.5°, which deviated from the expected 90°, especially the outlier of 64.8°. 
Interestingly, these axial-equatorial angles were all different and span a wide range of 42.7° 
(16.1° with the outlier excluded). As mentioned above and discussed in more detail below, the 
deviations observed were likely caused by the balance of the strained four membered sulfate 
chelate ring and wider six membered naphthalimide ligand chelate rings. 
4.4.1.2. Sulfate Coordination 
The small bond angle between the two oxygen atoms (64.9°) was likely caused by the constraint 
of the sulfate moiety which forms a four atom chelate ring when coordinated. This small chelate 
ring restricts the system, resulting in a smaller bond angles than is typically observed in copper 
complexes. The O – S – O bond angle between the coordinated oxygens, 103.8°, is smaller than 
the non-coordinated O – S – O angles, 109.5°, 109.9°, 109.9°, 111.0° and 112.4° (Table 4.2), 
which indicates that the strain was experienced across the four membered chelate ring. The 
larger bond angles are caused by the sulfur-oxygen double bonds which give larger bond angles 
than the single bonded O – S – O. The theory that the four membered chelate ring had this 
impact was reinforced by the fact that the bond angles around the sulfate moiety are 
comparable to those previously observed in crystal structures; see Table 4.2 for more.101  
Most notable of the literature structures compared here are the structures (CCDC deposition 
numbers 168978, 1308854, 1264272 and 753668) which also show sulfate bound as a bidentate 
ligand to the same metal centre, especially the structure that had a five-coordinate copper 
centre. The angles of the bidentate O – M – O bonds are 52.3°, 57.4°, 65.5° and 67.4° (with an 
average of 61.6° including this work) and the metal to oxygen bond lengths are 2.98 Å and 1.99 
Å; 2.13 Å and 2.13 Å; 2.12 Å and 2.17 Å; and 2.44 Å and 2.45 Å. This compares well to the 
structure listed in this work, which had a bidentate sulfate bond angle of 64.8° and bond lengths 
of 2.0 Å and 2.4 Å. One of these bond lengths was slightly shorter than those observed in the 
above structures while the other was on the longer side, both of which appear to be within the 
expected lengths for the copper sulfate oxygen bond. The structure (168978) with a copper 
centre bound to a bidentate sulfate had a bidentate angle of 53.2°, which was even smaller than 
the angle seen in this work, and also features different copper to sulfate oxygen bond lengths, 
the longer of which was longer than that observed in this work and likely accounts for the 
shorter angle observed in the literature structure. 




Table 4.4: Bond angles and their designations for various coordinated sulfate groups in crystal structures. The angles are defined as being bidentate (the angle 
between two oxygen atoms connected to the same metal centre), bridging (the angle between two oxygen atoms connected to different metal centres) or are 
undesignated (one or both of the oxygen atoms are not bound to a metal centre). These angles are shown predominantly as measured from the sulfur atom, 
with the last column showing the angles as measured from the metal centre as appropriate. 
CCDC Reference and Structure 
 
Angle 1 
(O1 – S – 
O2) 
Angle 2 
(O1 – S 
– O3) 
Angle 3 
(O1 – S 
– O4) 
Angle 4 
(O2 – S 
– O3) 
Angle 5 
(O2 – S 
– O4) 
Angle 6 




Angle of  
O – M – O 
This work 
 
103.9* 109.9 109.5 112.4 109.9 111.0 Bidentate 64.8* 
168978102 
 
108.0* 106.7 108.5 110.0 112.9 110.4 Bidentate 53.2* 




Table 4.4 (continued) 
CCDC Reference and Structure 
 
Angle 1 
(O1 – S – 
O2) 
Angle 2 
(O1 – S 
– O3) 
Angle 3 
(O1 – S 
– O4) 
Angle 4 
(O2 – S 
– O3) 
Angle 5 
(O2 – S 
– O4) 
Angle 6 




Angle of  
O – M – O 
1264272103 
 








100.2* 110.7 110.2 110.7 107.7 114.0 Bidentate 67.4* 
         
         
         




Table 4.4 (continued) 
CCDC Reference and Structure 
 
Angle 1 
(O1 – S – 
O2) 
Angle 2 
(O1 – S 
– O3) 
Angle 3 
(O1 – S 
– O4) 
Angle 4 
(O2 – S 
– O3) 
Angle 5 
(O2 – S 
– O4) 
Angle 6 




Angle of  
O – M – O 
1308854105 
 








109.3 111.5 111.9 107.4 μ 108.4 μ 108.3 μ Bridging NA 
         
         
         




Table 4.4 (continued) 
CCDC Reference and Structure 
 
Angle 1 
(O1 – S – 
O2) 
Angle 2 
(O1 – S 
– O3) 
Angle 3 
(O1 – S 
– O4) 
Angle 4 
(O2 – S 
– O3) 
Angle 5 
(O2 – S 
– O4) 
Angle 6 




Angle of  
O – M – O 
129805107 
 
111.5 109.5 109.3 109.0 109.4 108.2 Monodentate NA 
131233108 
 
110.8 μ 109.5 110.0 110.1 107.6 108.9 Bridging 175.6 μ 
         
         
         
         




Table 4.4 (continued) 
CCDC Reference and Structure 
 
Angle 1 
(O1 – S – 
O2) 
Angle 2 
(O1 – S 
– O3) 
Angle 3 
(O1 – S 
– O4) 
Angle 4 
(O2 – S 
– O3) 
Angle 5 
(O2 – S 
– O4) 
Angle 6 




Angle of  
O – M – O 
1605787101 
 
109.1 μ 114.3 110.6 109.4 111.6 101.8 Bridging 180.0 μ 
 
Key: * = bidentate angle, μ = bridging angle. No symbol indicates at least one oxygen is not coordinated. 
Average O – S – O angle for all oxygens: 109.4°     
Average O – S – O angle for unbound oxygens: 110.2° 
Average O – S – O angle for bridging structures: 108.9°   
Average O – S – O angle for bidentate structures: 103.5° 
Average O – M – O angle for bidentate structures: 61.7° (See Table 4.5) 
 




The bidentate coordination in general seems unfavourable, both due to the strained coordinate 
bond angles and due to the limited number of similar structures in the literature when 
compared to a bridging or monodentate binding mode. The lengthening of the second bond to 
the sulfate anion appeared to be a balance between the unfavourable angle and copper 
becoming four coordinate. A review109 comparing structures found that the average bond angle 
for oxygen-containing four-membered chelate rings was 57°, which was comparable to this 
structure and the other bidentate sulfate ligand structures listed above. The bidentate binding 
may have been observed in the structure reported in this wordue to the interactions of the 
aromatic systems encouraging the crystal formation and resulting in a more favourable structure 
than one that could form using bridging sulfate. It was also possible that the crowding of the 
naphthalimides in this structure encouraged the bidentate binding mode by precluding 
coordination of another species due to the lack of space remaining around the cooper centres. 
Table 4.5 summarises the O – M – O bond angle and bond lengths for the bidentate sulfate 
structures. Again the copper structure 168978102, which showed a lengthening of one copper to 
oxygen bond compared to the other bonds, is of particular interest. As mentioned previously, 
this highlights the lengthening of the metal to oxygen bond because of the unfavourable 
coordination angle.  
  




Table 4.5: Comparison of O – M – O bond angles for metal centres coordinated to a bidentate 
sulfate anion. 
Structure 
O – M – O 
Bond Angle 























































4.4.1.3. Naphthalimide Ligand Coordination 
It is not uncommon for copper complexes to adopt distorted geometries, with five coordinate 
complexes generally adopting square pyramidal structures along with the less common trigonal 
bipyramidal, and many structures existing as a distorted version of either geometry.109 Four 
coordinate complexes also demonstrate multiple geometric possibilities and were seen as both 
square planar and tetrahedral geometries, as well as with structures with properties of each 
geometry.109 Other structures displaying a distortion similar to the crystal structure reported in 
this work have been observed and it appeared to be due to the strain imparted on the complex 
by the ligand geometry. In particular, rigid ligands can force the metal centre into a different 
geometry in order to coordinate but will still form stable complexes.110-113 
As mentioned earlier in this discussion, the six membered chelate rings may have encouraged 
the distortion towards a square pyramid due to their larger bond angles than for five membered 
chelate rings. This was difficult to fully determine as copper structures often experience 
distortion. Two five membered ring structures are shown in Table 4.6, where each contains a 
bidentate and a tridentate ligand on a copper(II) centre. These both demonstrate a distorted 
square pyramidal geometry similar to that seen in the work reported in this chapter; the 
Aguilo110 et al structure has a τ5 = 0.25, while the Kumar111 et al structure has τ5 = 0.19. In these 
structures, the distortion likely arose due to the constraints from the ligands enforcing a set 
bond angle between coordinating atoms. The coordination sphere of the Kumar et al structure 
was composed of five nitrogen atoms. The structure reported by Aguilo et al also showed a 
distorted geometry. The coordination sphere, as for the collected structure, was composed of 
three nitrogen donor atoms from a tridentate ligand and two oxygen donor atoms from a 
bidentate ligand. The distortion was again likely due to the constraint from the bidentate ligand, 
which forms a five membered chelate ring with the copper centre and gives a bond angle of 
81.9°. The N – Cu – N bond angles for nitrogen atoms in the same five membered chelate ring in 
these structures are summarised in Table 4.6. 
  




Table 4.6: Bond angles for the literature five membered chelate ring compounds that display 
similar τ5 values to the structure collected in this work. 
Bonds Angle Structure Coordination Sphere 
Kumar et al 
 
 
N1 – Cu – N2 78.0° 
N2 – Cu – N3 83.2° 
N4 – Cu – N5 77.3° 
Aguilo et al 
 
 
N1 – Cu – N2 79.9° 
N2 – Cu – N3 80.3° 
Average 79.7° 
 
Structures with six membered chelate rings also demonstrate distortion, favouring larger bond 
angles109. The structures below include copper centres with six membered chelate rings , formed 
by nitrogen donor atoms in a tridentate ligand separated by propyl chains. The backbone of this 
ligand was equivalent to the backbone of the donor atom connectivity of the ligand used in this 
work. The structures listed below have τ5 = 0.03-0.69, with an average of 0.34. Most of the 
structures are therefore square pyramidal and comparable to the collected structure. All of the 
N – Cu – N angles listed were close to the expected 90° for a square pyramid. 
The impact of the six membered chelate ring on the bond angle appeared to increase the N – Cu 
– N bond angle. The N – Cu – N bond angles from the five membered chelate rings were 
compared the values give an average of 79.7°. By comparison, the six membered chelate rings 
give an average angle of 92.5°. From this, it was evident that the six membered chelate rings 
encourage a larger coordination angle.  
 
  




Table 4.7: Literature N – Cu – N bond angles, τ5 values and coordination geometry. 
Bonds Structure Angle 
τ5 and 
Geometry 
This work  





N3 – Cu – N5 92.3° 
242150114  















N3 – Cu – N4 95.5° 




Table 4.7 (continued) 









N2 – Cu – N3 90.2° 
725160116  





N5 – Cu – N9 93.8° 
979301117  





N2 – Cu – N3 88.9° 
Average: 92.5° 0.34 
 




The orientation of the tridentate ligands forming six membered chelate rings was relatively 
consistent across the structures, with the three nitrogen donor atoms located largely in the 
same plane as each other. A few exceptions to this occur, and these structures have tended 
towards more trigonal bipyramidal geometries as determined by the τ angles. This appeared to 
have occurred due to the bidentate ligand present encouraging the alternative form of 
wrapping, and as a result, the more trigonal bipyramidal geometry. This was also observed in the 
structure presented in this chapter; the bidentate sulfate ligand had encouraged a slightly more 
trigonal bipyramidal geometry. 
4.4.1.4. Coordination Sphere Bond Lengths 
The bond lengths of the coordination sphere consist of four approximately 2.0 Å bond lengths 
and one 2.4 Å bond length (Figure 4.6, Table 4.3). This longer bond appeared to be due to the 
balance between an unfavourable bond angle and an unfavourable bond length for the second 
sulfate oxygen, or the balance of the unfavourable bond angle with instead forming the lower 
four coordinate complex.  
Jahn-Teller distortion is observed frequently in six coordinate octahedral copper(II) complexes as 
lengthening or shortening of the axial bonds118 and was considered as a possibility for this 
distortion. It is also observed in lower coordinate complexes of copper(II)119 as well as in trigonal 
bipyramidal complexes of other first row transition metals120-121. Generally, it is observed as a 
lengthening of the equatorial coordinate bonds122, which was observed in one of three 
equatorial bonds in this structure. It was more likely that the extension observed in the Cu – O 
bond was due to the sulfate anion acting as a bidentate ligand and forming a four membered 
chelate ring, as this was also observed in the bidentate sulfate structures listed above. 
The bond distances seen in the collected sample were consistent with those seen in copper(II) 
complexes rather than copper(I); a Cu-N coordinate bond for a copper(II) complex is generally 
between 1.8-2.2 angstroms in length, versus the shorter 1.6-1.8 for copper(I) complexes123. This 
was expected for this complex as copper(II) was used in the starting material. This also indicated 
that the complex will indeed be neutral due to the 2+ charge on the metal centre, the neutral 
ligand and the SO42- ancillary ligand.  
4.4.1.5. Naphthalimide Pendants 
Another notable feature of the crystal structure was the distortion of the pendant 
naphthalimide moiety away from expected planarity (Figure 4.7). Distortion of aromatic systems 
is known in the context of polycyclic aromatic hydrocarbons (PAHs) and was most observed in 
extended systems or in systems where substituents on the molecules causes steric strain that 




was mitigated through ring distortion.124 In this case, the system consisted of only three rings 
without substantial steric strain, excepting possible intermolecular interactions. It seems unlikely 
that this distortion arose purely for similar reasons to those seen in PAH systems. This distortion 
was very minorly observed in the naphthalic anhydride starting material125, and was very evident 
in the crystal structure for naphthalimide.126 This is a difficult parameter to measure as it is not a 
traditionally observed torsion and was occurring in multiple directions to give the final result. 
Therefore, measuring the twisting was difficult to perform and this comparison was purely 
visual. The increase in distortion from the anhydride starting material to the imide product may 
correlate to the replacement of the anhydride oxygen for the imide nitrogen atom. In the 
collected structure, the three pendants were distorted in different ways, with the two terminal 
pendants twisting in a similar fashion and the middle differing by curving along the molecule 
instead. This could be due to the electronic or steric effects of either the tertiary nitrogen atom 
the linker connects to or the way the ring was located between the other two enforcing a certain 
conformation.  
It was unclear as to whether the observed twisting had implications for the stability of the 
pendants or their use in further complexation, and as such literature structures were analysed to 
see if they experienced similar distortion (Figure 4.8). The twisting may impact of the ability of 
the ligand to act as an intercalator, which was proposed as an additional functionality of these 
targets in Chapter 1. Naphthalimide structures have been used as intercalators in other studies 
to much success, which would suggest that the twisting may not have had an effect. Other 
literature compounds have also been observed demonstrating this twisting, some to a greater 
extent than observed in this work. It appears to trend towards greater distortion if groups were 
added to the naphthalene moiety, with it possibly encouraging twisting due to electronic effects. 
Addition of aromatic substituents to the naphthalimide may alleviate the twisting, which other 
variants to the imide group including coordination of an oxygen atom did not. Substitution to 
the naphthalimide with amines appear to intensify the distortion. A larger study would need to 
be done to determine these trends further, and a measurement system to account for the 
distortion across the whole naphthalimide group away from the expected planarity would be 
required for more in-depth analysis. 





             
Figure 4.7: This figure illustrates the degree of twisting within the rings of the collected 
structure (top), 1,8-naphthalic anhydride125 (middle) and naphthalimide126 (lower). For the 
collected structure, dashed lines have been overlaid on a side by side image, where a single 
line designates a plane between a set of atoms, and the second line demonstrates how this 
plane is twisted compared to a second plane of atoms. 













Figure 4.7 (continued). 
 






    
Figure 4.8: a) This structure includes a naphthalimidegroup coordinated to a metal centre 
via a carbon containing linker. The deformation of the napthalimide is demonstrated here 
as a twisting of the imide funtionality away from the naphthalene down the centre of the 
group from the nitrogen atom to the carbon atom at the bottom of the naphthalene ring 




Figure 4.8: b) This structure showed very intense deformation to the naphthalimide system, 
with the ring adjacent to the amine substituent curving substantially. The ring with the 
amine substituent also appeared to bend sightly in the opposite direction. 









Figure 4.8: c) This structure demonstrates counterrotation of the naphthalimide, with the 
imide twisting in one direction and the naphthalene in the other. This deformation is like 





Figure 4.8: d) This structure again demonstrates counterrotation of the naphthalimide, with 
the imide twisting in one direction and the naphthalene in the other. This deformation was 




Figure 4.8: e) This structure also showed aa slight twisting deformation 









Figure 4.8: f) This structure also contains an amine substitution to the naphthalene moiety, 
and correspondingly experiences the same distortion to the adjacent ring resulting in an 










Figure 4.8: h) This structure contains a coordinated naphthalimide, including coordination of 
the oxygen to the metal centre. It is unclear as to whether this compound retains imide 
character, yet the same twisting deformation was observed. 






   
Figure 4.8: i) This molecule was also coordinated through the oxygen, and showed twisting. 





Figure 4.8: j) This coordinated naphthalimide was a similar distance from the metal centre 




Figure 4.8: k) This naphthalimide was part of a ligand system, but was distant from the 
metal centre. In this structure, the naphthalimide was bent in the plane of the molecule, 
resulting in an overall curve to the naphthalimide. 







Figure 4.8: l) This naphthalimide showed very little deformation, despite the functionality. 
This may be due to the extended polycyclic aromatic substituent attached to the 
naphthalene moiety. Further analysis would be required to conclude this.  
The naphthalimides were not oriented symmetrically, with the central naphthalimide angling 
slightly towards one of the others. The cause of this interaction is unknown as the distance 
between the aromatic rings was likely too large for π interactions. It was possibly due to the 
packing of multiple molecules in the crystal structure. 
 
Figure 4.9: Distances and angles shown for the naphthalimide pendants, measured from the 
centre of the same ring in each naphthalimide. The packing pace fill diagram is also shown. 





Figure 4.9 (continued) 
 
4.4.2. Hexamine Starting Material and Ligand Synthesis 
The naming and CAS number of the purchased amine indicated it was the linear polyamine 4.1, 
however, the crystal structure obtained as product of reaction with this amine showed that 
there was some of the branched isomer 4.2 present in the mixture. 
 
 
Figure 4.10: Crystal structure of the copper naphthalimide product, and structure of the 
amine starting material required to make this compound. 
 
It was possible for both species to be present, with the branched species preferentially forming 
crystals over the linear species due to the additional primary amine (and therefore additional 
naphthalimide pendant) that it possessed encouraging crystallisation. ESI-MS results indicate 
that there may be some of the linear species present as a dinaphthalimide was detected along 
with excess naphthalic anhydride, and increasing the amount of naphthalic anhydride did not 




result in additional trinaphthalimide formation but rather increased detection of the free 
anhydride and the dinaphthalimide species with a naphthalamide attached. Further information 
on this can be observed in Appendix H.  
4.5. Conclusions 
This chapter explored the synthesis and characterisation of a novel copper polyamine complex 
possessing three pendant naphthalimide groups. The crystal structure was discussed and 
determined to have a distorted square pyramidal geometry around the copper centre with 
distortion of both bond lengths and bond angles occurring due to the sulfate ancillary ligand. 
The reproducibility of the experiment and the composition of the amine starting material were 
also explored. The amine was determined to be a mixture of both the compound named on the 
bottle; a linear polyamine, and a branched isomer that went on to form the ligand observed in 
the crystal structure. This was determined through X-ray crystallographic detection of the 
branched compound. 
The initial intention for the synthesis of this ligand was to use as an alternative to the ligand in 
the previous chapter, facilitating physical blocking of the platinum centre of a heterodinuclear 
complex. The crystal structure showed that the formation of the naphthalimide ligands and their 
subsequent complexation was possible following the route examined in this thesis, from 
polyamine and anhydride starting materials. The structure indicated that the trinaphthalimide 
species 4.4 would be unsuitable for the purpose of heterodinuclear complex synthesis. 
Additionally, the fact that complex 4.7 was not detected in the mixture, despite ligand 4.3 being 
detected, suggests that further synthesis with this material was not likely to yield cobalt 
complexes suitable for use in heterodinuclear compounds. 
  




 Conclusions and Future Work 
 
This thesis explored the synthesis and analysis of complex polyamine ligand mixtures, their 
separation by copper complexation, and subsequent cobalt complexation. The ligand design of 
was based around the need for a motif that had the capacity to physically block associative 
ligand exchange to the platinum centre of a heterodinuclear drug candidate. This ligand should 
complex the redox-sensing cobalt centre while extending out over the platinum centre, and as 
such the tetradentate naphthalimide target 2.1 was selected. 
Synthesis of the tetradentate naphthalimide ligand was based on imide formation from a 
hexamine starting material and 1,8-naphthalic anhydride. This reaction was performed using a 
mechanochemical procedure and afforded the desired ligand 2.1. Unfortunately, the amine 
starting material contained a range of impurities including branched compounds, piperazine 
derivatives and polyamines of different lengths. The purity of the dinaphthalimide ligand was 
judged by ESI-MS and NMR to be present as up to 35% of the reaction mixture. The side product 
compounds including 2.3, 2.4, 2.6, 2.8 and 2.13 contained different numbers of nitrogen atoms, 
some of which would be able to act as donor atoms for complexation. Many of the undesirable 
side products contained fewer donor atoms than the desired compound, and therefore the 
purification was attempted through complexation.  
The crude ligand material was reacted with copper sulfate, producing an oily blue solid and a 
deep blue solution. The solid contained much of the copper dinaphthalimide complexation 
product, [Cu(2.1)]2+, with many side products appearing in both phases when analysed by ESI-
MS. Following complexation, both phases were treated with EDTA to remove the copper from 
the complexes formed, each producing a solid and a solution. As for the complexation liquor 
prior to treatment, the solid and solution produced by EDTA treatment both contained 
predominantly side products. The complexation solid also produced a solid and a solution. The 
solid produced showed an enrichment of the dinaphthalimide ligand 2.1 compared to the crude 
material, but still retained substantial presence of impurities. The solution ESI-MS showed a 
large enrichment of the desired free dinaphthalimide ligand product 2.1. Unfortunately, this 
perceived enrichment was tempered by the copper EDTA complex from the copper removal, 
which was present in large amounts in solution but was not detected by ESI-MS due to the 
neutral or negative charge.  
To separate the dinaphthalimide 2.1 from the copper EDTA complex, the solution was extracted 
with chloroform. The chloroform extract only contained side products, which corresponded to 




an increase of the enrichment of the remaining solution. This solution was then treated using 
anion exchange chromatography to varying results, producing a precipitate prior to loading one 
of the solutions to the column that contained predominantly the dinaphthalimide product 2.1. 
This was then used for further reactions. The purification by complexation process was 
performed following various modifications, with methanolic addition of 40% stoichiometric  
pentahydrate copper sulfate showing the greatest enrichment. 
The procedure followed during the study of the complexation by purification process showed 
that, despite the substantial impurity of the amine starting material, the desired 
dinaphthalimide ligand product could be enriched following complexation by purification. During 
this work, this enrichment was achieved as both a slight increase observed in a large bulk of 
material, or a substantial increase in a small yield of material. This demonstrates that although 
the enrichment was possible, additional work would need to be done to improve upon the yield 
to make this material useful for further reactions. Additional work could also surround the 
further purification of the solid material produced following treatment of the copper 
complexation product with EDTA, as this solid showed some enrichment over the crude material 
and had a much greater mass than the more enriched material.  
Following synthesis and purification of the ligand material, two cobalt complexes were 
successfully synthesised in impure form. The two complexes were the dinitrite and carbonate 
complexes, chosen for their ability to displace the coordinated anions in favour of water using 
acid. This displacement was critical for the further steps of complexation to platinum. Both 
compounds were detected using ESI-MS in syntheses using crude and enriched ligand material 
syntheses, with the crude material resulting in the expected contamination of side products. The 
enriched material did not appear to increase the relative intensity by ESI-MS of the desired 
complexes, and this appeared to be due to the detection of a side product. This side product 
features a cobalt coordinated to a deprotonated form of the tetradentate naphthalimide ligand 
which was often detected as the major peak of the ESI-MS spectra. It was unclear as to the true 
amount of this product, and whether it was a stable complex in solution or produced during the 
ESI process.  
This complex could be detected during ESI-MS as a degradation product of the intended 
complexes, which would indicate the synthesis was largely successful, or it may be forming and 
precluding formation of the intended complexes, which would indicate that the desired 
complexation reaction was unfavourable. The fact that some reaction fractions did not contain 
the peak corresponding to this deprotonated complex, but did contain the peak corresponding 




to the nitrite complex, indicates that this species is not solely a degradation product. As a result, 
further work on this species and the complexation procedures in general would need to be 
undertaken in order to determine the true complex yield, and therefore its fitness for use for 
heterodinuclear complex synthesis. Future work could also include synthesis of a broader range 
of complexes. Syntheses involving cobalt coordinated to chloride, sulfate, ammonia and ethane-
1,2-diamine ligands have also been attempted during this work with only trace amounts of the 
complexes occasionally detected. 
Alongside this process, a second tetradentate dinaphthalimide ligand 4.3 was proposed in an 
attempt to generate fewer side products. Synthesis of this ligand was performed in the same 
manner as the previous and the solid produced many peaks in the ESI-MS spectrum. To 
determine if any of the desired ligand was present and to purify it, the material was reacted with 
copper. This produced a blue solid and a blue solution, which was allowed to stand and yielded 
bright blue crystalline material. Analysis of these crystals by x-ray diffraction allowed for 
structural elucidation, showing that a complex 4.6 had formed of copper coordinated to a 
branched trinaphthalimide ligand 4.4 and a sulfate anion. The presence of this ligand indicated 
that the starting material amine contained the branched isomer that had led to this complex, 
and further ligand material synthesis showed that this was not the major component of the 
reaction but was present in substantial amounts; NMR analysis suggested 20%. The crystal 
structure analysis showed that the copper(II) centre was five coordinate, forming six-membered 
chelate rings with the nitrogen donor atoms of the trinaphthalimide ligand. The sulfate anion 
coordinated through a bidentate bonding mode, causing a small bond angle between the copper 
centre and the two donor oxygen atoms due to the four membered sulfate chelate ring. This 
resulted in a distortion of the square pyramidal coordination geometry.  
To continue this work, more amine starting materials could be trialled to avoid the purity issues 
observed in this work. These amines could be manufactured or purified in a different manner to 
prevent side products from forming, or be composed of fewer repeating aminoethane units, 
resulting in fewer isomeric possibilities. Initial work has begun using two tetramine starting 
materials for this purpose and preliminary results indicated that some increase in enrichment 
can be achieved. Further work surrounding the use of different amines would give value to this 
project, especially if different hexaamines could be used for synthesis. The two tetramines used 
were chosen primarily due to their availability and lack of contamination, rather than their 
ability to form the tetradentate ligands required for dinuclear complex synthesis. Further work 
could trial various hexaamines in the attempt to find purer amines that can form tetradentate 
ligands. 




A further issue surrounded the differing solubility of the ligands and the metal centres they were 
complexing. The solubility of both the free ligands and any complexation products was low and 
precludes convenient study. This was also an issue with regards to future drug efficacy – 
compounds that are insoluble in aqueous media tend to make poor candidates for therapeutics 
as they cannot be absorbed by the body or easily transported through the bloodstream. It is thus 
important to attempt to increase the solubility of the ligands, and subsequently, their 
complexes. Ideally, both the ligand and the metal centre would be soluble in the same solvent to 
allow for reaction as this allows both species to be dissolved in the minimum volume, 
encouraging product formation. The ligands studied in this work were most soluble in 
chloroform, and the metal salts were predominantly water soluble. Methanol was used as a 
middle ground for syntheses, however, the increased reaction volume due to the lower solubility 
could be identified as a possible cause for the limited complexation. Future work into increasing 
the solubility of the ligand material may be able to alleviate this issue. This could be approached 
through substitution on the naphthalimide moiety. Substitution for a charged or polar group 
with low ability to act as a donor atom for complexation to platinum would potentially make the 
ligand more soluble in aqueous solutions. 
Preliminary exploration of this topic has focussed on substitution to the naphthalimide group 
using nitro and amino substituents, as well as through replacement of the naphthalimide group 
for the smaller phthalimide group. The nitro group was selected due to the increase in polarity 
this group may provide, while likely being a poor donor site to interact with the platinum centre 
it was designed to protect. Amino substitution was a further prospect for study due to the ready 
production from the nitro derivative and ability for further substitution to the amino group for 
other functional groups to produce a range of naphthalimide options. Preliminary syntheses in 
this area are ongoing. Work involving phthalimides was intended to increase the solubility by 
reducing the aromatic character of the diphthalimide product compared to the dinaphthalimide. 
The synthesis and purification process used to source the amine starting material appeared to 
have had major bearing on the range and quantity of the contaminants present. Alternative 
methods of synthesising this material may allow for an improvement in the purity of the amine 
starting material by preventing formation of the side products. Many of the synthetic routes 
proposed for the production of the hexamine starting material would likely encounter some 
level of the side product formation seen in the industrially produced sample and would still 
require much purification.  




Previous work indicated that the charge on the overall heterodinuclear complex prevented 
isolation of compounds62. It was highlighted that the complexes with a 3+ charge were too 
soluble to be isolated from side products, whereas the neutrally charged compounds were too 
insoluble to dissolve in solvents other than DMSO which then caused them to break down 
(Figure 1.5). The setting of my project surrounded the design of compounds that would 
physically block the platinum centre to prevent the interaction with solvent. Alternatively, future 
work could surround the synthesis of complexes with a different overall charge. This is beneficial 
for more than one reason; increasing the charge from neutral should prevent requiring DMSO 
for dissolution as it should be water soluble, which would prevent the unfavourable interaction, 
while additionally giving the compound more medicinal value as it would need to be water 
soluble to interact with the body. Ethylenediamine diacetic acid (EDDA) is a tetradentate ligand 
comprising two nitrogen donor atoms and two oxygen donor atoms. The acetic acid groups can 
be deprotonated to form coordinate bonds to the cobalt centre, giving the ligand a 2- charge. 
For a heterodinuclear complex with two bridging OH- ligands, the overall complex charge would 
be 1+ if EDDA were used as the cobalt coordination sphere. Work using this ligand has begun 
and is ongoing. 
To summarise, the results from this work indicate that synthesis of dinaphthalimide ligands was 
successfully able to produce the desired compound, 2.1, in an impure form due to the purity of 
the amine starting material used. Attempts to separate the desired ligand from the many 
impurities focussed on purification by complexation, relying on the different properties of the 
ligand 2.1, the complex Cu(2.1), and any side products to be sufficiently different to allow for 
their separation. This method showed moderate success, with enrichment of the desired 
compound observed. Cobalt complexes of 2.1 were also synthesised, although these were also 
faced with issues in purity. [Co(2.1)CO3]+ and [Co(2.1)(NO2)2]+ were detected by ESI-MS analysis 
and further work is occurring surrounding optimisation of the conditions of the reaction to 
produce more of the desired complexes. A crystal structure was also reported in this work, 
showing a novel copper complex of tridentate naphthalimide ligand 4.4. This structure provided 








The programs Olex297 with ShelXL99 and ShelXT99 were used for structural elucidation within 
Chapter 4. PyMol Education version 2.0135, Avogadro version 1.2.0136 and Mercury137 were used 
to generate the 3D rendered figures of both the crystal structures (PyMol, Mercury) and the 
theoretical models (Avogadro, PyMol) generated throughout this thesis. MestRe Nova138 was 
used to render and label NMR spectra. External crystal structures were sourced from the 
CCDC139 and are referenced by the paper associated with the structure. 
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Appendix A. Additional Chapter 2 Methods 
The methods detailed in this appendix were used to trial different reaction conditions in the 
purification by complexation process, intending to optimise the reaction conditions towards the 
most enriched material. 
A.1 Ligand Synthesis and Purification by Complexation using 33% 
Stoichiometric Aqueous Copper Sulfate 
This reaction utilised aqueous copper sulfate for the complexation reaction. 
Ligand synthesis 
This was performed following the procedure described in Section 2.2.6 with the following 
amendments:  
- 10.00 g, 50 mmol of 1,8-naphthalic anhydride was placed in a smaller 10 cm mortar  
- 20 mL of chloroform was added to the mortar  
- 4 mL, 17 mmol of 3,6,9,12-tetraazatetradecane-1,14-diamine was used 
- The reaction gave 17.19 g of a pale brown powder (m.p. 92-96°C decomposes) which was then 
analysed by ESI-MS (Table 2.1). Of note was the lower melting point which may be related to 
compositional differences between the attempts.  
Attempted Purification by complexation 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendments: 
- Crude ligand material (15.98 g) was placed in a 500 mL round bottom flask.  
- 200 mL of methanol was then added with stirring. 
- 2.21 g 8.88 mmol copper sulfate was dissolved in 6 mL warm water 
- The oily blue solid produced was washed twice with less than 5 mL minimal methanol each 
wash 
The solid and the reaction liquor were then characterised by ESI-MS (See Table B.1). 
Treatment of the reaction liquor from the reaction of copper with crude ligand material 






- 3.30 g 8.88 mmol solid disodium EDTA was used 
The solid and the reaction solution were then characterised by ESI-MS (See Table B.1). 
Treatment of the solid material from the reaction of copper with crude ligand material 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendments: 
- 200 mL of Water was added to the oily blue solid in the reaction vessel  
- 3.30 g 8.88 mmol solid disodium EDTA was used 






A.2 Ligand Synthesis and Purification by Complexation using 33% 
Stoichiometric Methanolic Copper Sulfate 
This reaction was the first described in this work to use methanolic copper sulfate for the 
addition of copper. 
Ligand synthesis 
This was performed following the procedure described in Section 2.2.6 with the following 
amendments:  
- 10.00 g, 50 mmol of 1,8-naphthalic anhydride was placed in a smaller 10 cm mortar  
- 20 mL of chloroform was added to the mortar  
- 4 mL, 17 mmol of 3,6,9,12-tetraazatetradecane-1,14-diamine was used 
- The reaction gave 17.00 g of a pale brown powder (m.p. 92-96°C decomposes). 
Attempted Purification by complexation 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendments: 
- Crude ligand material (15.99 g) was placed in a 500 mL two necked round bottom flask.  
- 200 mL of methanol was then added with stirring 
- 2.20 g 8.83 mmol copper sulfate was dissolved in 50 mL warm methanol 
- The oily blue solid produced was washed twice with less than 5 mL methanol each wash 
The solid and the reaction liquor were then characterised by ESI-MS (See Table B.2). 
Treatment of the reaction liquor from the reaction of copper with crude ligand material 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendment: 
- 3.30 g 8.88 mmol solid disodium EDTA was used 
The solid and the reaction solution were then characterised by ESI-MS (See Table B.2). 
Treatment of the solid material from the reaction of copper with crude ligand material 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendments: 
- 200 mL of Water was added to the oily blue solid in the reaction vessel  
- 3.30 g 8.88 mmol solid disodium EDTA was used 





A.3 Ligand Synthesis and Purification by Complexation using 40% 
Stoichiometric Methanolic Copper Sulfate 
This reaction saw the quantity of copper sulfate increased from 33% stoichiometric to 40%. This 
reaction was also repeated once at the same scale, once at 3.5x scale and once at 7.5x scale 
(which is the method described in Section 2.2.6, Ligand Synthesis and purification by 
complexation). 
Ligand synthesis 
This was performed following the procedure described in Section 2.2.6 with the following 
amendments:  
- 20.00 g, 100 mmol of 1,8-naphthalic anhydride was placed in the mortar  
- 40 mL of chloroform was added to the mortar  
- 8 mL, 34 mmol of 3,6,9,12-tetraazatetradecane-1,14-diamine was used 
- The reaction gave 33.62 g of a pale brown powder (m.p. 75-78°C decomposes) which was then 
analysed by ESI-MS (Table 2.1). Of note was the lower melting point which may be related to 
compositional differences between the attempts.  
Attempted Purification by complexation 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendments: 
- Crude ligand material (8.00 g) was placed in a 250 mL round bottom flask.  
- 125 mL of methanol was then added with stirring. 
- 1.35 g 5.42 mmol copper sulfate was dissolved in 75 mL warm methanol 
- The oily blue solid produced was washed twice with less than 5 mL minimal methanol each 
wash 
The solid and the reaction liquor were then characterised by ESI-MS (See Tables B.3, B.4, B.6). 
Treatment of the reaction liquor from the reaction of copper with crude ligand material 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendment: 
- 2.00 g 5.37 mmol solid disodium EDTA was used 





Treatment of the solid material from the reaction of copper with crude ligand material 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendments: 
- 125 mL of Water was added to the oily blue solid in the reaction vessel  
- 2.00 g 5.37 mmol solid disodium EDTA was used 
The oil and the reaction solution were then characterised by ESI-MS (See Tables B.3, B.4, B.6). 
Treatment of the Turquoise Solution Post EDTA 
The solution from the previous step was taken and extracted five times with 50 mL of 
chloroform, which was then analysed by ESI-MS (See Tables B.3, B.4, B.6).  
A.4 Ligand Synthesis and Purification by Complexation using 40% 
Stoichiometric Methanolic Anhydrous Copper Sulfate 
This reaction used anhydrous copper sulfate (at 40% stoichiometry) as the copper source for 
complexation. 
Ligand synthesis 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendment: 
- 34.20 g of pale brown powder was produced and analysed by ESI-MS (See Table B.5) 
Attempted Purification by complexation 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendments: 
- Crude ligand material (4.00 g) was placed in a 500 mL round bottom flask.  
- 70 mL of methanol was then added with stirring. 
- 0.43 g 2.69 mmol anhydrous copper sulfate was dissolved in 175 mL warm methanol 
- The oily blue solid produced was washed twice with less than 5 mL minimal methanol each 
wash 
The solid and the reaction liquor were then characterised by ESI-MS (See Table B.5). 





This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendment: 
- 0.65 g 1.75 mmol solid disodium EDTA was used 
The solid and the reaction solution were then characterised by ESI-MS (See Table B.5). 
Treatment of the solid material from the reaction of copper with crude ligand material 
This reaction was performed following the procedure described in Section 2.2.6 with the 
following amendments: 
- 275 mL of Water was added to the oily blue solid in the reaction vessel  
- 0.65 g 1.75 mmol solid disodium EDTA was used 
The oil and the reaction solution were then characterised by ESI-MS (See Table B.5). 
Treatment of the Turquoise Solution Post EDTA 
The solution from the previous step was taken and extracted six times with 30 mL of chloroform. 
Half of the aqueous phase was then run through DOWEX 1X8 resin in the chloride form to 
separate neutral and charged species by cation exchange. The sample was brought to pH 7-8 and 
loaded onto a 5 cm long 1 cm diameter column directly. The first fraction was eluted using 500 
mL of distilled water, giving a pale turquoise solution. The bright blue band that remained on the 
column was then eluted using 0.25 M NaCl solution followed by 1 M NaCl solution to ensure 






Appendix B. Additional Chapter 2 Results Flowcharts and Summary 
Tables 
The flowcharts in this appendix depict the distribution of compounds present at each stage of 
the reaction for the additional methods as presented in Appendix A1-4. These flowcharts were 
designed in the same way as Figure 2.4 on page 37. The flowcharts are followed by the summary 
tables compiled from the ESI-MS results for each iteration of the reaction. 
B.1 Ligand Synthesis and Purification by Complexation using 33% 



















Figure B.1: Flowchart depicting the partitioning of the various major species in the reactions 
fractions of the variation on the method described in Section 2.2.6 using 33% aqueous copper 
sulfate. The exact method for this reaction can be found in Appendix A.1. 
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Table B.1: Summarised ESI-MS results from the 33% aqueous copper sulfate reaction fractions. The values are expressed as relative intensities for the species of 
interest compared to the largest peak in that spectrum. The final row percentages for the desired compound was calculated by the desired product divided by the 
sum of the most common side products. 2.1, 2.4, Cu(2.1), 2.3 and 2.5. The desired compound was 2.1 except in the second, third and fourth relative intensity 
columns where Cu(2.1) was the desired compound, as highlighted in green for 2.1 and blue for the complex. 






























[2.17+2H+] 2+ 198.6231 198.6239 2+ for C22H31N5O2      0.02     
[M +1H+] 1+ 199.0388 1+ 199.0395 1+ for C12H7O3 0.17 0.10 0.12 0.07      0.13 
[2.2+2H+] 2+ 207.1362 2+ 207.1372 2+ for C22H40N6O2 0.09          
[2.25+2H+] 2+ 254.1047 2+ 254.1055 2+ for C30H28N4O4  0.05  0.02   0.02 0.04 0.03 0.07 
[2.13+2H+] 2+ 275.6268 275.6266 2+ for C32H33N5O4 0.12 0.15 0.06 0.15 0.05 0.28 0.08 0.12 0.11 0.07 
[2.18+2H+] 2+ 288.6334 288.6345 2+ for C34H35N5O4  0.06 0.08 0.07     0.11 0.11 
[2.1+2H+] 2+ 297.1459 2+ 297.1477 2+ for C34H38N6O4 1.0 0.05 0.03 0.04 0.06 0.81 1.0 1.0 0.05 0.18 
[2.4+2H+] 2+ 310.1548 2+ 310.1556 2+ for C36H40N6O4 0.68 0.98 1.0 1.0 0.20 1.0 0.62 0.75 1.0 1.0 
[2.19+2H+] 2+ 318.6673 2+ 318.6688 2+ for C36H43N7O4 0.15          
[Cu(2.1)]2+ 327.6038 2+ 
327.6047 2+ for 
[Cu(C34H36N6O4)]2+ 
 0.29 0.13 0.36  0.58     
[2.22+2H+] 2+ 331.6756 2+ 331.6767 2+ for C38H45N7O4 0.11  0.15    0.10   0.06 
[Cu(2.19)]2+ 349.1249 2+ 349.1257 2+ for [Cu(C36H41N7O4)]2+  0.09 0.11 0.10     0.10  
2.26 or 2.29 353.1963 
353.1978 1+ for C20H25N4O2  
or 2+ for C40H50N8O4 
         0.03 
[2.15+2H+] 2+ 365.6361 365.6372 2+ for C44H35N5O6  0.03        0.03 
[2.12+1H+] 1+ 370.2231 2+ 370.2243 1+ for C20H28N5O2 0.06     0.06 0.07    
[2.16+2H+] 2+ 374.6400 374.6425 2+ for C44H39N5O7          0.05 
[2.3 +2H+] 2+ 387.1578 2+ 387.1583 2+ for C46H42N6O6 0.49 1.0 0.36 0.86 1.0 0.77 0.62 0.69 0.86 0.85 
[2.5+2H+] 2+ 396.1623 2+ 396.1636 2+ for C46H44N6O7 0.26 0.19   0.15 0.37 0.24 0.13 0.23 0.18 
[2.20+2H+] 2+ 408.6780 2+ 408.6794 2+ for C48H47N7O6 0.23 0.22   0.11 0.31 0.30 0.17   
[2.6+2H+] 2+ 409.1703 2+ 409.1714 2+ for C48H46N6O7   0.12      0.09 0.36 
[2.23+2H+] 2+ 421.6852 421.6872 2+ for C50H49N7O6          0.10 
[2.24+2H+] 2+ 430.6904 430.6925 2+ for C50H51N7O7          0.06 
[Cu(2.20)]2+ 439.1355 
439.1363 2+ for 
[Cu(C48H47N7O6)]2+ 
   0.08       





B.2 Ligand Synthesis and Purification by Complexation using 33% 




















Figure B.2: Flowchart depicting the partitioning of the various major species in the reactions 
fractions of the variation on the method described in Section 2.2.6 using 33% methanolic copper 
sulfate. The exact method for this reaction can be found in Appendix A.2.
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2.5 2.4 2.1 
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Table B.2: Summarised ESI-MS results from the 33% methanolic copper sulfate reaction fractions. The values are expressed as relative intensities for the species of 
interest compared to the largest peak in that spectrum. The final row percentages for the desired compound was calculated by the desired product divided by the sum of 
the most common side products. 2.1, 2.4, Cu(2.1), 2.3 and 2.5. The desired compound was 2.1 except in the second, third and fourth relative intensity columns where 
Cu(2.1) was the desired compound, as highlighted in green for 2.1 and blue for the complex. 





























[2.17+2H+] 2+ 198.6231 198.6239 2+ for C22H31N5O2      0.03     
[2.30 +1H+] 1+ 199.0388 1+ 199.0395 1+ for C12H7O3 0.49 0.03 0.26 0.10   0.02 0.29   
[2.13+2H+] 2+ 275.6268 275.6266 2+ for C32H33N5O4 0.11 0.03 0.09 0.10  0.16 0.10 0.08 0.13 0.10 
[2.18+2H+] 2+ 288.6334 288.6345 2+ for C34H35N5O4   0.08 0.04     0.11  
[2.1+2H+] 2+ 297.1459 2+ 297.1477 2+ for C34H38N6O4 0.89 0.42 0.04 0.05 0.10 1.0 1.0 0.12 0.09 0.14 
[2.7+2H+] 2+ 306.1526 2+ 306.1558 2+ for C34H40N6O4 0.94          
[2.4+2H+] 2+ 310.1557 2+ 310.1556 2+ for C36H40N6O4 1.0 0.08 1.0 0.40 0.17 0.48 0.71 0.81 1.0 0.55 
[Cu(2.1)]2+ 327.6046 2+ 327.6047 2+ for [Cu(C34H36N6O4)]2+  1.0 0.21 0.17       
[2.22+2H+] 2+ 331.6756 2+ 331.6767 2+ for C38H45N7O4   0.18 0.07 0.03 0.11 0.10 0.04   
[Cu(2.19)]2+ 349.1258 2+ 349.1257 2+ for [Cu(C36H41N7O4)]2+   0.18   0.02   0.09  
2.26 or 2.29 353.1963 
353.1978 1+ for C20H25N4O2  
or 2+ for C40H50N8O4 
       0.01   
[2.12+1H+] 1+ 370.2231 2+ 370.2243 1+ for C20H28N5O2      0.06     
[2.3 +2H+] 2+ 387.1582 2+ 387.1583 2+ for C46H42N6O6 0.47 0.13 0.52 1.0 1.0 0.14 0.90 0.45 0.83 1.0 
[2.5+2H+] 2+ 396.1623 2+ 396.1636 2+ for C46H44N6O7 0.92  0.04 0.10 0.26 0.24 0.66 0.48 0.39 0.23 
[2.20+2H+] 2+ 408.6775 2+ 408.6794 2+ for C48H47N7O6  0.15        0.13 
[2.6+2H+] 2+ 409.1727 2+ 409.1714 2+ for C48H46N6O7 0.23  0.23 0.20   0.30? 1.0 0.14  
[2.23+2H+] 2+ 421.6852 421.6872 2+ for C50H49N7O6           
[2.24+2H+] 2+ 430.6904 430.6925 2+ for C50H51N7O7        0.10   
[Cu(2.20)]2+ 439.1343 439.1363 2+ for [Cu(C48H47N7O6)]2+  0.01         





B.3 Ligand Synthesis and Purification by Complexation using 40% 
























Figure B.3: Flowchart depicting the partitioning of the various major species in the reactions 
fractions of the variation on the method described in Section 2.2.6 using 40% methanolic 
copper sulfate. The exact method for this reaction can be found in Appendix A.3. 
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Table B.3 Summarised ESI-MS results from the repetition of the 40% methanolic copper sulfate reaction fractions. The values are expressed as relative intensities for the 
species of interest compared to the largest peak in that spectrum. The final row percentages for the desired compound was calculated by the desired product divided by the 
sum of the most common side products. 2.1, 2.4, Cu(2.1), 2.3 and 2.5. The desired compound was 2.1 except where Cu(2.1) was the desired compound, as highlighted in green 
for 2.1 and blue for the complex. 



























[2.30 +1H+] 1+ 199.0394 1+ 199.0395 1+ for C12H7O3 0.31 0.05     0.11    
[2.2+2H+] 2+ 207.1362 2+ 207.1372 2+ for C22H40N6O2 0.15          
[2.25+2H+] 2+ 254.1047 2+ 254.1055 2+ for C30H28N4O4       0.02    
[2.13+2H+] 2+ 275.6259 2+ 275.6266 2+ for C32H33N5O4 0.10 0.07 0.09 0.02 0.02 0.10 0.25 0.08 0.15 0.11 
[2.18+2H+] 2+ 288.6332 288.6345 2+ for C34H35N5O4   0.09       0.08 
[2.1+2H+] 2+ 297.1470 2+ 297.1477 2+ for C34H38N6O4 1.0 0.11 0.05 0.01 0.24 1.0 0.47 1.0 0.41 0.26 
[2.7+2H+] 2+ 306.1520 2+ 306.1558 2+ for C34H40N6O4 0.59          
[2.4+2H+] 2+ 310.1549 2+ 310.1556 2+ for C36H40N6O4 0.93 0.44 0.90 0.34 0.22 0.70 1.0 0.65 0.95 1.0 
[2.19+2H+] 2+ 318.6673 2+ 318.6688 2+ for C36H43N7O4      0.09    0.11 
[Cu(2.1)]2+ 327.6038 2+ 327.6047 2+ for [Cu(C34H36N6O4)]2+  1.0 0.35 0.22       
[2.22+2H+] 2+ 331.6756 2+ 331.6767 2+ for C38H45N7O4     0.03 0.13  0.11 0.09 0.14 
[Cu(2.19)]2+ 349.1231 2+ 349.1257 2+ for [Cu(C36H41N7O4)]2+  0.06 0.17 0.05       
2.26 or 2.29 353.1963 
353.1978 1+ for C20H25N4O2  
or 2+ for C40H50N8O4 
      0.09    
[2.12+1H+] 1+ 370.2235 2+ 370.2243 1+ for C20H28N5O2 0.07    0.02 0.16     
[2.16+2H+] 2+ 374.6421 374.6425 2+ for C44H39N5O7  0.03 0.04 0.02     0.03 0.05 
[2.3 +2H+] 2+ 387.1582 2+ 387.1583 2+ for C46H42N6O6 0.71 0.87 1.0 1.0 1.0 0.54 0.46 0.18 1.0 0.89 
[2.5+2H+] 2+ 396.1623 2+ 396.1636 2+ for C46H44N6O7 0.77 0.18 0.20  0.29 0.42 0.32 0.18 0.40 0.61 
[2.20+2H+] 2+ 408.6775 2+ 408.6794 2+ for C48H47N7O6 0.37 0.16   0.28 0.25  0.10   
[2.6+2H+] 2+ 409.1727 2+ 409.1714 2+ for C48H46N6O7   0.28 0.09   0.09  0.32 0.43 
[2.21+2H+] 2+ 417.6829 2+ 417.6847 2+ for C48H49N7O7 0.28     0.03   0.11 0.19 
[2.23+2H+] 2+ 421.6866 2+ 421.6872 2+ for C50H49N7O6  0.06 0.13 0.07 0.07      
[2.24+2H+] 2+ 430.6904 430.6925 2+ for C50H51N7O7         0.05 0.10 
[Cu(2.20)]2+ 439.1341 2+ 439.1363 2+ for [Cu(C48H47N7O6)]2+  0.16  0.09       
[Cu(2.21)]2+ 448.1413 1+ 448.1416 2+ for [Cu(C48H47N7O7)]2+   0.09        
 [2.8+2H+] 2+ 953.3300 953.3299 1+ for C58H45N6O8     0.03      





B.4 Ligand Synthesis and Purification by Complexation using 40% 

























Figure B.4: Flowchart depicting the partitioning of the various major species in the reactions 
fractions of the variation on the method described in Section 2.2.6 using 40% methanolic 
copper sulfate. The general method for this reaction can be found in Appendix A.3. 
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Table B.4: Summarised ESI-MS results from the repetition of the 40% methanolic copper sulfate reaction fractions. The values are expressed as relative intensities for the 
species of interest compared to the largest peak in that spectrum. The final row percentages for the desired compound was calculated by the desired product divided by 
the sum of the most common side products. 2.1, 2.4, Cu(2.1), 2.3 and 2.5. The desired compound was 2.1 except where Cu(2.1) was the desired compound, as highlighted 
in green for 2.1 and blue for the complex. 































[2.17+2H+] 2+ 198.6243 198.6239 2+ for C22H31N5O2      0.04     
[2.30 +1H+] 1+ 199.0391 1+ 199.0395 1+ for C12H7O3 0.31 0.06 0.23 0.04 0.03  0.08  0.10 0.25 
[2.2+2H+] 2+ 207.1362 2+ 207.1372 2+ for C22H40N6O2 0.15          
[2.25+2H+] 2+ 254.1056 2+ 254.1055 2+ for C30H28N4O4     0.02  0.02    
[2.13+2H+] 2+ 275.6258 2+ 275.6266 2+ for C32H33N5O4 0.10 0.08 0.09 0.04 0.08 0.06 0.06 0.13 0.08 0.12 
[2.18+2H+] 2+ 288.6332 288.6345 2+ for C34H35N5O4   0.12        
[2.1+2H+] 2+ 297.1470 2+ 297.1477 2+ for C34H38N6O4 1.0 0.09 0.06  0.65 1.0 0.14 1.0 0.10 0.28 
[2.7+2H+] 2+ 306.1520 2+ 306.1558 2+ for C34H40N6O4 0.59          
[2.4+2H+] 2+ 310.1544 2+ 310.1556 2+ for C36H40N6O4 0.93 0.41 1.0 0.45 0.66 0.31 0.14 0.66 0.65 1.0 
[Cu(2.1)]2+ 327.6035 2+ 327.6047 2+ for [Cu(C34H36N6O4)]2+  1.0 0.29 0.39       
[2.22+2H+] 2+ 331.6757 2+ 331.6767 2+ for C38H45N7O4     0.05   0.14   
[Cu(2.19)]2+ 349.1240 2+ 349.1257 2+ for [Cu(C36H41N7O4)]2+  0.08 0.23 0.07       
[2.15+2H+] 2+ 365.6361 365.6372 2+ for C44H35N5O6   0.03        
[2.12+1H+] 1+ 370.2235 2+ 370.2243 1+ for C20H28N5O2 0.07       0.09   
[2.3 +2H+] 2+ 387.1583 2+ 387.1583 2+ for C46H42N6O6 0.71 0.72 0.74 1.0 1.0 0.04 1.0 0.04 0.51 0.50 
[2.5+2H+] 2+ 396.1623 2+ 396.1636 2+ for C46H44N6O7 0.77 0.06  0.08 0.24 0.09 0.12 0.22 0.17 0.25 
[2.20+2H+] 2+ 408.6776 2+ 408.6794 2+ for C48H47N7O6 0.37 0.15  0.14 0.24      
[2.6+2H+] 2+ 409.1713 2+ 409.1714 2+ for C48H46N6O7   0.18    0.10  0.22 0.32 
[2.21+2H+] 2+ 417.6829 2+ 417.6847 2+ for C48H49N7O7 0.28          
[2.23+2H+] 2+ 421.6849 2+ 421.6872 2+ for C50H49N7O6     0.07      
[2.24+2H+] 2+ 430.6902 430.6925 2+ for C50H51N7O7          0.06 
[Cu(2.20)]2+ 439.1346 2+ 439.1363 2+ for [Cu(C48H47N7O6)]2+  0.11  0.10       
[Cu(2.27)]2+ 460.6548 460.6575 2+ for [Cu(C50H50N8O6)]2+    0.02       





B.5 Ligand Synthesis and Purification by Complexation using 40% 


























Figure B.5: Flowchart depicting the partitioning of the various major species in the reactions 
fractions of the variation on the method described in Section 2.2.6 using 40% methanolic 
anhydrous copper sulfate. The exact method for this reaction can be found in Appendix A.4. 
 
Dissolved in methanol and refluxed. Methanolic 
anhydrous CuSO4 added (at 0.4 stoichiometry) 
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Refluxed in water with 
solid EDTA (1:1 with 
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Table B.5: Summarised ESI-MS results from the 40% methanolic anhydrous copper sulfate reaction fractions. The values are expressed as relative intensities for the species of 
interest compared to the largest peak in that spectrum. The final row percentages for the desired compound was calculated by the desired product divided by the sum of the 
most common side products. 2.1, 2.4, Cu(2.1), 2.3 and 2.5. The desired compound was 2.1 except where Cu(2.1) was the desired compound, as highlighted in green for 2.1 and 
blue for the complex. 
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[2.30 +1H+] 1+ 199.0394 1+ 199.0395 1+ for C12H7O3 0.37 0.02 0.14 0.02 0.04 0.11       0.03 0.12 
[2.25+2H+] 2+ 254.1043 2+ 254.1055 2+ for C30H28N4O4 0.09   0.02  0.14       0.04 0.002 
[2.13+2H+] 2+ 275.6260 2+ 275.6266 2+ for C32H33N5O4  0.09 0.10 0.03  0.22 0.03 0.04 0.05  0.04  0.07 0.07 
[2.18+2H+] 2+ 288.6332 288.6345 2+ for C34H35N5O4   0.09           0.07 
[2.1+2H+] 2+ 297.1470 2+ 297.1477 2+ for C34H38N6O4 0.20 0.05 0.09 0.25 1.0 0.50 1.0 1.0 1.0 1.0 1.0 1.0 0.04 0.07 
[2.4+2H+] 2+ 310.1548 2+ 310.1556 2+ for C36H40N6O4 0.19 0.17 0.79 0.15 0.20 0.53 0.07 0.07 0.10 0.23 0.35 0.03 0.21 0.57 
[Cu(2.1)]2+ 327.6040 2+ 327.6047 2+ for [Cu(C34H36N6O4)]2+  1.0 0.32 0.06    0.37 0.51 0.16 0.06 0.50   
[2.22+2H+] 2+ 331.6767 2+ 331.6767 2+ for C38H45N7O4           0.06    
[Cu(2.19)]2+ 349.1231 2+ 349.1257 2+ for [Cu(C36H41N7O4)]2+   0.24            
2.26 or 2.29 353.1962 353.1978 1+ for C20H25N4O2  
or 2+ for C40H50N8O4      
0.03         
[2.15+2H+] 2+ 365.6353 365.6372 2+ for C44H37N5O6    0.04         0.03 0.04 
[2.3 +2H+] 2+ 387.1568 2+ 387.1583 2+ for C46H42N6O6 0.41 0.24 1.0 1.0 0.27 1.0 0.05      1.0 1.0 
Unknown 393.1487 2+ Unknown          0.56 0.54    
[2.5+2H+] 2+ 396.1623 2+ 396.1636 2+ for C46H44N6O7 0.26  0.10  0.18 0.32 0.07 0.06 0.10 0.41 0.38 0.09  0.11 
[2.20+2H+] 2+ 408.6769 2+ 408.6794 2+ for C48H47N7O6  0.09  0.41 0.12 0.27     0.28  0.16  
[2.6+2H+] 2+ 409.1609 2+ 409.1714 2+ for C48H46N6O7 0.13  0.23           0.29 
[2.23+2H+] 2+ 421.6866 2+ 421.6872 2+ for C50H49N7O6    0.08           
[Cu(2.20)]2+ 439.1338 2+ 439.1363 2+ for [Cu(C48H47N7O6)]2+  0.05             





B.6 Ligand Synthesis and Purification by Complexation using 40% 
Stoichiometric Methanolic Copper Sulfate, 3.5x Scale (0.5 scale 
























Figure B.6: Flowchart depicting the partitioning of the various major species in the reactions 
fractions of the variation on the method described in Section 2.2.6 using 40% methanolic 
copper sulfate. The general method for this reaction can be found in Appendix A.3. 
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Table B.6: Summarised ESI-MS results from the reaction fractions of the 40% methanolic copper sulfate reaction at 3.5x scale (0.5 compared to Section 2.2.6). The 
values are expressed as relative intensities for the species of interest compared to the largest peak in that spectrum. The final row percentages for the desired 
compound was calculated by the desired product divided by the sum of the most common side products. 2.1, 2.4, Cu(2.1), 2.3 and 2.5. The desired compound was 
2.1 except where Cu(2.1) was the desired compound, as highlighted in green for 2.1 and blue for the complex. 





























[2.30 +1H+] 1+ 199.0395 1+ 199.0395 1+ for C12H7O3 0.37 0.06 0.13   0.04  0.05 0.15 
[2.25+2H+] 2+ 254.1056 2+ 254.1055 2+ for C30H28N4O4 0.09 0.02    0.04    
[2.13+2H+] 2+ 275.6255 2+ 275.6266 2+ for C32H33N5O4  0.16 0.04 0.06 0.06 0.09 0.04 0.07 0.11 
[2.18+2H+] 2+ 288.6332 288.6345 2+ for C34H35N5O4  0.05 0.10   0.09    
[2.1+2H+] 2+ 297.1472 2+ 297.1477 2+ for C34H38N6O4 0.20 0.22 0.06 0.52 1.0 0.23 1.0 0.26 0.25 
[2.4+2H+] 2+ 310.1544 2+ 310.1556 2+ for C36H40N6O4 0.19 0.59 1.0 0.56 0.30 1.0 0.12 0.38 1.0 
[Cu(2.1)]2+ 327.6032 2+ 327.6047 2+ for [Cu(C34H36N6O4)]2+  1.0 0.28       
[2.22+2H+] 2+ 331.6757 2+ 331.6767 2+ for C38H45N7O4    0.05 0.06  0.05  0.13 
[Cu(2.19)]2+ 349.1240 2+ 349.1257 2+ for [Cu(C36H41N7O4)]2+  0.14 0.18       
[2.26 +1H+] 1+ 353.1965 1+ 353.1978 1+ for C20H26N4O2      0.02    
[2.12+1H+] 1+ 370.2236 2+ 370.2243 1+ for C20H28N5O2     0.08  0.06   
[2.16+2H+] 2+ 374.6400 374.6425 2+ for C44H39N5O7        0.05  
[2.3 +2H+] 2+ 387.1566 2+ 387.1583 2+ for C46H42N6O6 0.41 0.73 0.46 1.0 0.07 0.60  1.0 0.90 
[2.5+2H+] 2+ 396.1623 2+ 396.1636 2+ for C46H44N6O7 0.26   0.22 0.12 0.19 0.05 0.11 0.28 
[2.20+2H+] 2+ 408.6776 2+ 408.6794 2+ for C48H47N7O6  0.26  0.31  0.12  0.19  
[2.6+2H+] 2+ 409.1713 2+ 409.1714 2+ for C48H46N6O7   0.12 0.20     0.61 
[2.23+2H+] 2+ 421.6849 2+ 421.6872 2+ for C50H49N7O6    0.07      
[Cu(2.20)]2+ 439.1346 2+ 439.1363 2+ for [Cu(C48H47N7O6)]2+  0.10        





Appendix C. Additional Chapter 2 Discussion on the Fractions of the 
Purification by Complexation Method 
This appendix seeks to expand upon Section 2.4.3.1, Purification by Complexation Reaction 
Stages on page 63 by providing additional details around the speciation observed in each 
fraction of the complexation by purification method. 
Complexation reaction of copper with the crude ligand material (Section 2.2.6.2) 
The reaction of crude ligand with copper produced a deep blue solid and a deep blue liquor. 
Both the solid and the liquor contained a complex of the copper and desired compound, as 
identified by ESI-MS. The copper 2.1 complex was predominantly seen in the solid produced, 
with percentage compositions of 12% to 68% in the solid and 9% to 14% in the liquor (Tables 
B.1-B.6). The free dinaphthalimide piperazine and trinaphthalimide species (2.4 and 2.3, 
310.1556 2+ and 387.1568 2+) were also found in both fractions, often as the major compounds. 
The deep blue colour of both fractions suggested the presence of copper bound to nitrogen 
donor atoms. This hints at the possibility of copper complex formation that was not detected by 
ESI-MS, such as neutral species or species that do not ionise well.  
Aside from the partitioning of the desired compound and its complex between the two phases, 
the composition of the complexation solid and liquor was generally very similar in that each by-
product component still appeared in each phase, albeit in slightly different ratios. In general, the 
relative intensity of the dinaphthalimide piperazine (2.4, 310.1556 2+) to the trinaphthalimide 
species showed greater presence of the trinaphthalimide (2.3, 387.1583 2+) species in the solid 
(around 0.73 versus 0.46 relative intensity), and greater presence of the dinaphthalimide 
piperazine in the reaction liquor (0.59 versus 1.0 relative intensity) . The exact ratio of the 
components varied between experiments. 
The precipitate that formed during overnight refrigeration was also very similar between trials 
and was predominantly comprised of some of the remaining 2.3 compound precipitating from 
the liquor, along with more of the Cu(2.1) complex and some of 2.4. This fraction was collected 
and combined with the initial reaction solid to maximise the amount of the desired compound 
copper complex collected. This was done despite the greater presence of the trinaphthalimide 
side product 2.3 in the solid produced on cooling as this side product was already present in the 
complexation solid in large amounts, and thus collection of more complex was deemed more 






Treatment of the Reaction Solid with EDTA (Section 2.2.6.3) 
Treatment of the reaction solid with EDTA resulted in the solid changing from a deep blue oily 
solid to a brown oil, and the solution went from the faint deep blue of the slightly dissolved solid 
to an intense bright blue, characteristic of the copper EDTA complex. The treatment of the solid 
with EDTA was of particular interest given that this fraction showed the highest ratio of desired 
compound to side products (average percentage composition 51% 2.1). 
Despite the observation that the crude ligand material had a low solubility in water, the desired 
compound 2.1 appeared to have a high relative intensity in the aqueous phase following the 
removal of copper, appearing at an average of 51% composition and relative intensities up to 1.0 
(Tables B.1-B.6, 2.18). The desired compound was the major component detected in this phase, 
however, substantial amounts of both copper EDTA and free EDTA (as the EDTA was used in 
slight excess) are also present in this phase. As the enrichment was determined by the relative 
intensities of the peaks observed in the ESI-MS spectra, the presence of the neutral and 
undetected Cu(EDTA) species was not included in the comparisons performed to determine 
enrichment. As a result, the perceived enrichment of the desired ligand in the aqueous phase 
was much higher than the true result. The desired compound was likely a minor component of 
the aqueous solution, which was further illustrated the poor yield of 1.5% for the precipitate 
from this solution (Section 2.3.2). The solid produced by this reaction contained large amounts 
of the side product along with a high relative intensity of the desired compound. This showed 
that despite the cleanness of the solution, the majority of the desired compound ended up in 
this solid phase and thus the purification was inefficient. 
Treatment of the Reaction Liquor with EDTA (Section 2.2.6.4) 
The treatment of the reaction liquor with EDTA was also performed to gain further information 
about the species present in the reaction mixture. The deep blue liquid produced a mixed brown 
solid and an emerald green solution upon addition of EDTA. 
Both the solution and the solid following addition of EDTA contained the desired compound, the 
trinaphthalimide and naphthalamide species and the dinaphthalimide piperazine species in 
relative intensities of around 0.50, 1.00 and 1.00, respectively. This indicates that some of the 
desired compound 2.1 was lost to this fraction, but the recovery of it was unlikely to be worth 






Chloroform Extraction of the Reaction Solid Post EDTA Aqueous Solution (Section 2.2.6.5) 
To isolate the desired compound from the aqueous solution post EDTA treatment the solution 
was extracted using chloroform. The yield from this extraction was extremely low, around 0.6% 
of the mass of the initial crude ligand used, and the ESI-MS spectra for the chloroform extracts 
indicated that the extracted product was composed of primarily by-products. The nature and 
ratio of these side products varied greatly between the experiments. As a result, the extract was 
substantially less pure than the crude material. 
This meant that although the extraction had not succeeded in isolating the desired compound 
from the copper and EDTA products, it had removed some of the other contaminants from the 
aqueous solution. The aqueous solution following extraction was less contaminated when 
analysed by ESI-MS, with a greater relative intensity of the desired compound to other side 
products than was seen pre-extraction (1.0 to 0.30 versus 1.0 to 0.12 as seen in Table B.6). This 
was seen as an increase in the percentage composition of the desired compound in the solution 
before and after extraction, going from an average of 51% and maximum of 69% to an average 
of 63% and maximum of 85% (Table 2.18). 
Column of the Reaction Solid Post EDTA Aqueous Solution, Post Chloroform Extraction (Section 
2.2.6.5) 
The purpose of this column was to remove the free EDTA and the Copper EDTA complex from 
the free ligand. By adjusting the solution to pH 7.5, both the EDTA and the complex are likely to 
be negatively charged and can therefore be separated from the positively charged and neutral 
species. Running the pH 7.5 solution following extraction through the DOWEX 1X8 resin resulted 
in a pale blue fraction that ran through the column with the water as it was loaded and 
continued to elute with water. This fraction contained the desired compound when analysed by 
ESI-MS, along with some of the copper complex. This copper complex was not observed 
substantially in the solution prior to introduction in the column. This suggested the possibility of 
the complex forming in the column. A blue band was observed at the top of the column upon 
loading. This was likely to be the copper EDTA species as it did not move substantially under the 
water mobile phase, which would be expected as this complex would be negatively charged and 
therefore attracted to the positively charged resin.  
The bright blue band that formed at the top of the resin was eluted with 0.25-1M NaCl and 
further concluded to be the copper EDTA species. A small amount of a yellow compound 





were unsuccessful and required removal of the top layer of resin which was then washed with 
methanol to remove the compound. This compound was identified as ligand material that had 
crashed out due to poor solubility as determined by ESI-MS. This sample was also substantially 
contaminated by resin.  
The amount of desired compound retrieved by the column was low despite the quantity of 
crude material used. The exact mass cannot be determined following in vacuo removal of water 
from the fraction due to the presence of salt and the blue species that remains in the product 
following washing of the material. This reinforces the conclusion drawn in the previous 
subsection for this aqueous solution, that while the reaction can produce relatively pure 
material (as seen by the column ESI-MS results in Table 2.15 and Table 2.18) the process was 
inefficient. 
Precipitate following chloroform extraction of the complexation solid post EDTA solution 
The purest sample of desired compound was collected during the work up of the post 
chloroform extraction solution to prepare it for ion exchange chromatography. This material was 
still a pale blue, suggesting presence of undetected complexes. The ESI-MS spectrum showed 
the material to be predominantly the desired compound (89%, Table 2.15). The precipitate upon 
drying weighed 0.5 g and was obtained from an initial reaction mass of 30 g, indicating that this 
process was also very low yielding. Unfortunately, attempts to collect an NMR spectrum of this 
compound to compare to the crude material were unsuccessful. An inability to gather NMR data 
even when using a large number of scans was also observed for the crude material so this was 







Appendix D. Additional Chapter 2 Discussion comparing and 
contrasting the Variations to the Purification by Complexation 
method 
Methanolic versus Aqueous Copper Sulfate (Appendix B.1 and B.2) 
This variation surrounded the method by which copper was added to the methanolic solution of 
crude material. Using methanol resulted in a greater total reaction volume due to the lower 
solubility of the copper sulfate in methanol. The major difference between these two reactions 
surrounds the partitioning of the copper complex of the desired product versus the side 
products in the complexation solid, and subsequently, the solution produced following 
treatment of the this solid with EDTA (Tables B.1 and B.2). The initial reaction solid contains 
substantially greater amounts of the dinaphthalimide piperazine and trinaphthalimide 
compounds in the aqueous addition of copper versus the methanolic addition. This was likely 
due to the lower solubility of these species in the slightly more polar reaction solvent for the 
aqueous addition. The solid produced during the complexation reaction contained the majority 
of the copper complex of the desired compound and the methanolic addition showed the 
greater enrichment here, with 12% of the solid being complex for the aqueous reaction versus 
61% for the methanolic addition.  
33% Copper Versus 40% Copper (Appendix B.2 and B.3) 
The amount of copper used in the complexation was also varied between experiments. The 
choice of 33% stoichiometric copper was somewhat arbitrary and based around a bottle label 
that may have corresponded to the purity, so it was likely that this ratio could be changed to 
improve the purification. Free ligand of the desired compound 2.1 was detected by ESI-MS 
following copper complexation at 33% stoichiometry indicating insufficient copper was used to 
complete complexation. The copper used was increased to 40% stoichiometric, with all other 
reaction conditions maintained.  
The increase in copper increased the amount of the desired compound that was complexed, 
with the free desired ligand in the complexation solid going from 0.42 of the intensity of the 
complex peak to 0.09 of the intensity through increasing the amount of copper from 33% to 40% 
(Tables B.2 and B.3). The free ligand in the solvent remained low, at 0.04 and 0.06 of the 





The increased complex in the complexation solid corresponded to an increase in enrichment of 
the desired compound in the aqueous phase following EDTA treatment of this solid. The 
percentage of 2.1 in this fraction went from 54% to 69% upon increasing the copper 
stoichiometry. This increase was attributed to the additional complex present in the solid and 
could also be partially due to the extra solvent used to dissolve the additional copper allowing 
impurities to remain in solution and therefore not be observed in this step. 
Based on the observation of greater complexation of the desired compound, as well as greater 
enrichment of this compound in the aqueous phase (following EDTA treatment), upon increasing 
the amount of copper it was decided that the further reactions would also be performed at this 
stoichiometry. Further increasing the stoichiometry was not attempted as it could only result in 
a slight improvement over this method, as very little free 2.1 remained, but would come with 
the risk of also complexing poorer ligands or complexing these compounds in greater quantities 
than already occurring.  
Pentahydrate versus Anhydrous Copper Sulfate (Appendix B.3 and B.5) 
Another modification made to this method surrounded the use of anhydrous copper sulfate as 
the source of copper. When compared to the pentahydrate synthesis a similar enrichment was 
observed by ESI-MS. Unfortunately, the anhydrous copper was also much more prone to 
precipitating out of the warm methanol as the solvent cooled slightly and required a much 
greater volume to dissolve. This resulted in difficulty keeping the solution warm during addition 
to the ligand solution. Both the volume and tendency to precipitate made performing the 
reaction impractical.  
The complexation solid of the anhydrous reaction had a greater enrichment of the desired 
complex compared to the pentahydrate, appearing as 68% versus 44% (Table 2.18). This could 
be due to the increased reaction volume from the less soluble anhydrous copper favouring 
dissolution of the side products, as hypothesised in the previous subsection. This would reduce 
the amount of the side products present in the complexation solid, corresponding to the lower 
detection of the side products in the subsequent steps. As the methanol used was used without 
attempts to fully dry it, much of the water removed through the use of anhydrous copper may 
have been replaced in the increased methanol volume. This suggests that the increased volume 
may be the true reason for the increased enrichment, and further reactions using a greater 





Following the EDTA treatment of this solid, the solution produced by the anhydrous reaction was 
slightly less enriched by comparison to the pentahydrate. The increased enrichment for the 
anhydrous reaction in the solid was somewhat offset by the slightly lower enrichment of the 
desired compound following treatment of the solid with EDTA. The obvious need for further 
optimisation at this step coupled with the more difficult reaction procedure led to the decision 
to continue using the pentahydrate copper sulfate salt for further reactions.  
Reproducibility of the complexation process (Appendix B.3 and B.4) 
Following the observation that slight changes to the reaction conditions led to the decision to 
repeat the reaction to determine the reproducibility of the method. The reaction of crude 
material with 40% stoichiometric copper was attempted following the same procedure as was 
applied in the first iteration.  
The similarity between the two repetitions of this reaction (Tables B.3 and B.4) showed that this 
method was reproducible in terms of which compounds were detected in which fractions, 
however, the percentages of the desired compounds varied between the two trials. The 
aqueous solution following treatment with EDTA still showed the highest enrichment of the 
desired compound 38% and 69%). Across the different reaction fractions only minor differences 
in the compounds detected were observed. 
Scale up of the process (Table 2.15, Appendix B.4 and B.5)  
The reaction using 40% methanolic copper sulfate was also repeated at a 3.5x and 7.5x scale. As 
the scale increased, there was an observed decrease in the percentage of the desired compound 
in the fractions expected, even despite the slightly purer crude material used in the case of the 
7.5x scale reaction (Table 2.15). The desired complex Cu(2.1) in the complexation solid 
decreased from 44% to 39% to 22%. Conversely, it increased in the liquor from 14% to 16% to 
27%. The complex distribution has moved towards the reaction liquor. This could have been due 
to the fact that the volume required for dissolution did not increase by the same amount as the 
reactants, resulting in a more concentrated solution. This implies that decreasing the 
concentration of the solution may increase the enrichment of the desired complex Cu(2.1), 
which corresponds to the conclusion drawn in the previous subsection. Further work into this by 
varying the reaction volume would likely allow for further conclusions to be drawn. 
The following step of the reaction was similarly affected; upon addition of EDTA to the 
complexation solid, the enrichment previously seen in the solution drops from 69% to 67 % to 





in the solid produced (and lost to the complexation liquor in the previous step). The increase in 
the post EDTA solid is likely to be of benefit; as discussed in Section 2.4.3.1, the apparent 
enrichment in the solution was undermined by the lack of detection of the far more prevalent 
Cu(EDTA) complex. In the two scale up reactions, the solid produced in the also featured an 
enriched presence of the desired ligand 2.1 compared to the crude material, at 19% versus 23% 
for the 3.5x scale and 38% versus 44% for the 7.5x scale. Further investigation as to the payoff of 
this method still needs to be explored – while it produced a much greater yield of the enriched 
material in the solid material than observed in the solution in other iterations, the percentage 






Appendix E. Analysis of the Components in the Chapter 2 Reaction 
Mixtures 
E.1 Analysis of the Components in the Crude Ligand Reaction 
 
Compounds Containing six nitrogen atoms 
Figure E.1: Compound 2.1, ESI-MS peaks 593.2876 1+ and 297.1484 2+ (predicted 297.1477 2+ 
for C34H37N6O4 and 593.2876 1+ for C34H37N6O4) 
This desired compound was generally observed as a major component of the crude reaction 
mixture by ESI-MS relative intensities. The percentage of the crude ligand composition of this 
compound averaged 31% (judged by peak height versus total peak heights for identifiable 
compounds).  
The linear form of this compound was the desired ligand for further synthesis, yet there are 
many other branched isomers that may be present.
 
Figure E.2: Possible isomers of the desired product (top left) that may be contributing to the 
m/z signals at 593.2876 1+ and 297.1484 2+ (predicted 297.1477 2+ for C34H37N6O4 and 






Figure E.3: Compound 2.2, ESI-MS peak 207.1362 2+ (predicted 207.1372 2+ for C22H40N6O2) 
This compound was identified in the crude reaction mixtures in generally low amounts, less than 
0.10 relative intensity. In order to have this mass, the amine starting material would have to 
contain at least two primary amines, with addition of a naphthalimide moiety to only one of 
them. This suggests that, despite the excess of naphthalic anhydride used, complete eradication 
of this species may not be possible. Unfortunately, this compound was likely to be a better 
ligand than the dinaphthalimide species, even if branched, due to the greater number of 
available donor atoms and the lower bulk from the singular naphthalimide.  
 
Figure E.4: Compound 2.3, ESI-MS peaks 387.1578 2+ and 773.3088 1+ (predicted 387.1583 2+ 
for C46H42N6O6 and 773.3088 1+ for C46H41N6O6) 
This compound mass could correspond to one of three main isomers, as well as the possibility of 
a less probable nine membered ring compound. These isomers correspond to the symmetric and 
asymmetric monobranched amine species, as well as the dibranched species with three 
pendants. Of these isomers, one compound was symmetrical which may encourage the 
formation of complexes with copper as seen in the crystal structure in Chapter 4. These 
compounds all have three available donor atoms, making them less likely to form complexes 
than the desired compound. As seen in the crystal structure in Chapter 4, a tripodal ligand may 
coordinate to the copper along with a sulfate, creating a neutral complex. Such a complex would 
be difficult to detect by ESI-MS, and as in the case of the crystal structure compound, only free 
ligand was detected. If these compounds are indeed present in the purification mixture, they 
were notndetected and instead may only be detected as free ligand upon complex degradation. 






Heterocycles with nine members do exist in the literature, suggesting that the nine-membered 




dacn and dmpdacn141 Core of a heterocycle with amides140 
Figure E.5: Literature examples of nine-membered heterocycles. 
 
 
Figure E.6: Possible isomers that may be contributing to the m/z signals at 387.1578 2+ and 
773.3088 1+ (predicted 387.1583 2+ for C46H42N6O6 and 773.3088 1+ for C46H41N6O6). 
 
 
Figure E.7: Compound 2.4, ESI-MS peaks 310.1549 2+ and 619.3037 1+ (predicted 310.1556 2+ 
for C36H40N6O4 and 619.3033 1+ for C36H39N6O4) 
The dinaphthalimide piperazine compound was also detected by ESI-MS in the crude ligand 
mixture. In some iterations of the crude ligand synthesis, this piperazine compound (or its seven 





the free amine ESI-MS spectrum was around one third of the relative intensity of the desired 
amine mass.  
 
Figure E.8: Compound 2.5, ESI-MS peaks 396.1629 2+ and 791.3197 1+ (predicted 396.1636 2+ 
for C46H44N6O7 and 791.3194 1+ for C46H43N6O7)    
Formation of an amide in the ligand synthesis was an interesting observation. Despite the excess 
of anhydride used for a linear amine, the branched nature of some components of the amine 
mixture would suggest that any excess anhydride would form an imide with the additional 
terminal amines, rather than form amides with secondary amines of the chain. However, 
compounds with the correct mass for an additional pendant through an amide linkage 
frequently appear in the ESI-MS spectra. The relative intensity, when detected, varies from a 
trace component of the reaction mixture right through to the major component. This amide was 
likely to be a poorer ligand than the desired compound, both due to one of the donor atoms 
going from a secondary to tertiary amide (which would be a slightly poorer donor atom in the 
chelating system) as well as the added steric bulk of the additional naphthalimide. This 
compound could also exist as a number of isomers, some of which may have more steric strain 
than others due to the proximity of the naphthalimide and naphthalamide groups. 
 
Figure E.9: Compound 2.6, ESI-MS peaks 409.1713 2+ and 817.3355 1+ (predicted 409.1714 2+ 
for C48H46N6O7 and 817.3350 1+ for C48H45N6O7) 
This compound appears frequently in the ESI-MS spectra and was the piperazine equivalent of 
compound 2.5. This compound will likely share many of the properties of both compound 2.4 





amide tertiary nitrogen. The relative intensity of this compound ranges greatly from not being 
detected right through to having the largest relative intensity. 
 
Figure E.10: Compound 2.7, ESI-MS peak 306.1526 2+ (predicted 306.1558 2+ for C34H40N6O4) 
As for the previous amide, this compound was not always detected but the fact that it was 
detected at all was an interesting finding. This compound was only substantially detected in the 
crude ligand, with a maximum relative intensity of 0.94, however, there was some evidence for 
trace amount peaks in ESI-MS spectra of other reaction steps. This suggests that this compound 
was disfavoured upon refluxing, wherein the amide has the opportunity to hydrolyse and 
equilibrate to a more favourable imide. There were 21 potential isomers of this compound. 
 
Figure E.11: Compound 2.8, ESI-MS peak 953.3300 1+ (predicted 953.3299 1+ for C58H45N6O8)  
The presence of this compound confirms that the dibranched isomer of the free amine exists. 
The number of pendants on this amine was greater than the number of equivalents of free 
anhydride added to the reaction mixture, making this compound less likely to form in favour of 
less substituted compounds. The steric bulk of the additional naphthalimides may also 
discourage the formation. Additionally, only one isomer of the desired amine could form this 
species, while the compounds with fewer naphthalimides could be formed from many of the 
isomers. These factors may explain the infrequent and low detection of this compound. Only 





The complexation ability of this compound was low as the only available donor atoms are 
tertiary nitrogen atoms and the steric bulk of the four pendants would likely preclude 
coordination to these nitrogen atoms. It was also possible that this compounds infrequent and 
low detection was due to the inability to become protonated from the steric hinderance and 
lower basicity of the tertiary nitrogen compared to the secondary nitrogen atoms available in 
other species.  
 
Figure E.12: Compound 2.9, ESI-MS peaks 486.1746 2+ and 971.3405 1+ (predicted 486.1741 2+ 
for C58H48N6O9 and 971.3404 1+ for C58H47N6O9) 
As for 2.8, the additional naphthalimides than the reaction stoichiometry as well as the steric 
bulk may disfavour this compounds formation. Despite this, this compound was frequently 
detected as at up to a relative intensity of 0.10. Interestingly, unlike compound 2.7, this 
compound was detected even after the crude material has been refluxed and therefore given an 
opportunity to equilibrate to the more stable imides, as was seen for compound 2.5. Detection 
of this compound may be better than for 2.8 due to the number of possible isomers (four) which 
arises from the greater number of free amine isomers that could lead to the formation of 
species matching this mass. The complexation ability of this compound was likely to be low.  
 
Figure E.13: Compound 2.10, ESI-MS peak 400.1664 2+ (predicted 400.1661 2+ for C48H44N6O6 





This compound was detected in the ESI-MS spectra at relative intensities of 0.08. There was just 
one isomer of this compound, possibly explaining the lower detection. As for compound 2.6, this 
compound was likely to be a poor ligand. 
 
Figure E.14: Compound 2.11 ESI-MS peak 439.2807 1+ (predicted 439.2822 1+ for C24H35N6O2) 
 
This compound was detected as a trace component. 
 
 
Compounds containing five nitrogen atoms 
 
Figure E.15: Compound 2.12, ESI-MS peak 370.2243 1+ (predicted 370.2243 1+ for C20H28N5O2) 
The formation of this compound should be disfavoured by the reaction stoichiometry but was 
detected in the reaction mixture at relative intensities up to 0.16. This was similar to the 
detection of 2.2. This compound has four possible isomers. 
Unfortunately, this compound was likely to be a better ligand than the desired compound as it 
possesses the same number of donor atoms but a lower steric bulk from the reduced number of 
pendants. Purification by complexation may not be able to remove this compound from the 
reaction mixture, and it was identified in the most enriched sample of the desired compound. 
 
Figure E.16: Compound 2.13, ESI-MS peaks 275.6263 2+ and 550.2456 1+ (predicted 275.6266 
2+ for C32H33N5O4 and 550.2455 1+ for C32H32N5O4) 
This compound was detected at relative intensities up to 0.28, which was expected considering 
the relative intensity of the free amine compared to the free hexamine in the crude amine was 





This compound had fewer donor atoms than the desired compound and was likely to be 
outcompeted for coordination to copper. 
  
 
Figure E.17: Compound 2.14, ESI-MS peak 365.6361 2+ (predicted 365.6372 2+ for C44H37N5O6) 
This compound was detected in trace amounts at relative intensities of 0.04 in various reaction 
fractions. There was only one isomer. This compound had fewer donor atoms than the desired 
compound, and additional steric bulk from the third naphthalimide, and was likely to be 
outcompeted for coordination to copper. 
 
Figure E.18: Compound 2.16, ESI-MS peak 374.6423 2+ (predicted 374.6425 2+ for C44H39N5O7) 
ESI-MS peaks corresponding to this mass were identified in trace amounts, with relative 
intensities up to 0.05. There are 8 possible isomers of this compound. This compound had fewer 
donor atoms than the desired compound so was likely to be a poorer ligand. 
 
 
Figure E.19: Compound 2.17, ESI-MS peak 198.6234 2+ (predicted 198.6239 2+ for C22H31N5O2) 
This peak was identified in various reaction fractions in trace amounts up to 0.04 relative 







Figure E.20 Compound 2.18, ESI-MS peaks 288.6334 2+ and 576.2598 1+ (predicted 288.6345 2+ 
for C34H35N5O4 and 576.2611 1+ for C34H34N5O4) 
The highest relative intensity seen for this compound was 0.12 and there was only one isomer. 
This compound had two poorer donor atoms than the desired compound and was likely to be 
outcompeted for coordination to copper. 
Compounds containing seven nitrogen atoms 
 
Figure E.21: Compound 2.19, ESI-MS peaks 318.6685 2+ (predicted 318.6688 2+ for C36H43N7O4) 
This compound had been detected by ESI-MS in amounts around 0.20 relative intensity. The 
heptamine was the largest peak aside from that of the desired hexamine in the free amine ESI-
MS, so it would be expected that this compound would be detected in reasonable amounts. 
Unfortunately, due to the greater number of donor atoms it was likely that this compound 
would outcompete the desired compound for complexation, and the free ligand was observed in 
the ESI-MS spectrum for the most enriched sample of the desired compound. This indicated that 
the purification by complexation was not able to sperate this compound from the desired ligand. 
 
Figure E.22: Compound 2.20, ESI-MS peaks 408.6787 2+ 816.3502 1+ (predicted 408.6794 2+ for 
C48H47N7O6 and 816.3510 1+ for C48H46N7O6)  
This compound was detected extensively throughout the reactions with a maximum relative 





available donor atoms, the same number as the desired compound. The steric bulk of the third 
pendant may make this compound a poorer ligand than the desired compound.  
 
Figure E.23: Compound 2.21, ESI-MS peak 417.6847 2+ (predicted 417.6847 2+ for C48H49N7O7 
and 834.3616 1+ for C48H48N7O7) 
This compound was also extensively detected in the ESI-MS in various reaction fractions at a 
relative intensity up to 0.28. As for 2.5 and 2.6, the amide was detected after the crude material 
had been at reflux. Similar to 2.20, this compound had five donor atoms, making it a potentially 
better ligand than the desired compound. The additional naphthalimide and tertiary nitrogen 
atom may mean the desired compound can outcompete this compound to coordinate copper.  
 
Figure E.24: Compound 2.22, ESI-MS peak 331.6756 2+ (predicted 331.6767 2+ for C38H45N7O4) 
The compound mass was detected in the ESI-MS spectra at relative intensities up to 0.28. This 
ligand had five donor atoms, more than the desired compound, two of which are constrained by 
the piperazine ring therefore potentially reducing the ability of this compound to complex. 
 
Figure E.25: Compound 2.23, ESI-MS peak 421.6866 2+ (predicted 421.6872 2+ for C50H49N7O6) 
The peak corresponding to this mass was detected with relative intensities up to 0.13. This 
compound contains both a ring constrained piperazine moiety as well as a third naphthalimide 
reducing the number of donor atoms. This indicates that this was likely to be a poorer ligand 






Figure E.26: Compound 2.24, ESI-MS peak 430.6930 2+ (predicted 430.6925 2+ for C50H51N7O7) 
The compound mass was detected in the ESI-MS spectra at relative intensities around 0.10. As 
for 2.23, this ligand had both ring strain, a tertiary nitrogen and steric strain and therefore was 
likely to be a poorer ligand than the desired compound. 
 
Compounds containing four nitrogen atoms 
These compounds contain fewer donor atoms than the desired compound which would 
therefore be likely to outcompete these compounds. The tetramine and piperazine-derived 
tetramine compounds were detected in low amounts in the free amine, 0.05 and 0.13 
respectively, and these compounds were detected in trace amounts. 
 
Figure E.27: Compound 2.25, ESI-MS peaks 254.1055 2+ and 507.2022 1+ (predicted 254.1055 
2+ for C30H28N4O4 and 507.2033 1+ C30H27N4O4) 
 
Figure E.28: Compound 2.26, ESI-MS peaks 177.1018 2+ and 353.1965 1+ (predicted 177.1028 





E.2 Complexes Detected 
Although the intention of this process was to isolate the desired compound through 
complexation and subsequent separation of the complexation product, the presence of other 
potentially better ligands indicated that the desired tetradentate ligand compound would not be 
isolated. The possibility for neutral complexes had been discussed previously in the relevant 
sections, yet as they were by nature undetectable by ESI-MS unless they became charged, it was 
unsurprising that no complex was detected.  
Future work to identify other complexes, including to determine the presence of neutral species, 
could involve the comparison of relative intensities of compounds in the crude material versus 
the complexation products to detect any reduction in the height of peaks that correspond to 
compounds forming neutral complexes. A better understanding of any complexes forming may 
allow for better refinement of the purification conditions. 
During the analysis of the various ESI-MS spectra across the reactions, the following copper 
complexes were detected (Figures E29-35): 
 
Figure E.29: Complex [Cu(2.1)]2+, ESI-MS peak 327.6047 2+ (predicted 327.6046 2+ for 
[Cu(C34H36N6O4)]2+). Largest relative intensity: 1.00. 
This was the complex of the desired compound for purification and was detected extensively 






Figure E.30: ESI-MS of [Cu(2.1)]2+, showing the isotope pattern for the native (above) and 
simulated (below) spectra. 
 
Figure E.31: Compound [Cu(2.19)]2+ ESI-MS peak 349.1258 2+ (predicted 349.1258 2+ for 
[Cu(C36H41N7O4)]2+). Largest relative intensity: 0.24. 
 
 Figure E.32: Compound [Cu(2.20)]2+, ESI-MS peak 439.1370 2+ (predicted 439.1364 2+ for 






Figure E.33: ESI-MS of [Cu(2.20)]2+, showing the isotope pattern for the native (above) and 
simulated (below) spectra. 
 
 
Figure E.34: Compound [Cu(2.21)]2+, ESI-MS peak 448.1413 2+ (predicted 448.1416 2+ for 






Figure E.35: Compound [Cu(2.27)]2+, ESI-MS peak 460.6548 2+ (predicted 460.6575 2+ for 






Appendix F. Additional Chapter 3 Discussion 
F.1 Cobalt Carbonate Complex Synthesis 
The reaction to produce the carbonate complex can be divided into two stages – formation of 
the cobalt starting material and reaction of this material with the ligand. The formation of the 
cobalt starting material had to be done immediately prior to using it as the K3[Co(CO3)3] complex 
degrades over time, shifting from the bright deep green to a brownish green142. This complex 
was synthesised and added to the reaction in two different ways. The literature method89 
describes taking the slurry of the complex produced and using it directly. This reaction produced 
KCl as a by-product, and using the slurry directly resulted in adding this KCl into the reaction with 
the ligand material. In order to avoid having to desalt the mixture, the green slurry produced 
from the reaction of cobalt chloride with potassium bicarbonate was filtered and rinsed with 
water to remove any residual salt. Some of the finer particles of the solid were lost during 
filtering, and further loss was experienced during the rinsing as the complex had a slight 
solubility in water. Unfortunately, the process of filtering appears to have degraded some of the 
material, as observed by the darkening of the filter cake. It also meant the amount of the 
product present was unknown due to the losses experienced during the filtering process. 
Filtering of the slurry was abandoned, and the slurry used directly. The reaction of this slurry 
with the ligand material resulted in the solution changing colour from the amber of dissolved 
ligand to sap green upon addition of the slurry and slowly to burgundy as the reaction proceeds. 
The reaction produced a solid and a liquor, which then formed an oil upon cooling. 
The solid from this reaction was a deep green colour, suggesting it contained excess starting 
material that did not react or starting material that degraded prior to interacting with the ligand 
material. This starting material itself would not be detected by ESI-MS in positive ion mode as it 
was a negatively charged species. Additionally, it may not be detected at all due to 
decomposition of the carbonates from the formic acid generally added to encourage ionisation 
during the ESI process. 
Aside from the discussed detection of the deprotonated ligand complex in both syntheses, there 
was also potential evidence of other complexes in this material – a complex of cobalt to the 
desired ligand with an ancillary hydroxide ligand (334.1068 2+, predicted 334.1079 2+ for 
[Co(C34H36N6O4)(OH)]2+) detected with a relative intensity of 0.37, as well as a peak possibly 
corresponding to the desired complex and an associated water molecule (which may also be a 
hydroxide and a hydrogen carbonate, 729.2101 1+, a higher error match for the predicted 





viable these complexes are to exist as both seem unlikely; the former due to the possibly five 
coordinate cobalt and the latter due to the error in the predicted monoisotopic mass. 
The reaction with enriched material showed evidence of unreacted starting material that was 
not observed in the crude ligand reaction. This was likely because the reactions were each 
performed using the amount of cobalt required to react with the ligand in a 1:1 ratio, assuming 
the entirety of the ligand material was the desired compound. In both cases this was untrue, but 
the true proportion was unable to be determined. The crude material was likely to be around 
30% desired compound, while the enriched ligand was likely to be around 80% of the mass of 
the solid. This would mean that the crude ligand procedure was likely performed at a 
substantially higher cobalt excess compared to the enriched ligand procedure.  
The enriched ligand procedure did not produce an oil upon cooling. This may be in part due to 
the greater reaction volume required by comparison to the scale. 
F.2 Cobalt Nitrite Complex Synthesis 
The reaction performed with excess cobalt and crude ligand material resulted in the production 
of the purest sample of the desired complex. The excess cobalt was used following the 
observation that the material had low solubility in methanol. Increased solid presence would 
give a greater surface area of the suspended powder in solution which was done to attempt to 
increase the chances of reaction with the dissolved ligand material.  
The reaction liquor still contained substantial amounts of the desired complex even following 
the formation of the oil. This indicates that more of the desired complex could be recovered 
from this liquor, either by concentrating further and allowing to stand, or by completely 
removing the solvent. The colour difference between the solution and the solid does, however, 
suggest that they may not be composed of the same compounds as the oil was an orangey 
brown, while the solution was a brighter orange. This may be due presence of starting material 
or due to the formation of neutral complexes. In this reaction, the predominant side products 
from the crude ligand material (2.3, 2.4) would again be poorer ligands than the desired 
compound. Due to both the ring strain and presence of additional tertiary nitrogen atoms 
compared to the desired compound, the side products may have fewer donor atoms. The 
desired complex had two nitrite ligands remaining from complexation of the ligand, forming a 1+ 
charge overall. If the side products complexed using fewer donor atoms, the complexes would 
potentially retain more of the nitrite ligands, forming neutral (or negative) species that would 





The stoichiometric cobalt reaction produced an oil upon cooling; however, it was a much 
brighter orange than the oil seen in the excess cobalt reaction and the composition of this oil 
appears to be very similar to the liquor itself. Unlike the previous reaction with excess cobalt, 
this oil contains a decent proportion of the tripendanted side product. There was also an oil that 
formed immediately in the bottom of the Buchner flask upon hot filtration of the reaction 
mixture. This oil also resembles the liquor and cooling oil in that it was predominantly composed 
of the side products from the crude ligand mixture.  
The reaction preformed using the enriched ligand material was performed on a much smaller 
scale than the previous reactions and produced slightly different results. The most notable 
difference was the lack of oil produced by cooling the reaction liquor. This may have occurred 
due to the slightly larger volume of methanol used than was proportional for the scale of the 
reaction encouraging the contents that would form the oil to instead remain in solution upon 
cooling. Another difference was the presence of blue solid in this reaction. This was presumed to 
be from the enriched ligand material, which retained some of the blue colour from the copper 
procedure. The reaction liquor was in this case similar to the orange solid collected on the filter 
paper. In the previous reactions the reaction liquor and the oil produced upon cooling were very 
similar, so it was possible that the oil did not form after filtering in this reaction but just prior to 
filtering instead. This reaction was performed on a much smaller scale than the previous 
reactions, which would allow it to cool a lot more rapidly. In each reaction the refluxing reaction 
mixture was cooled on the hot plate until the mixture had ceased boiling. The smaller scale of 
this reaction may have allowed it to cool down to the point of oil formation prior to filtering as 
opposed to afterwards as in the previous reactions. In the reaction liquor, remaining free ligand 
was detected suggesting that the reaction may not have been complete either due to 
insufficient cobalt starting material or insufficient reaction duration.  
The purest sample of the desired 2.1 dinitrito complex was detected in the excess cobalt 
synthesis at a possible 5-10% yield. While this was a low yield, the reaction was performed using 
the crude material. This means the yield may be greater than observed as the desired mass was 
only around 30% of the species detected in the crude reaction. The fact that the crude material 
was used for this reaction also reduces the impact that a low yield had as the cobaltinitrite 
material was purchased and could potentially be recovered due to its high aqueous solubility. 
The ligand material appeared to be enriched during this reaction which would reduce the 






Appendix G. Additional Chapter 4 Methods and Results 
G.1 Methods 
Repetition of reaction using excess 1,8-naphthalic anhydride 
The synthesis that led to crystal formation was repeated using excess 1,8-naphthalic anhydride 
(C12H6O3 15.00 g, 75 mmol), chloroform (35 mL) and 3,7,10,14-tetraazahexadecane-1,16-diamine 
(C12H32N6, 5 mL approx. 20 mmol) giving 19.92 g crude material. 
15 g of this crude material was then dissolved in methanol (150 mL) in a 500 mL round bottom 
flask and placed on a hot plate with a magnetic stirrer. The flask was fitted with a condenser and 
the reaction mixture brought to reflux. Copper sulfate (CuSO4∙5H2O, 4.66 g, 18.7 mmol) was 
dissolved in warm methanol (125 mL) and added dropwise down the condenser. The reaction 
was refluxed for four hours. Once cool, the liquor (275 mL) was decanted and the solid in the 
round bottom flask was treated with EDTA by adding 300 mL of distilled water and returning the 
flask to reflux. Solid disodium EDTA (Na2C10H14N2O8∙2H2O, 6.96 g 18.7 mmol) was added in five 
roughly equal portions to the refluxing mixture and the flask neck rinsed with 5 mL of distilled 
water. The reaction mixture was refluxed for three hours producing a bright blue solution and a 
brown oily solid. 
Separately, the methanolic liquor was allowed to stand for one week to encourage crystal 
formation. The liquor was then decanted off the solid that formed, leaving the solid in a small 
amount of liquor to be analysed by powder diffraction. The liquor that was decanted was placed 
in a 500 mL round bottom flask and returned to reflux. Solid disodium EDTA 
(Na2C10H14N2O8∙2H2O, 6.96 g 18.7 mmol) was added in five roughly equal portions to the 
refluxing mixture and the flask neck rinsed with 5 mL of methanol. The reaction was refluxed 
overnight, producing a turquoise solution and a beige solid. 
G.2 Results 
Repetition of Crystallisation Conditions 
Synthesised Naphthalimide Ligand Material 
Largest peak unable to be assigned, many unassignable peaks 
Mass:  [M +2H+] 2+: m/z 401.1712 2+ (predicted 401.1739 2+ for C48H46N6O6)  
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 410 (predicted 410.1792 2+ for C48H48N6O7)  
Relative Intensity: 0.99 
[M +2H+] 2+: m/z 311 (predicted 311.1633 2+ for C36H42N6O4)  





[M +2H+] 2+: m/z 199.0398 1+ (predicted 199.0395 1+ for C12H7O3)  
Relative Intensity: 0.23 
Copper Complexation Solid 
Mass:  [M +2H+] 2+: m/z 401.1720 2+ (predicted 401.1739 2+ for C48H46N6O6)  
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 311.1624 2+ (predicted 311.1633 2+ for C36H42N6O4)  
Relative Intensity: 0.69 
[M +2H+] 2+: m/z 199.0399 1+ (predicted 199.0395 1+ for C12H7O3)  
Relative Intensity: 0.06 
[M +2H+] 2+: m/z 410 (predicted 410.1792 2+ for C48H48N6O7)  
Relative Intensity: 0.06 
C36H40N6O4Cu 341.6204 2+, not detected. 
C48H44N6O6Cu 431.6309 2+, not detected. 
C36H42N6O4CuSO4 390.6040 2+, C36H41N6O4CuSO4 780.2003 1+, not detected.  
C48H46N6O6CuSO4 480.6146 2+, C48H45N6O6CuSO4 960.2214 1+, not detected. 
Copper Complexation Solution 
Mass:  [M +2H+] 2+: m/z 311.1622 2+ (predicted 311.1633 2+ for C36H42N6O4) 
[M +1H+] 1+: m/z 621.3166 1+ (predicted 621.3189 1+ for C36H41N6O4) 
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 199.0393 1+ (predicted 199.0395 1+ for C12H7O3)  
Relative Intensity: 0.36 
[M +2H+] 2+: m/z 410.1759 2+ (predicted 410.1792 2+ for C48H48N6O7)  
Relative Intensity: 0.12 
[M +2H+] 2+: m/z 401 (predicted 401.1739 2+ for C48H46N6O6)  
Relative Intensity: 0.06 
Excess Anhydride 
Synthesised Naphthalimide Ligand Material 
Many unassignable peaks 
Mass:  [M +2H+] 2+: m/z 401.1713 2+ (predicted 401.1739 2+ for C48H46N6O6)  
Relative Intensity: 0.17 
[M +2H+] 2+: m/z 410.1770 (predicted 410.1792 2+ for C48H48N6O7)  
Relative Intensity: 0.97 
[M +2H+] 2+: m/z 311.1622 (predicted 311.1633 2+ for C36H42N6O4)  
Relative Intensity: 0.49 





Copper Complexation Solid 
Mass:  [M +2H+] 2+: m/z 311.1613 2+ (predicted 311.1633 2+ for C36H42N6O4)  
[M +1H+] 1+: m/z 621.3166 1+ (predicted 621.3189 1+ for C36H41N6O4) 
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 401.1707 2+ (predicted 401.1739 2+ for C48H46N6O6)  
Relative Intensity: 0.73 
[M +2H+] 2+: m/z 410.1758 2+ (predicted 410.1792 2+ for C48H48N6O7)  
Relative Intensity: 0.36 
[M +2H+] 2+: m/z 199.0392 (predicted 199.0395 1+ for C12H7O3)  
Relative Intensity: 0.06 
Copper Complexation Liquor 
Mass:  [M +2H+] 2+: m/z 311.1625 2+ (predicted 311.1633 2+ for C36H42N6O4)  
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 410.1770 2+ (predicted 410.1792 2+ for C48H48N6O7)  
Relative Intensity: 0.21 
[M +2H+] 2+: m/z 199.0401 (predicted 199.0395 1+ for C12H7O3)  
Relative Intensity: 0.20 
[M +2H+] 2+: m/z 401 2+ (predicted 401.1739 2+ for C48H46N6O6)  
Relative Intensity: 0.01 
Complexation Liquor Post EDTA Solid 
Mass:  [M +2H+] 2+: m/z 311.1626 2+ (predicted 311.1633 2+ for C36H42N6O4)  
[M +1H+] 1+: m/z 621.3177 1+ (predicted 621.3189 1+ for C36H41N6O4) 
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 410.1769 2+ (predicted 410.1792 2+ for C48H48N6O7)  
Relative Intensity: 0.22 
[M +2H+] 2+: m/z 401 2+ (predicted 401.1739 2+ for C48H46N6O6)  
Relative Intensity: 0.01 
[M +2H+] 2+: m/z 199.0398 (predicted 199.0395 1+ for C12H7O3)  
Relative Intensity: 0.06 
Complexation Liquor Post EDTA Solution 
Mass:  [M +2H+] 2+: m/z 311.1610 2+ (predicted 311.1633 2+ for C36H42N6O4)  
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 410.1754 2+ (predicted 410.1792 2+ for C48H48N6O7)  
Relative Intensity: 0.92 
[M +2H+] 2+: m/z 401 (predicted 401.1739 2+ for C48H46N6O6)  





[M +2H+] 2+: m/z 199.0386 (predicted 199.0395 1+ for C12H7O3)  
Relative Intensity: 0.06 
C36H40N6O4Cu 341.6204 2+, possible trace. 
Complexation Solid Post EDTA Solid 
Mss: [M +2H+] 2+: m/z 401.1720 2+ (predicted 401.1739 2+ for C48H46N6O6)  
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 199.0394 1+ (predicted 199.0395 1+ for C12H7O3)  
Relative Intensity: 0.20 
[M +2H+] 2+: m/z 311.1618 2+ (predicted 311.1633 2+ for C36H42N6O4)  
Relative Intensity: 0.16 
[M +2H+] 2+: m/z 410 (predicted 410.1792 2+ for C48H48N6O7)  
Relative Intensity: 0.01 
Complexation Solid Post EDTA Solution 
Mass: [M +2H+] 2+: m/z 311.1621 2+ (predicted 311.1633 2+ for C36H42N6O4)  
[M +2H+] 2+: m/z 621.3182 1+ (predicted 621.3189 1+ for C36H41N6O4) 
Relative Intensity: 1.0 
[M +2H+] 2+: m/z 401.1714 2+ (predicted 401.1739 2+ for C48H46N6O6)  






Appendix H. Additional Chapter 4 Discussion 
H.1 Amine Starting Material 
The number of peaks in the 13C NMR spectrum of the amine stating material shows six 
inequivalent carbon environments, which was expected for the linear compound 4.1. The 
branched compound 4.2, however, would likely have seven inequivalent carbon environments. 
The number of peaks in the 13C spectrum indicates that there was presence of at least one other 
compound (approximately one third as much as the main species, representing 25% of the 
mixture present based on integrals) yet the number of peaks of this height was greater than the 
expected seven so they cannot be assigned.  
 
H.2 Crude Ligand Material 
A substantial amount of branched amine 4.2 was present in the starting material which lead to 
formation of a trinaphthalimide species. Both the dinaphthalimide 4.3 and trinaphthalimide 4.4 
species were detected by ESI-MS, with either present as the major peak across the syntheses. A 
compound mass matching that of a compound with two naphthalimide groups and a 
naphthalamide, 4.5, was also detected. This was more likely to be the product of additional 
substitution to the linear dinaphthalimide 4.3, as it appears that the primary amines react with 
naphthalic anhydride before the secondary amines (as observed by the crystal structure and in 





that could only have formed if a secondary amine reacted without both primary amines reacting 
first. Therefore this peak cannot be attributed solely to the additional reaction to 4.3, but the 
majority was assumed to have arisen from this source as the presence of 2.7 in the previous 
chapter was inconsistent and often low. 
Complexation of Ligand Material 
The copper complex 4.5 was not detected by ESI-MS. This ligand may also form a copper 
complex with a sulfate ancillary ligand, resulting in a neutral complex that was not detected. This 
seems unlikely given that the analogous tetradentate dinaphthalimide ligand 2.1 formed a 
charged complex with copper as detected by ESI-MS. The reason for the lack of detection of this 
compound was unknown.  
Reproduction of Crystallisation Conditions 
Following the structural elucidation of the crystallised compound, efforts were focussed on 
reproducing the result. This is useful for multiple reasons – if the compound could be reliably 
crystallised it would allow the ligand to be collected in a very pure form. So far the evidence 
suggests that the 4.4 compound was formed from a minor component of the starting material, 
and as such its use for further syntheses was limited even if it was relevant for use in 
heterodinuclear complex synthesis unless it can be readily purified. Additionally, reproducibility 
indicates whether the complex formed was a consistent observation or if it was a random event 
caused by an irreproducible environment.  
During the repetition, the reaction scale and duration were maintained but the method of 
heating was switched from a steambath to a hotplate as the hot plate had fewer issues with 
effective use. The repeat reaction was visually indistinguishable from the original throughout. 
When the copper reaction liquor was allowed to stand once the reaction was complete, the 
liquid did not produce crystals as was observed in the first reaction but instead resulted in 
formation of a pale blue powder that resembled the colour of the crystals collected previously. 
This solid was collected and work to compare the powder diffraction pattern to the crystal 
structure is ongoing. 
In both reactions, the peak corresponding to 4.4 was the major peak, with small amounts of the 
other reaction components. The 4.3 species was detected predominantly in the solution. As 
mentioned previously, the copper complex of 4.4 was not detected directly in either reaction, 







The synthesis of the crystallised complex showed that the amine starting material was not 
composed solely of the named compound. The material observed by crystallography indicated 
that a branched species was also present in the reaction mixture, and NMR was insufficient to 
determine the proportions of the compounds. To determine what proportion of the amine 
starting material was present, the mechanochemical reaction to produce the ligand was 
repeated using excess naphthalic anhydride. If the relative intensities of the dinaphthalimide 
and trinaphthalimide species shifted further towards the trinaphthalimide species, then this 
would indicate greater presence of the branched isomer. 
The relative intensity of ligand 4.3 to ligand 4.4 product mass in the original stoichiometry was 
0.61:1.0 as observed by ESI-MS. This indicated that there were still substantial amounts of a 
dinaphthalimide species present. Following the reaction with excess anhydride, the relative 
intensity of the 4.3 to 4.4 peaks went from 0.61:1.0 to 0.49:0.17. This suggested that the amount 
of 4.4 had actually decreased. The formation of a dinaphthalimide with an additional 
naphthalamide, 4.5, was also observed in the reaction mixture and went from 0.99 relative 
intensity in the initial reaction (approximately the same amount as 4.4) to 0.97 in the excess 
anhydride reaction (five times that of 4.4) when observed by ESI-MS. As free anhydride was 
detected in both ESI-MS spectra, the evidence indicates that the branched isomer was likely a 
minor component of the reaction which corresponds to the NMR interpretation. 
The excess anhydride reaction was also followed through with treatment of the complexation 
liquor and solid with EDTA. This was done to determine if either of the major species (the 
trinaphthalimide and the dinaphthalimide) could be isolated using the purification by 
complexation technique covered in Chapter 2. Upon complexation, the trinaphthalimide 4.4 
species is detected as the major species in the complexation solid, while the dinaphthalimide 4.3 
and the dinaphthalimide with the additional naphthalamide 4.5 were the predominant species in 
the complexation liquor. Following removal of copper with EDTA, the same trend continued, 
with the dinaphthalimide detected as the major species in both the solid and the solution 
produced following treatment of EDTA, and the trinaphthalimide appearing as the major species 
in the solid produced following treatment of the complexation solid following treatment with 
EDTA. This suggests that the complexation by purification technique could be employed to 
separate these compounds for further studies, including the use of the enriched dinaphthalimide 
for cobalt complexation. 
